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 THE CITY UNIVERSITY OF NEW YORK 
ABSTRACT 
 
Oxocarbenium Ion and Alkene Metathesis Strategies for the 












Mentor: Professor David R. Mootoo 
 
Highly oxygenated cyclohexanes comprise the structures of a number of 
pharmacologically interesting molecules, including potently bioactive natural products 
and carbapyranosides. The latter, which are unnatural analogues of carbohydrates in 
which the ring oxygen of the parent sugar is replaced with a methylene group, have 
attracted interest as hydrolytically stable mimetics of their parent O-glycosides.  This 
research reports the development of two general methodologies for the synthesis of 
  
v 
highly oxygenated cyclohexanes: (1) Oxocarbenium Ion Cyclization (OCC) and (2) Ring 
Closing Metathasis (RCM).  
Chapter one gives a review of the literature on the synthesis for highly 
oxygenated cyclohexanes. 
Previous results from this laboratory have shown that OCCs on cyclic 
oxocarbeniums derived from 1-thio-1,2-O-isopropylidene precursotrs are highly 
stereoselective for cyclohexanes and tetrahydropyrans  with cis 3,4-diols. To expand the 
scope of the OCC methodology, the goal was to evaluate the OCCs on non-cyclic 
oxocarbenium ions derived from mixed thioacetal precursors. Chapter two describes 
reactions with alkene nucleophiles.  In particular, the OCC on an alkene-mixed thioacetal 
precursor aimed at the cyclohexane core of the immunosuppressive agent FR65814, was 
examined. This study revealed that OCCs on non-cyclic oxocarbenium ions could deliver 
cyclohexanes with trans 3,4-diols in high stereoselectivety. As for the previous 
observations on OCCs with cyclic oxocarbenium ions, these results can be explained in 
terms of conformational arguments.   
Chapter three discusses OCCs for non-cyclic oxocarbenium ions and enol-ether 
nucleophiles. These reactions were expected to give highly oxygenated cyclic enol ether 
precursors for carba- and C- pyranosides with trans 3,4-diols. However, in all cases, 
complex mixtures of products that suggested multiple deleterious pathways from the 
initial formed cyclization intermediates, was observed. This result contrasts to the 
successful OCCs involving cyclic oxocarbenium ions and enol ethers, and suggests that 
conformational rigidity is an important requirement for OCCs involving enol ether 
  
vi 
nucleophiles. Therefore, the OCC strategy appears to be limited to the synthesis of carba- 
and C- pyranosides with cis-3,4-vicinal diols. 
Chapter four describes a more general synthesis of carbapyranosides, which is 
based on the RCM of an enol ether – alkene substrate. This reaction delivers a six-
membered cyclic enol ether in which the enol ether oxygen is exocyclic, and contrasts 
with a related cyclization from the Postema group that provides C-1-substituted glycals, 
i.e. cyclic enol ethers with an endocyclic enol ether oxygen. This RCM strategy for 
carbapyranosides was applied to the carba-arabinose and carba-xylose analogues of the 
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1.1 Introduction 	  
Carbasugars represent a class of carbohydrate analogues in which the ring oxygen 
of a parent sugar has been replaced with a “CH2” group [Figure 1.1].1 - 5 Because of the 
structural similarities between a carbasugar and its parent sugar, the carbasugar has the 
potential to function like the parent sugar and may even confer favorable properties in 
relation to biological applications.  In particular the replacement of the ring oxygen with 
a methylene group leads to stability to chemical and enzymatic degradation, a feature that 
is relevant to the interrogation of pathways involving glycoside hydrolysis and the 
development of stable drugs. Conformational differences between carbasugars and their 
parents are also relevant to the use of carbasugars as structure-activity probes.6 – 10  
 
 
Figure 1.1 O- and carba pyranosides 	  
In this context, the structure and function of carbasuagrs have been extensively studied.11 
- 14 In a broader sense, carbasugars may be considered as polyhydroxylated cyclohexanes. 
Consequently, many of the methods used for the synthesis of carbasugsrs are 
modifications of strategies that were first developed for complex naturally occurring 
cyclohexanes [Figure 1.2].14, 15 - 21  	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Figure 1.2 Naturally occurring polyhydroxylated cyclohexanes 	  
This thesis research reports on new synthetic methods for highly oxygenated 
cyclohexanes. This chapter reviews the biological activities and synthesis of 
carbapyranosides and related polyoxygenated cyclohexanes.  	  
1.2 Biological Activities 	  
Given their structural similarities to their parent O-glycosides, carbasugars may 
interact with carbohydrate-processing enzymes as well as other protein receptors.22 - 24 As 
such, carbasugars could potentially act as mimetics in inhibiting or promoting a variety of 
carbohydrate mediated biological pathways, and may have drug applications. For 































Validoxylamine A 1.7: R1, R2 = H
Validoxylamine B 1.8: R1 = H; R2 = OH
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equivalent carba-β-D-glucopyranose 1.3.22, 23 Cyclophellitol 1.4, a naturally occurring 
carbasugar-like molecule is a potent inhibitor of β-glucosidases, and is potentially active 
against HIV target enzymes.24  
Carbasugars can also exist as subunits of more complex bioactive compounds 
[Figure 1.2]. For example acarbose 1.5 is an α-amylase inhibitor used for treatment of 
type ΙΙ insulin-independent diabetes.25 Naturally occurring carbasugar-like molecules also 
have potent biological properties. The novel immunosuppressant FR65814 1.6 with its 
highly functionalized cyclohexane core, is known to suppress the immune response at 
low concentration.26 Compounds 1.7 – 1.11 belong to a family of antibiotics known as the 
validamycins.27, 28  
 Carbasugars 1.12 – 1.15 were prepared by McCasland and coworkers and is often 
used as building blocks for alkylated derivatives like 1.16 and 1.17, and other more 
complex molecules.29 Compounds 1.16 and 1.17 are examples of unnatural carbasugars 
[Figure 1.3]. They are used as primers for the process of biocombinatorial glycosylation 
in B16 mouse melanoma cells.30  
The greater hydrolytic stability of the pseudo- glycosidic bond to both acidic and 
enzymatic cleavage make carbasugar analogues of bioactive carbohydrates attractive as 
metabolically stable drugs. For the same reason carbasugars cannot be processed by 
glycosidases and transferases, but because they bind to these enzymes with similar 
affinity as their parent sugars, can inhibit their activity.  
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Figure 1.3 Unnatural carbasugars and carba-derivatives 	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This property is relevant to drug applications. For example, the α-amylase 
inhibitor 1.5, is a carbasugar containing tetrasaccharide, used in the treatment of type II 
insulin-independent diabetes.25 Carbasugar derivatives 1.18 - 1.20 also exhibit potent α-
glucosidase inhibitory effects [Figure 1.4].31  
	  
1.3 Synthesis 	  
Carbasugars have been synthesized from: sugar precursors and non-sugar 
precursors. Starting the synthesis with a sugar usually guarantees the enantiomeric purity 
of the carba derivative. The presence of hydroxyl groups that can be related to those in 
the product is an additional advantage. However, selective functionalization of the OH 
groups can be problematic. Generally the stereoselective introduction of the methylene 
group in the carbasugar is the most challenging operation. This can be accomplished in 
the course of, or prior to the ring forming reaction.   
The more popular strategies used in the synthesis of highly oxygenated cyclohexanes 
include:  1. Nucleophilic Cyclization 2. Electrophilic Cyclization 3. Radical Cyclization 4. Ring-Closing Olefin Metathesis (RCM) 5. Cycloaddition 6. Claisen Rearrangement 7. Microbial Oxidation of Arenes 8. Modification of naturally occurring precursors  
	   7	  
The methods will be illustrated for the synthesis of carbapyranose, but for the most part 
can also be used for carbafuranoses.14 
	  
1.3.1 Nucleophilic Cyclization 	  
This approach generally involves the base promoted intramolecular addition of a 
stabilized anion to an aldehyde (X = H) or ketone (X = alkyl or aryl group) [Scheme 1.1]. 
Examples of the different nucleophilic reactions are shown in Figure 1.5.  
 
Scheme 1.1 Generalized nucleophilic addition strategy 
 
1.3.1.1 Phosphorus-Stabilized Carbanions 	  
Paulsen and co-workers reported the intramolecular Horner-Emmons reaction on 
keto-phosphonate 1.25 to generate enone 1.26 [Figure 1.5 A].  Reduction of the ketone 
and alkene in 1.26 followed by alcohol protecting group operations gave a mixture of 
four diastereomeric carbapyranosides 1.27.32 The cyclization precursor 1.25 was obtained 




















X = H, alkyl, aryl
Y = anion stalilization group
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1.3.1.2 Carbonyl-Stabilized Carbanions 	  
An example is the sequence of enolate reactions in the reaction of the iodo 
compound 1.29 and the mono sodium salt of dimethyl malonate. Treatment of the 
product with pyridine and acetic anhydride provided the acetate 1.30 as the major 
product. Krapcho decarboxylation conditions on 1.30 led to decarboxylation and 
elimination of the acetate giving the α,β-unsaturated ester, which was transformed to 5a-
carba-α-L-mannopyranose penta acetate 1.31. Several other related enolate strategies on 
sugar-derived substrates have been reported.33 - 41 
Casiraghi and co-workers have developed a versatile version of this approach 
from non-carbohydrate precursors. Thus the aldehydo-lactone 1.34 was obtained in six 
steps starting with the vinylogous cross-aldolization of furan 1.32 and glyceraldehyde 
derivative 1.33 [Figure 1.5 C].42 The base promoted cycloaldolyzation on 1.34 produced 
the carbasugar derivative 1.35. This approach was also applied to carbafuranosides.  An 
analogous strategy from 5-siloxy-thiophene and pyrrole was used to prepare thiol and 
amino containing carbasugars.43, 44 	  
1.3.1.3 Nitro-Stabilized Carbanions 	  
This strategy was used by Kitagawa and co-workers to prepare carbapyranosides 
[Figure 1.5 - D]. The cyclization precursor 1.38, which was obtained in four steps from 
the furanose derivative 1.37, was first refluxed in AcOH to remove the isopropylidene.  
	   9	  
 
Figure 1.5 Representative nucleophilic cyclizations 
 
Then, on treatment with NaOH in methanol 1.39 was produced. Radical-mediated 
denitration followed by removal of the isopropylidene under acidic conditions yielded 
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from the key nitro-intermediate 1.39.46 More recently, a completely stereoselective 
intramolecular nitroaldol condensation leading to carbasugars, was reported by Estevez 
and co-workers.47 
	  
1.3.1.4 Ferrier Carbocyclization on hex-5-enopyranosides  	  
The Ferrier carbocyclization reaction is a metal catalyzed rearrangement of enol 
ether pyrans to cyclohexanones.48 - 50 An example is the rearrangement of 1.42 to 1.43 in 
the presence of mercury (ΙΙ) chloride [Figure 1.4 – E]. 	  	  
 
Scheme 1.2 Ferrier Carbocyclization 
 
The first step is the hydroxymercuration of the vinyl ether moiety in 1.42. Loss of 
methanol from the resulting hemiacetal 1.42a gives the dicarbonyl intermediate 1.42b. 
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cyclohexanone 1.43 [Scheme 1.2].  This strategy has being applied to a variety of 
different substituted cyclohexanes, including amino-substituted derivatives.51 - 56  	  
1.3.1.5 Nucleophile Opening of Epoxides  	  
Epoxides have also been used as electrophiles in nucleophilic cyclizations. An 
example is the silicon-induced domino reaction starting from bis-epoxide 1.45 and the 
dithiane 1.46 [Figure 1.5 – F]. Nucleophilic opening at the methylene carbon of one 
epoxide, followed by a 1,4-Brook rearrangement, and then intramolecular opening of the 
second epoxide at the secondary carbinol gave cyclohexane 1.47. Protecting group 
operations followed by dithioketal hydrolysis gave the cyclohexanone 1.48, which was 
converted in a straightforward fashion to a mixture of carbapyranosides 1.49. Schaumann 
and co-workers also applied this strategy in their preparation of highly oxygenated 
cyclohexanes.49 
 
1.3.2 Electrophilic Cyclization 	  
The synthesis of highly oxygenated cyclohexanes has also being achieved by 
electrophilic cyclizations in which an intermediate cation is trapped by pi – nucleophile. 
[Scheme 1.3]. 
The more well known variations of this strategy are:  
I. Triisobutylaluminium (TIBAL)-Induced Electrophilic Cyclization  
II. Oxocarbenium Ion-Enol Ether Cyclization 
III. Mukaiyama-type Aldol Cyclization reaction. 
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Scheme 1.3 Generalized electrophilic cyclization 	  
1.3.2.1 Rearrangement of Hex-5-enopyranosides 	  	  
An example of this strategy is the TIBAL-mediated reductive rearrangement of 
1.54 to give a highly functionalized cyclohexane 1.55.57 Activation of the ring oxygen 
with TIBAL leads to formation of the furfuryl cation and an aluminium coordinated 
enolate. An enolate-cation cyclization gives a cyclohexanone intermediate, which 
undergoes reduction to give the cyclohexanol 1.55 [Scheme 1.4]. One major advantage 
of this approach is that the reaction proceeds with retention of the stereochemistry at C-1 
where the aglycon moiety remains intact. It is also interesting to note that with 
Ti(OiPr)Cl3 the rearrangement can occur without reduction of the keto function.58 The 
success of this rearrangement of C-glycosides to carbasugars, is heavily dependent on an 
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Scheme 1.4 TIBAL Rearrangement of Hex-5-enopyranoside 
	  
1.3.2.2 Oxocarbenium Ion- Enol Ether Cyclization 	  
The OCC reaction has been used in a stereoselctive synthesis of carbaglycoside 
1.63. The synthesis starts with the 1-thio-1,2-isopropylidene acid 1.57 and alcohol 1.58 
which can either be a sugar or non-sugar moiety [Scheme 1.5] to give ester 1.59. Tebbe 
methylation on 1.59 gave the cyclization precursor 1.60. Exposure of 1.60 to methyl 
triflate (MeOTf) and 2,6-di-tert-butyl-4-methylpyridine (DTBMP) in anhydrous CH2Cl2 
led to 1.62. This reaction is believed to go via an oxocarbenium ion intermediate 1.61. 
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Scheme 1.5 OCC Synthesis of C-1-substituted Carbasugars 	  
1.3.2.3 Mukaiyama-Type Aldol Cyclization 	  
This strategy was applied in the SnCl4-promoted aldol-type cyclization of 
silylenol ether 1.65 to generate a carbasugar substrate 1.66 [Scheme 1.6]. Treatment of 
1.66 with n-Bu3SnLi and HCHO resulted in desulfonylation, which was followed by 
reduction and protection groups operations to give the highly functionalized cyclohexane 
1.67.61 This strategy has also being used in the synthesis of aminocarbasugars62 and 
carbasugar derivatives.63  
 
 



















1.59 X = O
1.60 X = CH2
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1.3.3 Radical Cyclization 	  
The radical-induced cyclization reaction has been used as a key step in the 
synthesis of highly oxygenated cyclohexane derivatives [Scheme 1.7]. An example is the 
Bu3SnH-promoted 6-exo-trig radical ring closure on the iodo alkene 1.69 which produced 
the oxygenated methyl cyclohexane 1.70.64 Also, samarium (II) iodide initiated pinacol 
coupling on dialdehyde 1.72 resulted in the polyoxygenated cyclohexane 1.73.65 This 
radical cyclization strategy has been applied to other carbasugar derivatives.66 - 75  
 
 
Scheme 1.7 Radical cyclization 	  
1.3.4. Ring-Closing Olefin Metathesis 	  
With the advantage of easy to handle catalysts that work efficiently with a variety 
of functional groups, the RCM strategy emerged as a key step in the synthesis of 
carbapyranosides. There are four general RCM approaches for making carbasugars 
[Figure 1.6].76 - 80 The resulting cyclohexenes can be further manipulated to give more 
substituted carbapyranoside derivatives. The RCM reaction has also been used in the 
































1.72 R1 = CHO; R2 = O
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Figure 1.6 Ring Closing Metathesis 	  
1.3.5. Cycloaddition Reaction 	  
An example is the Diels-Alder cycloaddition of furan 1.83 and maleic anhydride 
1.84 to give the 7-oxanorbornene 1.85 [Scheme 1.8]. The cyclo adduct 1.85 is then 
hydroxylated and after protecting group operations, provided the carbasugar 1.86.81 
Cycloaddition reactions have been used extensively to make carbasugars and carbocyclic 
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Scheme 1.8 Carbasugars from 7-oxanorbornene derivatives 	  
1.3.6 Claisen Rearrangement 	  
Claisen rearrangement of the C-5 pyrano-glycal 1.88 provided an efficient entry 
to the carbocycle 1.89, which was hydroxylated to give carbasugar 1.86 [Scheme 1.10].87 
 
Scheme 1.9 Claisen Rearrangement reaction to make carbasugar 
 
1.3.7 Aromatic Derivatives 	  
Microbial oxidation of arene 1.117 gave rise to cyclohexadiene diol 1.118, which 
has been used to synthesize carbasugars [Scheme 1.11]88. This strategy was employed in 
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Scheme 1.10: Synthesis of carbasugar from Aromatic compound 	  
1.3.8 From Natural Sources 	  
Carbapyranoside derivatives have also been prepared from naturally occurring 
molecules such as quinic acid,91 shikimic acid92 and cyclitols93 [Figure 1.7]. Their rich 




































(-)-Quinic acid 1.94(-)-Shikimic acid 1.93
Myo-Inositol 1.95
1.86
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1.4 Conclusion 	  
Development of novel synthetic strategies for the synthesis of pseudo-sugars and 
their structure activity relationship (SAR) studies is an area of organic chemistry that 
continues to expand. The most popular methodologies reported in the literature were 
briefly outlined in this chapter. However, there is still a need for general and efficient 
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2.1 Background 	  
FR65814 2.1 is a novel sesquiterpene, which was isolated from the culture broth 
of Penicillium jensenii F-28331. Unlike other members of its family, which are potent 
anti-angiogenesis agents,2-5 2.1 exhibits a different biological activity and is an 
immunosuppressant.6 These compounds have a highly oxygenated cyclohexane ring with 
multiple stereogenic centers and two epoxides [Figure 2.1]. Their biological effects as 
well as structural complexity have led to interest in their synthesis.7 – 11 
 
Figure 2.1 FR65814 and structurally similar natural products 
Chida and coworkers reported the first total synthesis of 2.1.10b In this approach 
the cyclohexane framework was constructed from commercially available 4,6-O-
benzylidene-α-D-glucopyranoside 2.8 [Scheme 2.1]. One of the key steps was a 
Hg(OCOCF3)2 catalyzed Ferrier carbocyclization-elimination sequence on 2.9 to give 
cyclohexenone 2.10 in 84% yield.12,13 Reduction of 2.10 under Luche conditions14 
proceeded stereoselectively to give the allylic alcohol, which was protected as the THP 
ether. The acetyl group was then removed with sodium methoxide and the resulting 
FR65814 2.1
Fumagillin 2.6: R = C(O)CH=CH)4CO2H

















Ovalicin 2.4:  R = Me
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Scheme 2.1 Chida’s synthesis of FR65814 	  
hydroxyl group was deoxygenated via xanthate ester to give 2.11. The THP protecting 
group was removed with pyridinium p-toluenesulfonate in ethanol then a Johnson-
Claisen rearrangement on the resulting allylic alcohol derivative, provided the ethyl ester 
2.12. Saponification of 2.12 and an iodolactonization-deiodination sequence on the crude 
acid provided the γ lactone 2.13 as a single product.15 In preparation for elaboration of 
the side chain, a Wittig olefination was next performed on the lactol derivative of 2.13. 
This was followed by silylation of the resulting alcohol, then a hydroboration-
perruthenate oxidation sequence on the alkene portion of the silyl ether derivative to give 
aldehyde 2.14.16 One of the most problematic steps was the stereoselective synthesis of 
the E-alkene in 2.15. First, 2.14 was converted to the silyl enol ether which was then 
oxidized with stoichiometric amount of Pd(OAc)2 to provide the α,β-unsaturated 
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1. DIBALH, then Ph3PCH3Br, nBuLi2. TBSOTf, 2,6-lutidine
3. BH3.THF, then H2O2, NaOH4. TPAP, NMO, 61% (4 steps)








3. VO(acac)2, t-BuOOH 50% (3 steps)
2.17
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minor product (8% yield).17 The next big challenge was the spiroepoxide formation. 
DIBALH reduction of aldehyde 2.15 followed by desilylation on the crude alcohol 
afforded a diol derivative. The primary alcohol was selectively protected as the silyl ether 
and the cyclohexanol was oxidized to the cyclohexanone. Treatment of the 
cyclohexanone with a stabilized sulfur ylide gave spiro epoxide 2.16 as a single 
diastereomer.18 A Stille coupling of the iodide derivative 2.17 with isobutenyltributlytin 
further lengthened the side chain and regioselective epoxidation of the homoallylic 
alcohol led to FR65814, 2.1. The major drawbacks to the Chida’s synthesis are: the 
overall yield is very low (0.8 %) and the synthetic sequence is lengthy - over 34 steps 
from 2.8.  
Yamaguchi and coworkers later reported a more concise synthesis (15 steps) of 
2.1 [Scheme 2.2].19 The Yamaguchi approach also provided RK-805 2.2 and Fumagillol 
2.7.  The key reaction was the L-proline catalyzed asymmetric α-aminoxylation20 on the 
ketone 2.18, which afforded 2.19 in 93% yield and greater than 99% ee. Because of the 
easy access to the starting material, the reaction was performed on large scale. However, 
subsequent elaboration to 2.1, 2.2 and 2.7 was not straightforward. Thus, the 
diastereoselective epoxide construction from the carbonyl 2.19 was problematic because 
of facile racemization and low selectivity. Both the one-step epoxidation with a sulfur 
ylide and the conventional two-steps Wittig olefination-epoxidation sequence yielded 
unfavorable results. After much experimentation, the cyano bis(trimethylsilyl) ether 2.20 
was obtained in moderate yield but high diastereoselectivity. The cyanohydrin derivative 
2.20 set the stage for the subsequent diasteroselective construction of the spiro-expoxide 
moiety of 2.24. First, a two steps transformation of the cyanide 2.20 to the diol derivative 
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was performed with DIBALH then all protecting groups were removed in the presence of 
acid amberlyst in THF/H2O with concomitant dehydration to afford a cyclohexenone diol 
derivative. The primary alcohol was selectively protected to give the silyl ether 2.21. 
 
Scheme 2.2 Yamaguchi’s synthesis of FR65814, RK-805 and Fumagillol 
 
 The next challenge was the stereoselective construction of the side chain. To 
overcome this hurdle, a Michael addition of a vinyl zincate to the α,β-enone 2.21 was 
performed and the Michael addition product was trapped as the silyl-enol ether 2.22. 
Dimethyl dioxirane (DMD) epoxidation of the silyl-enol ether 2.22 proceeded in a 
diastereoselective fashion without any further oxidation of the tri-substituted alkenes. The 
silyl ether was next transformed to the tosylate 2.23. The end game strategy involved the 
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2.22
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important for optimal stereoselectivity. Thus, regioselective VO(acac)2/TBHP mediated 
epoxidation of 2.23 was followed by treatment with K2CO3 in MeOH to generate the 
spiroepoxide 2.24. Diastereoselectivity was reduced when the bis-epoxidation sequence 
was reversed. Bis-epoxide 2.24 was converted to FR65814 (and other members of the 
ovalacin family) as shown in Scheme 2.2. 	  
This thesis work focuses on an oxocarbenium-alkene cyclization strategy for the 
cyclohexane core of 2.1 and related frameworks. This chemistry builds on earlier 
oxocarbenium ion-alkene cyclizations from this laboratory. Thus, the mixed-thioacetal-
alkene 2.25, when treated with methyl triflate gave the cyclohexane 2.27 as a single 
diastereomer in which the isopropenyl appendage was anti to the syn isopropylidene 
residue [Scheme 2.3].21 The cyclization presumably occurs via the cyclic oxocarbenium 
ion intermediate 2.26. The important aspects of the key transformation (2.25 è  2.27) 
are: (1) 2.25 is prepared from readily available material; (2) the synthesis is high 
yielding; (3) a single alkene regioisomer is produced as one of four possible 
diastereomers.   
The stereoselectivity is explained in terms of the transition state (TS) intermediate 
2.26 which has the largest number of equatorial substituents of a chair like structure, and 
is presumably the lowest energy TS [Figure 2.2].  
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Figure 2.2 OCC Transition states intermediates - cyclic precursor 
The other TS 2.29, 2.31, and 2.33 are less favored because they all had one or more 
substituents in the pseudo-axial position on a chair-like TS, or involved a trans-fused five 
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The more substituted alkene 2.36 was not observed. One possible reason is A(1,3) strain in 
the TS 2.35 leading to 2.36 [Scheme 2.4]. Another reason could be kinetic deprotonation 
of 2.35 that favors formation of 2.27. 
 
Scheme 2.4 Oxocarbenium Ion Cyclization 
The OCC product 2.27 was subsequently converted to 2.28, which constituted a 
formal synthesis of Fumagillin.22 Given the structural similarity of Fumagillin and 
FR65814 we envisaged a synthesis of FR65814 from a similar OCC strategy on 2.37 
[Scheme 2.5].  
 
Scheme 2.5 Oxocarbenium ion-alkene cyclization - non-cyclic precursor 
 
The expected stereoselectivity in the OCC for 2.37 follows a similar rationale to 
the result for the Fumagillin precursor 2.25. The main difference is that the mixed 
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oxocarbenium ion intermediate 2.26 dictates the cis stereochemistry in the eventual 
isopropylidenedeoxy residue. In the non-cyclic case however, the absence of ring strain 
should favor the TS 2.38 which has all the substituents in the equatorial position. TS 
2.41, 2.43 and 2.45 are less favored, because they contain one or more substituents in an 
axial position [Figure 2.3]. 
 
Figure 2.3 OCC Transition state intermediates - non-cyclic precursor 
 
When 2.39, the product from the non-cyclic oxocarbenium ion, is compared to 
2.27, the product from the cyclic oxocarbenium ion, the relative stereochemistry for the 
neighboring chiral carbons are the same except at positions C3/C4. At positions C1/C2 
and C2/C3, the relative stereochemistry is trans whereas, in 2.39 the relationship at 
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Table 2.1 Relative stereochemistry of 2.23 versus 2.39 
 
Therefore, we hypothesize that the OCC on 2.37 should generate 2.39 as the 
only/major product. The compound 2.39 can be transformed to 2.47 using a similar 
sequence that was used for the analogous transformation in the Fumagillin series 
[Scheme 2.6].23 A very closely related analogue of 2.47 was transformed to FR65814 in 
Chida’s synthesis. Thus 2.39 is a potential precursor to FR65814.  
 


































cf: 2.27 → 2.28
cf: 2.15 → 2.1
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2.2 Results and Discussion 	  
2.2.1	  Synthesis	  of	  OCC	  Precursor	  
	  
For the mixed thioacetal 2.37, commercially available 3,4-dihydro-2H-pyran 2.48 
was first treated with catalytic osmium tetroxide and NMO to give the hemiacetal 2.49 in 
75% yield [Scheme 2.7]. Treatment of 2.49 with benzenethiol, under acidic conditions 
gave α-hydroxy dithioacetal 2.50 (98%). The primary hydroxyl group in 2.50 was then 
protected as the pivalate ester to give 2.51 in 88% yield.   The secondary alcohol in 2.51 
was next protected as the benzyl ether 2.52 in 98% yield. Treatment of the thioacetal 2.52 
with acetic acid and NIS furnished the acetoxy phenylthioacetal 2.53 in 90% yield, as 
predominantly a single diastereomer (dr = 5:1). Compound 2.53 was then carefully 
treated with benzyl alcohol and catalytic BF3.Et2O to give the mixed thioacetal 2.54 in 
84% yield, as mainly one acetal diastereomer (dr = ca 4:1). Treatment of 2.54 with 
DIBAL-H followed by DMP oxidation of the resulting alcohol gave the aldehyde 2.56 in 
88% yield over two steps. Aldehyde 2.52 was then treated with 2-methylpropenyl 
lithium. 
	   31	  
 
Scheme 2.7 Synthesis of non-cyclic OCC precursor 
Derivatization of the product as its silyl ethers furnished the epimeric products 2.37 and 
2.37’ as an approximate 1:1 mixture (70% yield over two steps).  This mixture was 
inseparable. 
	  
2.2.2 OCC Studies 
	  
The mixed thioacetal-alkene mixture 2.37/2.37’ was subjected to the OCC 
reaction conditons used in earlier studies: methyl triflate, 2,6-di-t-butyl-4-methylpyridine, 
CH2Cl2, molecular sieves, 24 h. This reaction produced in 84% yield, an inseparable 
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diastereomers, after desilylation of the mixture to give alcohols 2.61, 2.62 and 2.63 
[Scheme 2.9]. Alcohol 2.61 was purified as a single product [Figure 2.5], but 2.62 and 
2.63 was an inseparable mixture in a respective ratio of 2:3. The alcohols were obtained 
in 99% yield and the ratios of 2.61:2.62:2.63 was 70:18:12.  
 
 
Scheme 2.8 OCC reaction on 2.37/2.37’ 
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Scheme 2.9 Alcohol derivatives of the OCC products 
The relative stereochemistry of 2.61, 2.62 and 2.63 were assigned by analysis of J values 
for vicinal protons on the cyclohexane ring. The large J values in 2.61 (J1,2 =10.4, J2,3 = 
10.6, J3,4 =10.5 Hz) supported a diastereomer with all the substituents in the equatorial 
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Figure 2.5 1H NMR spectrum of 2.61 
Observation of a NOE between H1 and H3, and H2 and H4 also supported this 
assignment of the relative stereochemistry of the cyclohexane in 2.61 [Figure 2.6].  
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Figure 2.6 Conformational analysis of 2.61 
 NMR	  analysis	  was	  also	  done	  on	  the	  2.62/2.63	  mixture	  [Figure 2.8]	  and	  the relative 
stereochemistry assigned by analysis of J values for vicinal protons on the respective 
cyclohexane rings. Values	   of	   J1,2 = 2.6, J2,3 = 10.4, and J3,4 = 11.8 Hz supported 
structure 2.62, with the C2, C3, and C4 substituents in the equatorial positions and the C1 
group in the axial position. Similarly, the J values for 2.63 (J1,2 = 2.7, J2,3 = 2.5, and 
J3,4 = 2.8 Hz) supported C1, C3 axial substituents and C2 and C4 equatorial groups. A 
NOE between H2 and H4 in both 2.62 and 2.63 supported the assigned structures [Figure 
2.7]. 
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Figure 2.8 1H NMR spectrum of 2.62/2.63 mixture 
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This data means that the OCC on 2.37 gave a single diastereomer 2.39, whereas the 
epimeric substrate 2.37’ afforded a 1:1 mixture of two products 2.57 and 2.58 [Scheme 
2.10]. This result is consistent with our earlier prediction and suggests that 
conformational effects are a major influence on the stereochemistry of these OCCs 
[Figure 2.3]. The synthetic remification of the result is that the synthesis of 2.37 
essentially constitute a highly diastereoselective synthesis of the cyclohexane core of 
FR65814. 
 
Scheme 2.10 OCC results on 2.37/2.37’ 	  
2.3 Future Work 	  
Based on the foregoing results, a streamlined and enantioselective synthesis 
of 2.69 can be conceived for FR65814 [Scheme 2.11]. 	  
2.4 Conclusion  	  
The OCC strategy on a non-cyclic mixed thioacetal-alkene provides a highly 
stereoselective route to an advanced precursor for FR65814. The complementary 
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suggest that the OCC reaction is potentially a potent method to generate stereochemically 
complex cyclohexanes and THPs. To expand on the scope of this methodology, enol 
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2.5 Experimental 	  
General Information:  	  
All reactions were carried out in oven-dried glassware under an atmosphere of 
nitrogen or argon using standard syringe and septa technique, unless otherwise noted. 1H 
NMR and 13C NMR spectra were recorded at 500 or 400 MHz at ambient temperature 
with CDCl3, C6D6 as the solvent unless otherwise stated. Chemical shifts are relative to 
CDCl3 (1H, 7.27; 13C, 77.2), C6D6 (1H, 7.16; 13C, 128.4) or TMS (1H, 0.00) and are 
reported in parts per million. 1H COSY experiments were used to assigned signals for 
selected nuclei and all 13C NMR spectra were recorded with complete proton decoupling. 
High and low-resolution mass spectra were obtained using a Finnegan MAT-90 
spectrometer.  
Flash column chromatography (FCC) was performed using 200-400 mesh silica 
gel (Scientific Absorbents, Inc.) and employed a stepwise solvent polarity gradient 
correlated with mobility on thin layer chromatography (TLC). Thin layer 
chromatography was done on 0.25 mm silica gel HF254 alumina sheets (Whatman), and 
the chromatograms were observed under ultra violet light and were visualized by heating 
the TLC plate after it was dipped in ammonium molybdate solution. 
Product yields refer to chromatographically and spectroscopically pure materials, 
unless reported otherwise.  Standard procedures were used to purify solvents when 
necessary. Petroleum ether refers to the fraction of petroleum ether boiling between 40 
and 60 OC and ether is diethyl ether. 
 




BF3.Et2O (12.9 mL, 0.1 mol) was slowly added to a mixture of 2.4926, (12.0 g, 0.1 
mol) and benzenethiol (20.9 mL, 0.2 mol) in anhydrous CH2Cl2 (200 mL) at 0 OC under 
an atmosphere of argon. The reaction mixture was slowly brought to rt while being 
monitored by TLC. After 1 h, TLC showed the complete disappearance of the starting 
material. The reaction was then quenched by adding saturated aqueous NaHCO3 and the 
product extracted with EtOAc. The combined organic phase was dried (Na2SO4), filtered, 
and concentrated under reduced pressure to yield a crude oil. FCC of the residue gave 
2.50 (31.5 g, 98%): Rf = 0.51 (40% EtOAc/petroleum ether); 1H NMR (500 MHz, C6D6) 
δ 1.47-1.53 (m, 2H), 1.55-1.63 (m, 1H), 1.75-1.82 (m, 2H), 2.90 (bs, 1H), 3.46 (m, 2H), 
3.63 (m, 1H), 4.26 (d, 1H, J = 4.3 Hz), 7.08-7.30 (m, 6H), 7.41-7.12 (m, 6H), 7.23-.27 
(m, 4H); 13C NMR (125 MHz, CDCl3) δ 29.5, 30.9, 62.9, 67.1, 72.9, 128.1, 128.3, 129.3, 





Pivaloyl chloride was added dropwise at 0 OC to a mixture of 2.50 (10.0 g, 31.3 
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dichloromethane under and atmosphere of argon. The reaction mixture was stirred and 
maintained at 0 OC until TLC indicated complete disappearance of the starting material. 
The mixture was then poured into water and the aqueous phase extracted with EtOAc. 
The combined organic phase was washed with brine, dried (Na2SO4), filtered, and 
concentrated in vacuo, to give a crude oil. FCC of the residueal oil gave 2.51 (10.0 g, 
88%): Rf = 0.54 (20% EtOAc/petroleum ether); 1H NMR (500 MHz, CDCl3) δ 1.17 (s, 
9H), 1.64-1.76 (m, 2H), 1.78-1.85 (m, 1H), 1.88-1.93 (m, 1H), 2.65 (d, 1H, J = 5.2 Hz), 
3.78 (m, 1H), 4.04 (td, 2H, J = 1.70, 6.35 Hz), 4.41 (d, 1H, J = 4.40 Hz), 7.26-7.29 (m, 
6H), 7.40-7.44 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 25.5, 27.4, 30.3, 39.0, 64.2, 67.3, 
70.8, 72.5, 109.4, 128.3, 128.4, 129.3, 129.4, 133.0, 133.03, 134.0, 134.03, 178.7; 
ESIHRMS (M+Na)+ calculated for C22H28O3S2Na 427.1398, found 427.1364. 
 
4-(benzyloxy)-5,5-bis(phenylthio)pentyl pivolate (2.52) 
 
 	  
NaH (1.9 g, 60% in mineral oil, 47.0 mmol) was carefully added to a solution of 
2.51 (8.5 g, 23.5 mmol) in dry DMF (80 mL) at 0 OC under an argon atmosphere. The 
reaction mixture was allowed to warm to rt and stirred for an additional 0.5 h. Bu4NI (0.9 
g, 2.4 mmol) was then added. The reaction mixture was re-cooled to 0 OC and BnBr (3.4 
mL, 28.2 mmol) was slowly added. The ice bath was removed and the reaction was kept 
at rt until TLC indicated complete disappearance of the starting material. After 2 h the 
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diethyl ether and the combined organic phase was washed with brine, dried (Na2SO4), 
filtered, and concentrated in vacuo. FCC of the crude residue yielded 2.52 (10.1 g, 98%): 
Rf = 0.61 (10% EtOAc/petroleum ether); 1H NMR (500 MHz, CDCl3). δ 1.19 (s, 9H), 
1.51-1.56 (m, 1H), 1.73-1.86 (m, 2H), 1.93-2.00 (m, 1H), 3.68-3.71 (dt, 1H, J = 3.30, 
8.95 Hz), 3.97 (td, 2H, J = 1.80, 6.50 Hz), 4.41 (d, 1H, J = 11.75 Hz), 4.55 (d, 1H, J = 
3.20 Hz), 4.57 (d, 1H, J = 11.70 Hz), 7.16-7.18 (m, 2H), 7.23-7.27 (m, 9H), 7.32-7.34 
(m, 2H), 7.39-7.41 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 25.5, 27.5, 27.8, 39.0, 63.8, 
64.0, 72.7, 80.4, 127.9, 128.0, 128.1, 128.4, 128.6, 129.2, 129.3, 132.8, 133.0, 135.0, 
135.1, 138.0, 178.8; ESIHRMS (M+Na)+ calculated for C29H34O3S2Na 517.18, found 
517.19. 
 
5-acetoxy-4-(benzyloxy)-5-(phenylthio)pentyl pivolate (2.53) 	  	  
 	  
To a mixture of 2.52 (9.4 g, 20.8 mmol) and glacial acetic acid (9.5 mL, 0.2 mol) 
in dry DCM (104 mL) was added NIS (9.8 g, 41.7 mmol). The reaction mixture was 
stirred at rt for 3 - 4 h. The reaction mixture was then poured into a saturated aqueous 
Na2S2O3. The phases were separated and the aqueous phase extracted with 
dichloromethane. The combined organic phase was washed with saturated aqueous 
NaHCO3, washed with brine, dried (Na2SO4), filtered, and concentrated in vacuo, 
yielding a crude oil. The oil was purified by FCC to give 2.53 (7.4 g, 90%): Rf = 0.60 
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1H), 1.74-1.85 (ovrlp m, 3H), 2.03 (s, 3H), 3.69 (m, 1H), 3.98-4.04 (m, 2H), 4.47 (d, 1H, 
J = 11.4 Hz), 4.75 (d, 1H, J = 11.5 Hz), 6.38 (d, 1H, J = 2.8 Hz), 7.27-7.32 (m, 9H), 7.44-
7.46 (m, 2H); 13C NMR (125 MHz, CDCl3, major isomer) δ 21.3, 25.1, 27.4, 39.0, 64.1, 
72.6, 79.8, 83.0, 128.1, 128.4, 128.6, 129.4, 132.9, 133.7, 137.9, 170.1, 178.8; 13C NMR 
(125 MHz, CDCl3, minor isomer) δ 24.8, 27.7, 64.1, 73.4, 79.3, 82.7, 128.2, 128.6, 129.3, 
132.9; ESIHRMS (M+Na)+ calculated for C25H32O5SNa 467.1898, found 467.1866. 
 
4,5-bis(benzyloxy)-5-(phenylthio)pentyl pivolate (2.54) 
 
 	  
To a mixture of 2.53 (5.0 g, 12.5 mmol) and benzyl alcohol (2.6 mL, 24.9 mmol) 
in anhydrous dichloromethane (100 mL), was added BF3.Et2O at 0 OC under and inert 
atmosphere. The reaction was slowly warmed to rt and was followed by TLC. After TLC 
indicated the disappearance of the starting material, the reaction was quenched with 
saturated aqueous NaHCO3. The mixture was then extracted with diethyl ether, dried 
(Na2SO4), filtered, and concentrated in vacuo to give a crude oil. FCC of the oil yielded 
2.54 (6.2 g, 84%): Rf = 0.5 (10% EtOAc/petroleum ether); 1H NMR (500 MHz, CDCl3) δ 
1.15 (s, 9H), 1.57-1.73 (m, 2H), 1.75 (m, 2H), 3.64 (q, 1H, J = 5.5 Hz), 3.97 (m, 2H), 
4.42 (d, 1H, J = 12.0 Hz), 4.50 (d, 1H, J = 12.0 Hz), 4.59 (d, 1H, J = 10.7 Hz), 4.81 (d, 
1H, J = 4.2 Hz), 4.88 (d, 1H, J = 11.8 Hz), 7.17-7.19 (m, 2H), 7.23-7.27 (ovrlp m, 11H), 
7.41-7.43 (m, 2H); 13C NMR (125 MHz, CDCl3, major isomer) δ 24.8, 27.4, 39.0, 64.4, 
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135.1, 137.3, 138.4, 178.8; 13C NMR (125 MHz, CDCl3, minor isomer) δ 25.0, 28.2, 
64.38, 70.77, 72.8, 73.9, 80.9, 92.2, 127.8, 127.94, 127.98, 128.35, 128.39, 128.48, 





A 1 M solution of DIBAL-H in heptane (18.6 mL, 18.6 mmol) was added 
dropwise over 10 min. to a solution of 2.53 (5.0 g, 9.3 mmol) in anhydrous CH2Cl2 (50 
mL), at -78 OC, under an argon atmosphere. The reaction was allowed to warm to rt and 
mentained at this temperature for an additional hour. The mixture was then cooled to 0 
OC and a saturated aqueous solution of Rochelle’s salt was added with vigorous stirring 
until a clear mixture was obtained. The phases were then separated and the aqueous phase 
extracted with EtOAc. The organic phase was dried (Na2SO4), filtered, and concentrated 
in vacuo, to give the crude alcohol 2.55 (4.0 g, quant.): Rf = 0.5 (20% EtOAc/petroleum 
ether); 1H NMR (500 MHz, CDCl3) δ 1.50 (bs, 1H), 1.56-1.70 (m, 2H), 1.78 (ddt, 2H, J = 
1.6, 2.0, 5.7 Hz), 3.57 (t, 2H, J = 2.70 Hz), 3.69 (q, 1H, J = 4.7 Hz), 4.45 (d, 1H, J = 11.4 
Hz), 4.50 (d, 1H, J = 11.8 Hz), 4.62 (d, 1H, J = 11.4 Hz), 4.86 (d, 1H, J = 4.4 Hz), 4.90 
(d, 1H, J = 11.8 Hz), 7.1890-7.2073 (m, 2H), 7.2479-7.2836 (m, 13H), 7.4259-7.4524 
(m, 2H); ); 13C NMR (125 MHz, CDCl3, major isomer) δ 27.5, 28.9, 63.1, 70.8, 72.8, 
81.0, 92.3, 127.6, 127.9, 128.0, 128.4, 128.44, 128.56, 128.57, 129.3, 133.2, 135.1, 137.3, 
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128.60, 129.18, 129.22, 129.26, 133.62, 33.62, 135.14; ESIHRMS (M+Na)+ calculated 




The crude alcohol 2.55 (3.20 g, 6.44 mmol) was dried by removal of the benzene-
water azeotrope, then dissolved in dry dichloromethane (40 mL). DMP (5.5 g dissolved 
in 10.9 mL of DCM, 12.9 mmol) was added to the mixture and the reaction was stirred at 
rt for 4 h, under an argon atmosphere. The reaction was quenched by addition of 
saturated aqueous NaHCO3 and mixture extracted with CH2Cl2. The combined organic 
phase was dried (Na2SO4), filtered, and concentrated in vacuo, yielding a crude oil. FCC 
of this material afforded 2.56 (2.9 g, 88% from 2.54): Rf = 0.58 (20% EtOAc/petroleum 
ether); 1H NMR (500 MHz, CDCl3) δ 2.05 (dt, 2H, J = 1.1 Hz, J = 7.1 Hz) 2.42 (td, 2H, J 
= 1.6, 7.2 Hz), 3.68 (q, 1H, J = 5.6 Hz), 4.38 (d, 1H, J = 11.4 Hz), 4.52 (d, 1H, J = 11.9 
Hz), 4.58 (d, 1H, J = 11.4 Hz), 4.81 (d, 1H, J = 4.4 H z), 4.90 (d, 1H, J = 11.9 Hz), 7.19-
7.28 (m, 4H), 7.26-7.28 (m, 9H), 7.43-7.45 (m, 2H), 9.64 (t, 1H, J = 1.6 Hz); 13C NMR 
(125 MHz, CDCl3 major isomer) δ 23.7, 40.0, 70.9, 72.8, 80.1, 91.9, 127.8, 128.0, 128.1, 
128.46, 128.48, 128.56, 128.6, 129.3, 133.3, 134.9, 137.2, 138.2, 202.4; 13C NMR (125 
MHz, CDCl3 minor isomer) δ 24.7, 40.31, 70.98, 73.85, 80.19, 92.2, 127.96, 128.06, 
128.23, 128.35, 128.48, 128.61, 128.63, 129.23, 133.7, 134.94, 137.19, 138.22, 202.22; 
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Mixed thioacetal cyclization precursor (2.37/2,37’) 	  
 	  
To a solution of (Z)-1-bromo-1-propene (0.2 mL, 1.6 mmol) in anhydrous diethyl 
ether (2 mL), at -78 OC, was added t-BuLi (1.1 mL of a 1.7 M solution in pentane, 1.9 
mmol) under an inert atmosphere. The reaction was maintained at this temperature 1 hr 
then allowed to warm to -40 OC. The solution of 2-methylpropenyl lithium formed was 
cannulated into a solution of aldehyde 2.56 (130 mg, 0.30 mmol) in dry ether (1.5 mL) 
and cooled to -40 OC, under an argon atmosphere. The reaction mixture was kept at -40 
OC for 30 min then warmed to rt and stirred at this temperature for 0.5 h. The reaction 
was then quenched by the addition of a saturated aqueous NH4Cl and the aqueous phase 
extracted with ether. The organic extract was washed with brine, dried (Na2SO4), filtered, 
and concentrated in vacuo.  FCC of the residue gave a mixture of allylic alcohols (101 
mg) as a yellow oil: Rf = 0.52 (20% EtOAc/petroleum ether); 1H NMR (500 MHz, C6D6) 
δ 1.15-1.22 (m, 1H), 1.34 (dd, 1H, J = 3.7, 8.9 Hz), 1.43 (ovlrp s, 4H), 1.49 (q, 1H, J = 
7.4 Hz), 1.54 (s, 3H), 1.61 (s, 3H), 1.65-1.68 (m, 2H), 3.60 (m, 1H), 4.20 (m, 1H), 4.37-
4.43 (ovlrp m, 2H), 4.55 (d, 1H, J = 11.5 Hz), 4.76 (dd, 1H, J = 1.5, 4.5 Hz), 4.81 (d, 1H, 
J = 11.8 Hz), 5.03 (d, 1H, J = 6.8 Hz), 7.10-7.13 (m, 2H), 7.16-7.19 (ovrlp m, 14H, Ar-
C6D6 solvent peak), 7.35-7.37 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 18.5, 26.0, 27.1, 
27.4, 33.7, 33.8, 68.9, 70.8, 72.9, 81.2, 92.6, 127.6, 127.8, 128.0, 128,2, 128.4, 128.5, 








t-BuLi, Et2O, -78 OC
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The product (100 mg, 0.2 mmol) from the previous step, TBDPSCl (0.1 mL, 0.2 
mmol) and imidazole (24.7 mg, 0.4 mmol) in dry DMF (1 mL) was stirred under argon 
for 3 h. The reaction mixture was then diluted with water and extracted with ether. The 
organic extract was dried (Na2SO4), filtered and evaporated under reduced pressure. The 
crude product was purified by FCC to give a 1:1 ratio of 2.37:2.37’ (140 mg, 70% from 
2.56) as a yellow oil: Rf = 0.64 (20% EtOAc/petroleum ether); 1H NMR (500 MHz, 
C6D6) δ 0.92 (s, 10H), 0.98 (s, 3H), 1.13-1.25 (m, 3H), 1.43 (s, 7H), 1.58-1.67 (m, 2H), 
3.47-3.53 (m, 1H), 4.18-4.25 (m, 1H), 4.32-4.39 (ovrlp m, 2H), 4.49 (dd, 1H, J = 3.4, 
11.4 Hz), 4.68 (d, 1H, J = 4.8 Hz), 4.78 (dd, 1H, J = 5.7, 11.7 Hz), 4.99-5.02 (m, 1H), 
7.06-7.09 (m, 2H), 7.12-7.23 (ovlrp m, 30H, Ar buried under C6D6 solvent peak), 7.24-
7.28 (m, 5H), 7.53-7.56 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 18.1, 18.2, 19.5, 22.6, 
25.7, 26.7, 27.2, 27.3, 70.7, 70.8, 70.9, 72.9, 80.7, 81.3, 81.4, 92.9, 93.0, 127.4, 127.6, 
127.7, 127.8, 127.9, 128.2, 128.3, 128.4, 128.5, 128.6, 128.7, 129.1, 129.4, 129.6, 133.1, 
136.1, 136.2, 138.6, 138.8, 151.6, 165.0. 	  
OCC products (2.39, 2.57, 2.58) 
 	  
The mixture of silyl ethers 2.37/2.37’ (80 mg, 0.1 mmol), 2,6-di-tert-butyl-4-
methylpyridine (0.2 g, 1.0 mmol), and freshly activated powdered 4A molecular sieves 
(160 mg) in anhydrous dichloromethane (3 mL), was stirred for 15 min at rt, under an 
argon atmosphere, then cooled to 0 OC. Methyl triflate (0.1 mL, 0.8 mmol) was then 
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which time, Et3N (0.1 mL) was added. The mixture was then diluted with ether, washed 
with saturated aqueous NaHCO3 and brine, dried (Na2SO4), filtered and evaporated under 
reduced pressure. The residue was subjected to FCC to give an inseparable mixture of 
2.39, 2.57 and 2.58 (56.6 mg, 84%): Rf = 0.6 (20% EtOAc/petroleum ether); 1H NMR 
(500 MHz, CDCl3) δ 0.74-0.81 (m, 5H), 0.91 (s, 23H), 1.14-1.25 (m, 5H), 1.29-1.33 (m, 
1H), 1.45 (s, 3H), 1.50 (s, 3H), 1.52-1.57 (m, 2H), 1.60 (s, 4H), 1.65-169 (m, 2H), 1.72-
1.77 (m, 1H), 2.26 (t, 1H, J = 10.5 Hz), 2.78 (t, 1H, J = 10.4 Hz), 2.97 (dd, 1H, J = 2.7, 
11.3 Hz), 3.15 (dd, 1H, J = 8.8, 10.8 Hz), 3.27-3.32 (m, 1H), 3.38 (td, 1H, J = 4.6, 10.6 
Hz), 3.46 (td, 1H, J = 4.3, 10.6 Hz), 3.65 (d, 1H, J = 2.2 Hz), 4.23 (d, 1H, J = 12.0 Hz), 
4.41 (dd, 2H, J = 10.7, 12.1 Hz), 4.49 (s, 3H), 4.52 (d, 2H, J = 7.6 Hz), 4.70 (d, 1H, J = 
10.6 Hz), 4.83 (d, 2H, J = 9.6 Hz), 4.86 (bs, 1H), 4.90 (bs, 1H), 7.13-7.22 (m, 21H), 7.23-
7.28 (m, 13H), 7.29-7.35 (m, 5H). 	  
 
Cyclitols (2.61, 2.62, 2.63) 	  	  
 	  
A solution of the mixture of 2.39, 2.57 and 2.58 (50 mg, 0.084 mmol) and Bu4NF 
(1.0 M in THF, 0.2 mL) in THF (0.5 mL) and was stirred at rt for 12 h, then concentrated 
in vacuo. FCC of the residue produced 2.61 (20.9 mg, 70%) and an inseparable mixture 
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For 2.61: Rf = 0.58 (20% EtOAc/petroleum ether); 1H NMR (500 MHz, C6D6) δ 
1.21-1.32 (m, 2H), 1.72 (s, 3H), 1.87 (bs, 1H), 1.99-2.10 (m, 2H), 2.14 (t, 1H, J = 10.5 
Hz), 3.38 (dd, 1H, J = 8.8 Hz, J = 10.7 Hz), 3.46 (ovrlp m, 2H), 4.53 (d, 1H, J = 10.9 
Hz), 4.61 (q, 2H, J = 11.5 Hz), 4.86 (d, 1H, J = 11.0 Hz), 4.97 (bs, 1H), 5.05 (t, 1H, J = 
1.5 Hz), 7.20-7.32 (ovrlp m, 10H, Ar- C6D6 signal) 
For 2.62: Rf = 0.58 (20% EtOAc/petroleum ether); 1H NMR (500 MHz, C6D6) δ 
0.79 (t, 1H, J = 6.9 Hz), 0.88 (d, 1H, J = 8.4 Hz), 1.21 (m, 1H), 1.52-1.58 (m, 1H), 1.48 
(bs, 1H), 1.71 (s, 3H, Me), 2.32 (dd, 1H, J = 2.5, 10.8 Hz), 3.53 (ovrlp m, 2H), 3.95 (td, 
1H, J = 4.1, 10.8 Hz), 4.32 (s, 2H), 4.34 (d, 1H, J = 12.4 Hz), 4.48 (d, 1H, J = 12.1 Hz), 
4.89 (s, 1H), 4.95 (s, 1H), 7.14-7.26 (ovrlp m, 10H, partially buried under C6D6 solvent 
signal).    	  
For 2.63: Rf 1H NMR (500 MHz, C6D6) δ 0.75-0.81 (ovrlp m, 4H), 0.91 (m, 18H), 
1.16-1.25 (ovrlp m, 4H), 1.29-1.33 (m, 1H), 1.45 (s, 2H), 1.50 (s, 2H), 1.52-1.57 (m, 1H), 
1.60 (s, 3H), 1.65-1.69 (m, 2H), 1.72-1.77 (m, 1H), 2.26 (t, 1H, J = 10.1 Hz), 2.78 (t, 1H, 
J = 10.1 Hz), 2.97 (dd, 1H, J = 2.7, 11.3 Hz), 3.14 (dd, 1H, J = 8.8, 10.8 Hz), 3.30 (m, 
1H), 3.38 (td, 1H, J = 4.6, 10.8 Hz), 3.46 (td, 1H, J = 4.4, 10.6 Hz), 3.65 (bs, 1H), 4.23 
(d, 1H, J = 12.1 Hz), 4.40 (d, 1H, J = 12.1 Hz), 4.43 (d, 1H, J = 10.8 Hz), 4.49 (s, 2H), 
4.52 (d, 1H, J = 7.4 Hz), 4.70 (d, 1H, J = 10.8 Hz), 4.82-4.86 (ovrlp m, 3H), 4.90 (bs, 
1H), 7.13-7.8 (ovrlp m, 6H), 7.23-7.27 (ovrlp m, 4H), 7.29-7.35 (ovrlp m, 4H), 7.55-7.61 
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3.1 Introduction 	  
To extend the scope of OCC’s with non-cyclic oxocarbenium ions, we next 
examined the cyclization, with enol ether nucleophiles instead of simple alkenes (Scheme 
3.1). The enol ether reaction was previously shown to be successful for OCCs on cyclic 
isopropylidene oxocarbenium ions 3.2, but has not been tested on non-cyclic 
oxocarbenium ions 3.6.1 Key attributes of the enol ether cyclization are the versatility of 
the enol ether products. In addition, the method may be applicable to disaccharide 
frameworks (ie. when R is a sugar residue).  	  
 
Scheme 3.1 OCC with enol ether nucleophiles 	  
Thus, in the OCC from cyclic mixed thioacetal-enol ether like 3.1, the pseudo 
disaccharide 3.4, where R is a sugar ring, was prepared.  The key OCC was promoted 
using methyl triflate (MeOTf) and gave the cyclic enol ether 3.3a as the only region- and 
diastereo- isomer. Neither the alkene regioisomer 3.3b nor the trans- isopropylidinedioxy 


















cyclic mix thioacetal enol-ether











































3.3b (not observed) pseudo disaccharidewhen R = Sugar
3.4
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and or torsional effects that are related to the cyclic acetal.2 Stereoselective 
hydroboration-oxidation on 3.3a provided 3.4 as the only diastereomer in 94% yield 
[Scheme 3.1 A].  
In applying the OCC strategy to non-cyclic mixed thioacetal-enol ether systems like 
3.5 [Scheme 3.1 B]. There are three major concerns: 
1. Will the reaction be as high yielding as for the 1,2-O-isopropylidene systems?  
2. Will the reaction be regioselective, for the allylic product 3.7a over the 
homoallylic isomer 3.7b? 
3. Will the reaction be stereoselective, for the trans vicinal dialkoxy product over 
the cis product? 
The disaccharide variation of these OCCs is also attractive for the synthesis of C-
disaccharides. Both carba- and C-disaccharides are of interest as non-hydrolyzable 
bisubstrate transition state mimetics of glycosyl processing enzymes. 3-7 Thus they have 
the potential to act as specific inhibitors of glycosidases and glycosyl transferases. 
Because of their conformational differences compared to O-glycosides, 8-12 carba- and C- 
glycosides may also be useful for probing the binding of carbohydrate ligands to 
receptors. 
As for the carba-frameworks the synthesis of C-disaccharides via enol ether 
cyclizations on cyclic oxocarbenium ion precursors has been sucessful, 13 but has not 
been tested for non-cyclic oxocarbenium ions. Thus, the cyclization of the mixed 
thioacetal-enol ether like 3.9, where R is a sugar ring, gave a single product 3.11, which 
was transformed to C-disaccharide 3.12 in high yield and excellent stereoselctivity 
[Scheme 3.2 A]. 
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Therefore, in addition to evaluating non-cyclic oxocarbenium ion precursors for carba 
frameworks, it was also of interest to investigate the analogous methodology for C-
glycosides, i.e. 3.13 è 3.16 [Scheme 3.2 B]. 	  
 
Scheme 3.2: C-disaccharides via OCCs with enol ether nucleophiles 
 
3.2 Results and Discussion 	  
3.2.1 Synthesis of mixed thioacetal-enol ether precursors for carbaglycosides  	  	  
The synthesis of the key intermediate 3.17 [Scheme 3.3] began with Pinnick 
oxidation of diastereomeric aldehydes 2.56, (which was previously synthesized in chapter 
two), to give a mixture of acids 3.17. DCC coupling of 3.17 with cholestanol 3.18 gave 
ester 3.19, which was subjected to Tebbe olefination to give the desired mixed thioacetal-
enol ether 3.20.  
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Scheme 3.3: Synthesis of non-cyclic Oxocarbenium ion precursor to carbaglycosides 
 
3.2.2 Synthesis of mixed thioacetal-enol ether precursors for C-glycosides  	  
The synthesis of the mixed thioacetal-enol ether 3.27 commenced with PCC 
oxidation of the known alcohol 3.2114 to give the aldehyde derivative. Treatment of the 
aldehyde with benzenethiol and catalytic BF3.OEt2 resulted in dithioacetal 3.22 in 90% 
yield from 3.21 [Scheme 3.4]. The primary alcohol in 3.22 was next protected as the 
pivolate ester and the secondary alcohol methylated to give 3.23 in 90% yield over 2 
steps. Controlled treatment of dithioacetal 3.23 with NIS in acetic acid afforded the 
acetoxy-thioacetal 3.24, which was treated with benzyl alcohol and catalytic BF3.OEt2 to 
give the mixed thioacetal 3.25 in 67% yield over 2 steps. It should be noted that the 
dibenzylacetal product was not observed. Selective hydrolysis of the acetate in 3.25 using 
KOH in a mixture of THF/H2O afforded the secondary alcohol with no indication of 
pivolate migration or cleavage. DCC promoted esterification of the alcohol and propionic 
acid gave propionate 3.26, which was converted to the non-cyclic mixed thioacetal-enol 
ether 3.27 under Tebbe methylenation conditions. The overall yield of 3.27 from 3.25 
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Scheme 3.4: Synthesis of mixed thioacetal precursor for C-pyranosides 	  	  
Synthesis of the more oxygenated cyclization precursor 3.34 started with the 
known enoside 3.28, which was obtained via the Ferrier rearrangement on tri-O-acetyl-D-
glucal.15 Protecting group manipulations afforded the di-O-benzyl ether 3.29, which after 
ozonolysis and treatment of the derived aldehyde with benzenethiol in the presence of 
BF3.OEt2, provided dithioacetal 3.30 [Scheme 3.5].  Compound 3.30 was converted to 
the mixed thioacetal 3.32 as described for the synthesis of 3.25. Deacetylation of 3.32 and 
DCC esterification of the resulting alcohol and stearic acid gave ester 3.33. Tebbe 
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Scheme 3.5: Synthesis of non-cyclic mixed thioacetal precursor for fully oxygenated C-
pyranosides 
 
3.2.3 Attempted OCC on carbaglycoside precursors 	  
With the non-cyclic mixed thioacetal-enol ether 3.20 in hand, the next step was to 
test the key OCC for the carbaglycoside synthesis. Thus 3.20 was treated with methyl 
triflate and 4-methyl-2,6-di-tert-butylpyridine in anhydrous dichloromethane, following 
the conditions that were successful for OCCs on cyclic mixed thioacetal-enol ethers. The 
reaction showed no evidence for the desired allylic product 3.36 [Scheme 3.6]. The thin 
layer chromatography (TLC) showed a complex mixture of products that were 
inseparable and difficult to characterize. Identification of cholestanol in this mixture 
suggested that decomposition of the precursor or product enol ether 3.20 or 3.36 may 
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Scheme 3.6: Attempted OCC on carbaglycoside precursor 
 
This result suggests that cyclic oxocarbenium ions are critical for the success of 
OCCs with enol ether nucleophiles. Therefore, the use of non-cyclic mixed thioacetal-
enol ether precursors for carbapyranosides was not further pursued. The analogous OCC 
for C-glycosides was next investigated.  
	  
3.2.4 Attempted OCC on C-glycoside precursors 	  
The non-cyclic mixed thioacetal-enol ethers 3.27 and 3.34 were treated under the 
standard cyclization conditions [Scheme 3.7]. The desired products 3.39 and 3.42 were 
not observed. In both cases, a mixture of several products were obtained, HNMR analysis 
of the major products were consistent with the dienes 3.38 (ca 20%) and 3.41 (35%) 
respectively.  
At this juncture, the synthesis of both the C-disaccharide and carbadisaccharide 
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In contrast to the results obtained with cyclic mixed thioacetal enol-ether 
substrates, the OCC’s on the non-cyclic mixed thioacetal-enol ether precursors were not 
successful. This suggests that the success in OCCs with cyclic oxocarbenium ions and 
enol ether nucleophiles may be linked to conformational effects [Scheme 3.8].  
 Thioacetal enol ethers 3.1 and 3.9 selectively give the cyclic enol ether products 
3.3a and 3.11 respectively. The acetonide ring in the corresponding cation intermediates Ι 
and Π provides conformationally restrained frameworks that undergo selective 
deprotonation to 3.3a and 3.11 respectively. In the absence of the conformational strain, 
the intermediates from substrates like 3.20 and 3.34 (i.e. ΙΙΙ and ΙV) are not formed in 
high yield, or do not lead to the analogous enol ether products 3.36 and 3.42 respectively 
to any significant extent. In the case of the C-glycoside substrate 3.34, the formation of 
small amount of diene 3.41 may be an indication that 3.43 is in fact first formed but 
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Scheme 3.8 Cyclic versus non-cyclic mix thioacetal enol-ether OCC 
 
3.4 Summary 	   1. The OCCs on non-cyclic mixed thioacetal-enol ether substrates were found to 
give a mixture of several products, which suggested competing pathways from the 
cyclic oxocarbenium ion intermediates produced in the initial OCC. This result is 
in contrast to OCCs on cyclic mixed thioacetal precursors, which gave high yields 
of single cyclic enol ether products. These data suggest that conformational 
factors are critical for the success of OCCs of mixed thioacetal-enol ether 
substrates.	  2. Although the OCCs on the mixed thioacetal-enol ethers were not successful, their 










































less flexible3.1 X = CH2, Y = O
3.9 X = O, Y = CH2
I X = CH2, Y = O
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substrates, which are more suitable for OCCs, as for example the precursors 
described in chapter 2. The synthesis of mixed thioacetals, involving the 
iodonium ion promoted reaction of dithioacetal precursors may also find wider 
synthetic application.	  
The following chapter describes the development of an alternative strategy 
to cyclic enol ethers of the type expected from the unsuccessful mixed thioacetal-
enol ether OCCs.	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3.5 Experimental 
 




To a solution of aldehyde 2.56 (700 mg, 1.61 mmol) in a mixture of CH3CN:H2O (29:6 
mL), at 0 OC was added NaH2PO4 3.H2O (2.22 g, 1.61 mmol), and a solution of NaClO2 
(0.18 g, 1.93 mmol) in H2O (29 mL) and H2O2 (0.2 mL). The mixture was stirred at 0 OC 
until TLC indicated the disappearance of the starting material. Solid Na2SO3 was then 
added to the reaction. The reaction mixture was diluted with water and the organic phase 
was extracted with ether. The combined extract was dried (Na2SO4), filtered, and 
evaporated in vacuo to give the respective acid (640 mg, 88%). To the crude acid (600 
mg, 1.42 mmol) in DCM (5.0 mL) was added hexadecanol (413 mg, 1.71 mmol), DCC 
(585 mg, 2.84 mmol) and DMAP (17.3 mg, 0.14 mmol). The reaction mixture was stirred 
for 1 h then diluted with ether and filtered. The filtrate was successively washed with 0.1 
N aqueous HCl and brine, dried (Na2SO4), filtered, and evaporated in vacuo. FCC of the 
residue gave ester 3.19 (900 mg, 98%) as colorless oil: Rf = 0.62 (10% EtOAc: petroleum 
ether); 1H NMR (500 MHz, CDCl3) δ 0.91 (t, 3H, J = 7.0 Hz), 1.28-1.32 (m, 27H), 1.61 
(m, 1H), 1.90 (m, 1H), 2.12 (m, 1H), 2.45 (m, 2H), 3.67 (m, 1H), 4.04 (t, 2H, J = 6.8 Hz), 
4.58 (d, 1H, J = 11.4 Hz), 4.64 (d, 1H, J = 11.8 Hz), 4.67 (d, 1H, J = 11.5 Hz), 4.69 (d, 
1H, J = 5.4 Hz), 4.71 (d, 1H, J = 11.8 Hz), 4.76 (d, 1H, J = 11.3 Hz), 7.39-7.29 (M, 15H); 
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29.7 (three signals), 30.1, 31.9, 64.6, 68.9, 69.9, 73.2, 78.8, 103.3, 127.6, 127.7 (two 
signals), 127.8, 127.9, 128.0, 128.4 (two signals), 137.8, 138.0, 138.4, 173.8. 
 
Tebbe Methylenation (General Procedure) 
 




To a solution of ester 3.19 (120 mg, 0.186 mmol) and pyridine (0.1 mL) in a 
anhydrous mixture of toluene: THF (3:1.5 mL), was added, under an argon atmosphere 
and at –78 OC, Tebbe reagent (1.22 mL, 0.5M in THF). The reaction mixture was 
warmed to rt and stirred at this temperature for 1 h. The mixture was then slowly poured 
into a solution of 1M aqueous NaOH at 0 OC, and the resulting suspension extracted with 
ether. The combined organic phase was washed with brine, dried (Na2SO4), filtered and 
concentrated in vacuo. The enol ether residue was partially purified on a basic alumina 
column to give 3.20 (76.6 mg, 60%) as a yellow oil, which was used in the next step 
without further purification: Rf = 0.61 (alumina, 10% EtOAc: petroleum ether); 1H NMR 
(500 MHz, C6D6) δ 1.03 (t, 3H, J = 6.8 Hz), 1.45-1.37 (m, 30H), 1.71 (m, 2H), 2.20 (m, 
1H), 2.58 (m, 1H), 2.68 (m, 1H), 3.68 (t, 2H, J = 6.5 Hz), 3.87 (m, 1H), 4.07 (d, 1H, J = 
1.5 Hz), 4.14 (d, 1H, J = 1.3 Hz), 4.64 (d, 1H, J = 11.9 Hz), 4.67 (d, 1H, J = 12.0 Hz), 
4.69 (d, 1H, J = 11.5 Hz), 4.73 (d, 1H, J = 12.0 Hz), 4.76 (d, 1H, J = 12.0 Hz), 4.83 (d, 
1H, J = 5.7 Hz), 4.90 (d, 1H, J = 11.6 Hz), 7.22 (m, 3H), 7.31-7.26 (m, 6H), 7.42 (t, 4H, J 
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29.3, 29.6, 29.7, 29.8, 29.9 (three signals), 30.0, 31.3, 32.1, 67.2, 68.9, 69.7, 73.1, 79.7, 
81.0, 104.0, 127.3 (two signals), 127.4, 127.5 (two signals),127.7 (three signals), 127.9, 
128.1, 128.3 (two signals), 128.4 (two signals), 138.4, 138.6, 138.7, 139.5, 163.6. 
 
Attempted OCC on 3.20 
 
 The mixed thioacetal-enol ether 3.20 (70 mg, 0.11 mmol), 2,6-di-tert-butyl-4-
methylpyridine (0.2 g, 1.0 mmol), and freshly activated powdered 4A molecular sieves 
(140 mg) in anhydrous dichloromethane (3 mL), was stirred for 15 min at rt, under an 
argon atmosphere, then cooled to 0 OC. Methyl triflate (0.1 mL, 0.8 mmol) was then 
added and the mixture subjected to the standard OCC reaction conditions used in the 
synthesis of 2.39. The reaction resulted in a complex mixture of products which were 
inseparable by FCC and therefore could not be properly characterized. NMR analysis of 
the complex mixture suggested the formation of multiple alkenes as indicated by 






PCC oxidation of 3.21 (9.5 g, 65.07 mmol) afforded an aldehyde (7.5 g, 90%) as a 
colorless oil: Rf = 0.5 (20% EtOAc: petroleum ether). To the crude (7.0 g, 48.6 mmol) 
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(6.9 mL, 48.6 mmol) was added dropwise under an atmosphere of argon. The reaction 
mixture was slowly brought to rt. When TLC indicated complete disappearance of the 
starting material (ca sh), reaction mixture was poured into a saturated aqueous solution of 
NaHCO3. The aqueous phase was extracted twice with EtOAc. The combined organic 
phase was dried (Na2SO4), filtered, and concentrated under reduced pressure to yield a 
crude oil, which after FCC purification gave 3.22 (14.6 g, quant): Rf = 0.4 (25% EtOAc: 
petroleum ether); 1H NMR (500 MHz, C6D6) δ 1.75 (dd, 1H, J = 3.0, 9.4 Hz), 1.98 (m, 
1H), 3.34 (dd, 1H, J = 7.0, 11.1 Hz), 3.52 (dd, 1H, J = 3.3, 11.1 Hz), 4.07 (m, 1H), 4.58 
(dd, 1H, J = 4.9, 9.4 Hz), 7.18-7.24 (m, 6H), 7.35-7.40 (m, 4H); 13C NMR (500 MHz, 
CDCl3) δ 39.2, 55.1, 66.5, 69.8, 128.1, 128.2, 129.2, 132.9, 133.1, 133.7, 134.0. 
Methyl ester 3.23 
 
 	  
To a mixture of 3.22 (10.0 g, 32.7 mmol), DMAP (0.40 g, 3.27 mmol) and 
pyridine (5.3 mL, 65.4 mmol) in dry dichloromethane (164 mL) at 0 OC was added 
dropwise, a solution of pivaloyl chloride (4.4 mL, 36.0 mmol) in dry dichloromethane 
(40 mL). The reaction mixture was stirred at 0 OC for 4 h, at which time the reaction 
mixture was poured into water. The aqueous phase was extracted with EtOAc, and the 
combined organic extract was washed with brine, dried (Na2SO4), filtered and the solvent 
removed under reduced pressure. FCC of the residue furnished the pivolate ester; (10.8 g, 
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1.76 (dd, 1H, J = 2.9, 9.9 Hz), 1.97, (m, 1H), 2.18 (bs, 1H), 3.89 (dd, 1H, J = 6.3, 11.5 
Hz), 3.99 (dd, 1H, J = 3.7, 11.5 Hz), 4.21 (m, 1H), 4.60 (dd, 1H, J = 4.4, 9.9 Hz), 7.17-
7.23 (m, 6H), 7.34-7.36 (m, 2H); 7.40-7.42 (m, 2H); 13C NMR (500 MHz, CDCl3) δ 27.4, 
39.1, 39.5, 54.6, 67.9, 68.2, 128.0, 128.2, 128.6, 129.2, 129.5, 132.8, 133.1, 133.2, 133.6, 
134.0, 178.9. 
A mixture of the secondary alcohol from the previous step (10.0 g, 25.6 mmol), 
DMAP (0.31 g, 2.56 mmol) and acetic anhydride (10 mL) in ethyl acetate (40 mL) was 
stirred at rt for 1 h. The solvent was then concentrated in vacuo. FCC of the residue gave 
the acetylated product 3.23 (11.0 g, 74%) as a colorless oil: Rf = 0.7 (20% EtOAc 
:petroleum ether); 1H NMR (500 MHz, C6D6) δ 1.04 (s, 9H), 1.86-1.91 (ovrlp m, 4H), 
2.09-2.15 (m, 1H), 3.89 60 (dd, 1H, J = 5.5, 11.9 Hz), 4.15 60 (dd, 1H, J = 3.9, 11.9 Hz), 
4.27 60 (dd, 1H, J = 5.2, 9.2 Hz), 5.39 (m, 1H), 7.19-7.24 (m, 6H), 7.35-7.41 (m, 4H); 
13C NMR (500 MHz, CDCl3) δ 21.1, 27.3, 37.3, 39.0, 55.0, 64.4, 69.6, 128.3, 128.5, 





A portion of 3.23 (8.0 g, 18.5 mmol) was subjected to the NIS mediated thioacetal 
exchange procedure that was used for the preparation of 2.52. FCC of the crude product 
afforded 3.24 (5.42 g, 90 %) as a thick oil: Rf = 0.6 (20% EtOAc: petroleum ether);  1H 
3.23
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NMR (500 MHz, C6D6) δ 1.06 (s, 9H), 1.85-2.04 (ovrlp m, 8H), 3.84 (dd, 1H, J = 6.2, 
11.9 Hz), 4,08 (dd, 1H, J = 3.8, 11.9 Hz), 5.04 (m, 1H), 6.02 (dd, 1H, J = 3.8 Hz, J = 10.5 
Hz), 7.23-7.25 (ovrlp m, 5H partially buried under C6D6 solvent peak), 7.39-7.41 (m, 
2H); 13C NMR (500 MHz, CDCl3) δ 25.6, 32.1, 32.3, 32.4, 32.5, 39.3, 45.7, 62.9, 69.7, 
72.0, 72.1, 72.2, 73.5, 73.6, 75.1, 78.5, 78.9, 97.2, 123.8, 123.9, 127.7, 127.8, 127.9, 
128.0, 128.4, 128.4, 128.6, 136.5, 138.7, 138.8, 138.9. 
Acetylphenylthioacetal 3.24 from the previous step (5.2 g, 14.2 mmol) was 
subjected to the procedure that was used for the preparation of 2.54. FCC of the crude 
product afforded the benzyl thioacetal 3.25 (5.2 g, 90%) as colorless oil: Rf = 0.65 (20% 
ethyl acetate: petroleum ether); 1H NMR (500 MHz, C6D6) δ 1.03 (s, 9H), 1.79 (s, 3H), 
1.86-2.06 (m, 2H), 3.82 (m, 1H), 4.07 (dd, 1H, J = 3.8, 11.8 Hz), 4.53 (d, 1H, J = 11.5 
Hz), 4.62 (dd, 1H, J = 3.1, 10.1 Hz), 4.83 (d, 1H, J = 11.5 Hz), 5.11-5.15 (m, 1H), 7.20-
7.25 (ovrlp m, 8H), 7.37-7.41 (m, 2H); 13C NMR (500 MHz, CDCl3) δ 21.1, 27.3, 29.9, 
37.2, 38.2, 39.0, 64.6, 64.9, 69.1, 69.5, 70.3, 82.8, 85.0, 128.1, 128.2, 128.3, 128.4, 128.5, 





Aqueous 1 N KOH was added at rt to a solution of 3.25 (4.83 g, 11.7 mmol) in 
1/1 THF/H2O (30 mL). The solution was maintained below pH 11. When TLC indicated 
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complete disappearance of the starting material, the reaction mixture was adjusted to pH 
4 by addition of 1N HCl. The solvent was then removed in vacuo and the residue 
triturated with ethyl acetate and filtered through a pad of celite. The filtrate was 
concentrated under reduced pressure and the residue purified by FCC to give the free 
alcohol as a colorless oil: Rf = 0.52 (20% EtOAc: petroleum ether); 1H NMR (500 MHz, 
C6D6) δ 1.08 (s, 9H), 1.89-2.04 (ovrlp m, 3H), 3.79 (t, 1H, J = 5.6 Hz), 3.89 (dd, 1H, J = 
5.7, 7.5 Hz), 3.95-4.02 (m, 1H), 4.29 (d, 1H, J = 13.4 Hz), 4.40 (d, 1H, J = 11.6 Hz), 4.89 
(d, 1H, J = 13.4 Hz), 4.94 (dd, 1H, J = 6.8, 11.5 Hz), 6.96-7.13 (m, 7H), 7.23 (dd, 2H, J = 
7.2, 14.3 Hz), 7.52-7.54 (m, 2H); 13C NMR (500 MHz, C6D6) δ 27.6, 39.1, 40.3, 41.2, 
67.7, 68.4, 68.6, 68.8, 0.6, 70.8, 85.3, 86.9, 127.3, 128.3-128.8 (partially buried under 
C6D6 solvent peak), 129.0, 129.1, 129.4, 129.5, 134.6, 134.8, 138.0, 138.3, 178.3.  
DCC coupling of the alcohol (2.0 g, 5.58 mmol) from the previous step and 
propanoic acid (0.8 mL, 10.75 mmol) under standard esterification protocol afforded 
ester 3.26 (2.2 g, 88%) as a colorless oil: Rf = 0.7 (10% ethyl acetate: petroleum ether); 
1H NMR (500 MHz, C6D6) δ 0.95 (q, 3H, J = 7.5 Hz), 1.03 (s, 9H), 182-2.14 (ovrlp m, 
4H), 3.83 (dd, 1H, J = 6.0, 11.1 Hz), 4.06 (dd, 1H, J = 3.8, 11.9 Hz), 4.51 (d, 1H, J = 11.4 
Hz), 4.63 (dd, 1H, J = 3.1, 10.1 Hz), 4.87 51 (d, 1H, J = 11.6 Hz), 5.19 (m, 1H), 7.19-
7.26 (ovrlp m, 8H), 7.38-7.41 (m, 2H); 13C NMR (500 MHz, CDCl3) δ 9.2, 27.3, 27.7, 
37.2, 38.3, 39.0, 64.6, 65.0, 68.9, 69.3, 70.2, 70.4, 83.0, 85.0, 128.1, 128.2, 128.3, 128.4, 
128.7, 128.8, 128.9, 129.1, 129.2, 131.8, 132.1, 133.1, 133.7, 143.4, 134.7, 137.0, 137.3, 
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Mixed Thioacetal-Enol Ether 3.27 
 
 	  
Tebbe methylenation on 3.26 (500 mg, 1.17 mmol) afforded a crude enol ether 
3.27 (0.35 g, 68%) as a light yellow oil. The crude product was filtered through a basic 
alumina column and was used in the next step without further purification: Rf = 0.75 
(alumina, 10% ethyl acetate: petroleum ether); 1H NMR (500 MHz, C6D6) δ 0.95 (t, 3H, J 
= 7.5 Hz), 1.10 (s, 9H), 1.94-2.02 (m, 2H), 2.11-2.39 (m, 2H), 3.96 (d, 1H, J = 2.3 Hz), 
4.02 (d, 1H, J = 2.8 Hz), 4.15 (dd, 2H, J = 5.1, 11.0 Hz), 4.43 (d, 1H, J = 11.7 Hz), 4.66 
(m, 1H), 4.94 (d, 1H, J = 11.5 Hz), 4.99 (t, 1H, J = 7.0 Hz), 6.96-7.14 (ovrlp m, 6H), 7.27 
(m, 2H), 7.54-7.57 (m, 2H); 13C NMR (500 MHz, C6D6) δ 12.5, 12.6, 27.6, 29.0, 29.1, 
30.6, 38.3, 39.1, 39.3, 34.0, 55.6, 64.2, 64.4, 64.7, 70.7, 70.9, 71.1, 71.7, 71.9, 81.7, 82.0, 
82.2, 84.4, 86.0, 128.1-128.7 (partially buried under C6D6 solvent peak), 128.8, 129.0, 
129.4, 129.5, 129.6, 133.1, 133.3, 133.6, 134.0, 134.6, 135.0, 138.1, 163.5, 163.7, 177.7, 
178.8. 
Attempted OCC on 3.27 
 
Mix thioacetal-enol ether 3.27 (100 mg, 0.237 mmol), 2,6-di-tert-butyl-4-
methylpyridine (0.42 g, 2.10 mmol), and freshly activated powdered 4A molecular sieves 
(200 mg) in anhydrous dichloromethane (6 mL), was stirred for 20 min at rt, under an 
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added and the mixture subjected to the standard OCC reaction conditions used in the 
synthesis of 2.39. The reaction resulted in a mixture of products, the major of which was 
an undesired diene. The desired cyclic enol ether was not obtained from the reaction. 
NMR analysis of the complex mixture suggested the formation of multiple alkenes as 




To a solution of 3.28 (13.0 g, 53.3 mmol) in MeOH (177 mL) was added solid 
NaOMe (0.57 g, 10.7 mmol) then the reaction mixture stirred vigorously until the starting 
material completely disappeared as indicated by TLC. At that point, a solution of 10% 
HCl/MeOH was carefully added until the pH of the solution was 7. The solvent was then 
removed under pressure and the residue partitioned between ether and saturated aqueous 
NaHCO3. The organic phase was washed with brine, dried (Na2SO4), and concentrated in 
vacuo. The crude material was azeotroped with toluene and used for the next step without 
further purification. 
To a solution of the crude diol (8.5 g, 53.1 mmol) in dry DMF (106 mL) at 0 OC 
was added NaH (2.66 g 60% in mineral oil, 66.53 mmol) and the reaction mixture stirred 
at that temperature, under an atmosphere of nitrogen for 30 min. Benzyl bromide (12.6 
mL, 106 mmol) was slowly added followed by tetrabutylammonium iodide in one portion 
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completed as indicated by TLC, the mixture was poured into water and extracted with 
ether (3x). The combined ether extract was washed with brine, dried (Na2SO4), and then 
concentrated in vacuo. FCC affored the product mixture 3.29 (14.8 g, 82%) as a colorless 
oil: Rf = 0.66 (10% ethyl acetate: petroleum ether); 1H NMR (500 MHz, CDCl3) δ 3.41 
(s, 3H), 3.71 (d, 2H, J = 3.7 Hz), 3.91 (t, 1H, J = 3.0 Hz), 4.15 (dd, 1H, J = 1.1, 9.4 Hz), 
4.41 (d, 1H, J = 11.6 Hz), 4.49 (d, 1H, J = 12.4 Hz), 4.57 (d, 1H, J = 11.6 Hz), 4.63 (d, 
1H, J = 12.2 Hz), 4.89 (bs, 1H), 5.74 (dt, 1H, J = 2.5, 10.3 Hz), 6.04 (d, 1H, J = 10.3 Hz), 
7.20-7.31 (ovrlp m, 10H, partially buried under CDCl3 solvent peak); 13C NMR (500 
MHz, CDCl3) δ 31.2, 56.0, 69.0, 69.3, 70.5, 71.2, 73.6, 95.9, 126.6, 127.8, 127.9, 128.0, 
128.05, 128.5, 128.6, 131.0, 138.2, 138.4. 
 
Dithioacetal 3.30 	  
 
A solution of 3.28 (10.6 g, 31.2 mmol) 4:1 DCM:MeOH (250 mL) was cooled to 
-78 OC. A stream of O3 in O2 was bubbled through the solution until the starting material 
3.29 was not detected by TLC (10% EtOAc: petroleum ether). The mixture was purged 
with N2 and then triphenylphosphine (12.26 g, 46.76 mmol) was added. The solution was 
warmed to rt, stirred for 2 h, and concentrated in vacuo to give a slurry, which was 
partially purified by FCC and used directly for the next step. To a solution of the partially 
purified aldehyde (8.7 g, 23.4 mmol) from the previous step in DCM (100 mL), was 
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mixture was cooled to 0 OC and BF3.Et2O (3.32 mL, 23.4 mmol) was added slowly while 
stirring. The reaction mixture was warmed to rt and stirred for an additional 1 h. When 
the reaction was completed as indicated by TLC, the reaction mixture was poured into a 
saturated solution of NaHCO3. The organic phase was separated and the aqueous phase 
extracted (2x) with EtOAc. The combined organic layers were combined, washed with 
brine, dried (Na2SO4), and then concentrated in vacuo.  FCC of the resulting residue 
afforded 3.30 (11.1 g, 87% over the two steps) as a single product: Rf = 0.64 (20% EtOAc 
: petroleum ether); 1H NMR (500 MHz, C6D6) δ 2.39 (d, 1H, J = 6.5 Hz), 3.39 (dd, 1H, J 
= 4.8, 9.5 Hz), 3.51 (dd, 1H, J = 3.1, 9.5 Hz), 3.81 dd, 1H, J = 1.1, 8.7 Hz), 4.02 (m, 1H), 
4.31 (q, 2H, J = 11.7 Hz), 4.41 (d, 1H, J = 11.7 Hz), 4.87 (d, 1H, J = 11.7 Hz), 4.98 (d, 
1H, J = 1.3 Hz), 7.07-7.22 (ovrlp m, 19H, partially buried under C6D6 solvent peak), 
7.36-7.38 (ovrlp m, 2H); 13C NMR (500 MHz, CDCl3) δ 61.5, 70.6, 70.7, 73.4, 75.2, 
80.8, 127.3, 127.5, 127.9, 128.0, 128.3, 128.4, 128.6, 129.1, 129.2, 131.4, 132.2, 135.2, 
135.7, 137.9, 138.0. 	  
Dithioacetal-Methyl Ester 3.31 
 
 	  
Alcohol 3.30 (10.0 g, 21.1 mmol), DMAP (0.51 g, 4.22 mmol) and acetic 
anhydride (10 mL) in EtOAc (50 mL) were stirred at rt. The reaction was monitored by 
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and the solvent removed under reduced pressure. FCC of the residue gave the acetylated 
product 3.31 (10.7 g, 98% from diol) as a colorless oil: Rf = 0.78 (20% EtOAc: petroleum 
ether); 1H NMR (500 MHz, C6D6) δ 1.78 (s, 3H), 3.65 (dd, 2H, J = 2.8 Hz, J = 11.2 Hz), 
4.19 (dd, 1H, J = 2.2, 8.1 Hz), 4.30 (d, 1H, J = 11.9 Hz), 4.40 (d, 1H, J = 12.2 Hz), 4.48 
(d, 1H, J = 11.1 Hz), 4.51 (d, 1H, J = 2.2 Hz), 4.85 (d, 1H, J = 11.0 Hz), 5.29 (m, 1H), 
7.13-7.25 (ovrlp m, 20H partially buried under C6D6 solvent peak), 7.29-7.31 (ovrlp m, 
2H); 13C NMR (500 MHz, CDCl3) δ 21.2, 63.1, 68.2, 73.2, 73.3, 75.3, 79.3, 127.8, 127.9, 
127.92, 127.94, 128.1, 128.5, 128.6, 129.2, 129.3, 132.3, 132.7, 135.1, 135.4, 138.0, 




Dithioacetal 3.30 (9.8 g, 19.0 mmol) was subjected to the NIS mediated thioacetal 
exchange procedure that was previously described. FCC of the crude product afforded the 
acetylphenylthioacetal (5.42 g, 82 %) as a thick oil: Rf = 0.65 (20% EtOAc: petroleum 
ether);  1H NMR (500 MHz, C6D6) δ 1.79 (s, 3H), 1.81 (s, 3H), 3.53 (dd, 2H, J = 4.2 Hz, 
J = 10.9 Hz), 3.91 (dd, 1H, J = 2.8 Hz, J = 7.9 Hz), 4.25 (d, 1H, J = 12.5 Hz), 4.33 (d, 
1H, J = 11.6 Hz), 4.36 (d, 1H, J = 11.6 Hz), 4.60 (d, 1H, J = 11.6 Hz), 5.06 (m, 1H), 6.12 
(d, 1H, J = 2.8 Hz), 7.07-7.12 (ovrlp m, 13H), 7.25-7.27 (ovrlp m, 2H); 13C NMR (500 
MHz, CDCl3) δ 21.3, 68.0, 72.1, 73.4, 74.3, 78.9, 83.4, 127.9, 128.0, 128.1, 128.3, 
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The product from the previous step (5.0 g, 14.4 mmol) was subjected to the 
procedure that was used for the preparation of 2.54. FCC of the crude product afforded 
the benzylthioacetal 3.32 (5.12 g, 90%) as colorless oil: Rf = 0.75 (20% EtOAc: 
petroleum ether); 1H NMR (500 MHz, C6D6) δ 1.82 (s, 3H), 3.55 (dd, 2H, J = 3.4, 10.9 
Hz), 3.62 (dd, 1H, J = 5.7, 11.0 Hz), 3.94 (t, 1H, J = 5.1 Hz), 4.28 (d, 1H, J = 12.0 Hz), 
4.36 (d, 1H, J = 11.7 Hz), 4.49 (d, 1H, J = 11.2 Hz), 4.61 (d, 1H, J = 11.2 Hz), 4.80-4.83 
(ovrlp m, 2H), 5.33 (m, 1H), 7.08 (m, 2H), 7.14-7.19 (ovrlp m, 16H), 7.34 (m, 2H); 13C 
NMR (500 MHz, CDCl3) δ 12.1, 21.3, 68.2, 70.5, 72.8, 73.2, 74.6, 79.8, 91.4, 127.6, 
127.16, 127.79, 127.8, 127.9, 128.0, 129.18, 129.2, 133.1, 135.0, 137.1, 138.16, 138.2, 
170.2. 	  
Mixed Thioacetal Ester 3.33 
 
 	  
To a solution of 3.32 (3.3 g, 8.33 mmol) dissolved in MeOH (30 mL) was added 
solid NaOMe (0.05 g, 0.83 mmol) then the reaction mixture stirred vigorously until the 
starting material completely disappeared as indicated by TLC. At that point, a solution of 
10% HCl/MeOH was carefully added until the pH of the solution was 7. The solvent was 
then removed under pressure and the residue partitioned between ether and saturated 
aqueous NaHCO3. The organic phase was washed with brine, dried (Na2SO4), and 















	   75	  
100%) as a viscous oil: Rf = 0.58 (20% EtOAc: petroleum ether); 1H NMR (500 MHz, 
C6D6) δ 2.49 (d, 1H, J = 5.8 Hz), 3.53 (dd, 2H, J = 3.0, 9.6 Hz), 3.79 (dd, 1H, J = 3.0, 7.8 
Hz), 4.02 (m, 1H), 4.28 (d, 1H, J = 11.8 Hz), 4.39 (q, 2H, J = 11.4 Hz), 4.50 (d, 1H, J = 
11.4 Hz), 4.76 (d, 1H, J = 11.1 Hz), 4.82 (d, 1H, J = 11.8 Hz), 5.18 (d, 1H, J = 3.2 Hz), 
7.08 (m, 2H), 7.14-7.24 (ovrlp m, 16H), 7.44 (m, 2H); 13C NMR (500 MHz, CDCl3) δ 
70.8, 70.9, 71.0, 73.6, 74.5, 81.2, 93.6, 127.3, 127.88, 127.9, 128.0, 128.1, 128.2, 128.47, 
128.49, 128.5, 128.6, 129.2, 132.7, 136.0, 137.4, 138.1, 138.3. 
DCC coupling of the alcohol from the previous step (500 mg, 1.41 mmol) from 
the previous step and stearic acid (0.6 g, 2.12 mmol) under standard esterification 
protocol afforded ester 3.33 (0.7 g, 80%) as a colorless oil: Rf = 0.8 (15% EtOAc: 
petroleum ether); 1H NMR (500 MHz, C6D6) δ 0.92 (t, 3H, J = 7.2 Hz), 1.16-1.34 (ovrlp 
m, 28H), 1.55 (m, 2H), 2.11 (m, 2H), 3.69 (dd, 1H, J = 6.9, 9.7 Hz), 3.76 (dd, 1H, J = 
6.0, 9.7 Hz), 4.22-4.25 (ovrlp m, 3H), 4.49 (d, 1H, J = 11.3 Hz), 4.58 (d, 1H, J = 11.1 
Hz), 4.95 (d, 1H, J = 11.1 Hz), 5.02 (d, 1H, J = 11.0 Hz), 5.15 (d, 1H, J = 7.5 Hz), 5.95 
(t, 1H, J = 3.1 Hz), 6.92-7.00 (ovrlp m, 3H), 7.05-7.20 (ovrlp m, 11H partially buried 
under C6D6 solvent peak), 7.31-7.36 (ovrlp m, 4H), 7.60-7.61 (m, 2H); 13C NMR (500 
MHz, C6D6) δ 14.7, 23.5, 25.6, 29.8, 30.1, 30.2, 30.25, 30.4, 30.47, 30.48, 30.53, 30.55, 
32.7, 34.7, 68.7, 71.0, 72.0, 73.5, 75.6, 79.3, 91.0, 127.6, 128.1, 128.3, 128.5, 128.65, 
128.7,  128.8, 128.86, 128.9, 129.0, 129.3, 129.6, 133.0, 134.3, 136.0, 137.6, 138.9, 
139.2, 173.0; ESIHRMS (M+Na)+ calculated for C49H66O5SNa 789.4631, found 
789.4536. 
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Mixed Thioacetal-Enol Ether 3.33 	  
 	  
Tebbe methylenation on 3.33 (300 mg, 0.48 mmol) afforded a crude enol ether 
3.34 (0.2 g, 66%) as a light yellow oil. The enol ether residue was partially purified on a 
basic alumina column and was used in the next step without further purification: Rf = 
0.77 (alumina, 10% EtOAc: petroleum ether); 1H NMR (500 MHz, C6D6) δ 0.91 (t, 4H, J 
= 6.8 Hz), 1.27-1.33 (ovrlp m, 36H), 1.56 (m, 2H), 2.12 (t, 2H, J = 7.5 Hz), 3.80 (dd, 1H, 
J = 4.3, 10.3 Hz), 3.89 (dd, 1H, J = 3.7, 10.3 Hz), 4.03 (d, 1H, J = 2.0 Hz), 4.18 (d, 1H, J 
= 2.0 Hz), 4.29 (q, 2H, J = 11.9 Hz), 4.39 (d, 1H, J = 11.3 Hz), 4.52 (t, 2H, J = 5.1 Hz), 
4.83 (d, 1H, J = 10.8 Hz), 4.94-5.01 (ovrlp m, 3H), 5.32 (d, 1H, J = 5.1 Hz), 6.95-7.24 
(ovrlp m, 16 H partially buried under C6D6 solvent peak), 7.43 (d, 2H, J = 7.4 Hz), 7.61 
(d, 1H, J = 7.0 Hz); 13C NMR (500 MHz, C6D6) δ 14.7, 23.4, 24.4, 28.1, 29.6, 29.9, 30.0, 
30.1, 30.2, 30.3, 30.46, 30.5, 30.53, 32.7, 36.2, 43.7, 68.3, 71.2, 73.8, 75.6, 76.5, 80.6, 
83.3, 93.3, 127.7, 127.9, 128.0, 128.1, 128.3, 128.5, 128.6, 128.7, 128.8, 128.83, 128.87, 
129.0, 129.5, 133.8, 136.3, 138.0, 139.3, 139.6161.9; ESIHRMS (M+Na)+ calculated for 














3.33 3.34R = CH3(CH2)14




For diene: Rf = 0.8 (alumina, 20% EtOAc: petroleum ether); 1H NMR (500 MHz, C6D6) δ 
0.91 (t, 3H, J = 6.8 Hz), 1.31-1.32 (m, 24H), 1.46 (m, 4H), 2.43 (m, 2H), 3.69 (dd, 2H, J 
= 3.3, 4.6 Hz), 4.16 (m, 1 H), 4.19 (m, 1H), 4.30 (d, 1H, J = 11.9 Hz), 4.40 (s, 2H), 4.44 
(d, 1H, J = 12.3 Hz), 4.64 (t, 1H, J = 7.5 Hz), 5.71 (dd, 1H, J = 2.4, 2.5 Hz), 5.92 (t, 1H, J 
= 1.5 Hz), 7.08-7.31 (m, 10H); 13C NMR (500 MHz, C6D6) δ 14.1, 22.8, 25.0, 29.51, 
29.5, 29.7, 29.8, 29.8, 29.9, 69.4, 70.2, 70.6, 73.0, 77.3, 112.0, 124.3, 125.4, 127.2, 127.3, 
127.4, 128.1, 128.2, 128.3, 128.4, 138.7, 138.8, 148.0; ESIHRMS (M+H)+ calculated for 
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A Ring Closing Metathesis Strategy for the Synthesis of 
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4.1 Introduction 	  
Due to the requirement of cyclic oxocarbenium ions, the OCC synthesis of 
carbaglycosides is limited to pyranose analogues with cis-3,4- vicinal diols. In quest for a 
more general synthesis of carbapyranosides a RCM strategy was envisaged [Scheme 
4.1]. 	  
 	  
Scheme 4.1 OCC versus RCM approach to C- and carbaglycoside 	  
Postema and coworkers have reported a convergent and flexible RCM approach 
to C-1 glycals 4.13 from olefin-enol ether precursors 4.12 [Scheme 4.1].1 The RCM 
precursor 4.12 was obtained by first coupling an acid derivative to an olefin alcohol 
followed by a Tebbe methylenation. Our plan for carbasugars will employ a similar 
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RCM approach to carbaglycosides
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   80	  
precursor (cf 4.7 vs. 4.12). This will generate 4.8, which is similar to the OCC product 
4.4 except that the C3/4 vicinal diol in 4.4 is cis whereas in 4.8 the relative 
stereochemistry at C3/C4 can either be cis or trans. This makes the RCM approach to 
carbasugars a more general one than the OCC. The RCM product 4.8 via the same 
hydroboration-oxidation transformation described earlier. While successful RCMs have 
silyl enol ethers of simple unsaturated ketones [Scheme 4.2],2 to the best of our 
knowledge, this reaction has not been executed on complex carbohydrate-like 
frameworks as proposed here. Our goal was to test this strategy on carbasugars of the 
potent antitumor agent OSW-1. 
 
 
4.2 OSW-1  	  
The naturally occurring saponin OSW-1 [Figure 4.1] is a member of the 
cholestane glycoside family, and was first isolated by Sashida and coworkers in 1992 
from the bulbs of a perennial, Ornithoglum Saudersiae grown in Southern Africa.3 The 
OSW-1 family of compounds is characterized by a hydrophilic glycoside moiety linked 
to a lipophilic steroidal segment. OSW-1 and its natural analogues 4.17b – 4.18b [Figure 
4.1], exhibit antitumor activities against human promyelocytic leukemia HL-60 cells 













Grubbs II catalystScheme 4.2 Grubbs mediated RCM of silyl enol ethers
	   81	  
 
Figure 4.1. OSW-1 analogues 
 
Glycosylated natural products are abundant in nature and have shown a wide 
range of biological activities.5 Many of these compounds are clinically approved agents 
or are in development as such. 5 - 10 The sugar attachments of these natural products are 
invariably critical for activity, either by facilitating delivery to, or interacting with the 
drug target. Thus modification of the sugar segments of natural products is a popular 
strategy in drug development. 10 - 15 In this vein SARs of C- and carba- glycosides of 
OSW-1 could provide a clearer understanding of its mode of action and provide insight 
for improving antitumor selectivity.  	  
4.3 Structure-Activity-Relationship Studies 	  
SARs for OSW-1 suggest that: (1) the aglycone and the sugar residue are both 
crucial for the activity of OSW-1 and, (2) the nature of the ester groups on the 
disaccharide moiety are also important for activity.5 C- and carba- analogues of OSW-1 
may be useful for elucidating the role of the disaccharide moiety in the overall mode of 
action of OSW-1 [Figure 4.2]. Because of the greater stability of their pseudo-glycoside 
linkages, greater activity of the C- or carba- analogue may be an indication that glycoside 











          R1     R2
4.17a  H      p-Methoxybenzoyl (OSW-1)
4.17b  H      3,4-Dimethoxybenzoyl
4.17c  H      (E)-cinnamoyl
4.18a  Glc   p-Methoxybenzoyl 
4.18b  Glc   (E)-cinnamoyl
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analogues would suggest that glycoside hydrolysis may be required for activity. 
However, such conclusions must be approached with caution because the C- and carba- 
modification also leads to electronic and conformational changes relative to the parent 
glycoside, and these may also influence changes in activity. It may be possible to tease 
out these effects by using mixed, O-,C- and carba- analogues.  
 
4.4 Results and Discussion 	  
4.4.1 RCM strategy for carbapyranosides  	  
This strategy was first tested on cholestanol and a racemic olefin-acid precursor. 
Thus, a mixture of olefin-acid derivatives 4.28a and 4.28b were prepared from 4.22 via a 
sequence of standard chemical transformations beginning with mCPBA epoxidation on 
4.22 to 4.23. Opening of 4.23 with sodium thiophenolate afforded thio-alcohol 4.24, 
which was converted to benzyl ether 4.25. Oxidation of thioether 4.25 followed by 
Pummerer rearrangement on the resulting sulfoxide gave the thioacetal 4.26 as a 
diastereomeric mixture. Vinyllithium addition to 4.26 gave a inseparable mixture of anti 
and syn alcohols, which were protected as their PMB-ethers (±) 4.27a anti and (±) 4.27b 











Figure 4.2 4.17a OSW-1: X = Y = O
                      4.19 OSW-1: bis - C-: X = CH2; Y = O
                      4.20 OSW-1: bis - carba-: X = O: Y = CH2
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the derived primary alcohols provided an inseparable mixture of acids (±) 4.28a anti and 




Scheme 4.3 Synthesis of olefin-acid intermediates 
 
DCC coupling of the olefin-acids (±) 4.28a anti and (±) 4.28b syn with 
cholestanol gave a 2:1 mixture of anti:syn diastereomers 4.29a/4.29a’ anti and 
4.29b/4.29b’ syn, which when subjected to Takai olefination procedure provided in 
approximately 2:1 ratios of 4.30a/4.30a’ anti and 4.30b/4.30b’ syn in 75% overall yield 
from the acid precursors [Scheme 4.4]. 
Grubbs II mediated RCM on the mixture of olefin-enol ethers 4.30a/4.30a’ and 
4.30b/4.30b’ gave a 1:1 mixture of cyclic enol ethers 4.31a/4.31a’ and 4.31b/4.31b’ in 
90% yield. The product ratio was calculated based on the two sets of doublets assigned to 
the characteristic H2’ peak at 4.95 ppm [Figure 4.3]. Note carefully that only two, and 
not four signals are observed for H2’ and C2’ in the 1H and 13C NMR. We assumed that 



















1. mCPBA, -78, 0C
2. Ac2O, NaOAc
    reflux, 12 h, 80%
Br, t-BuLi1.
2. PMBCl, NaH, DMF









(±) 4.27a - anti (±) 4.27b - syn
4.27a () - anti
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of our knowledge this is by far the most complex example of an RCM of this type (i.e. in 
which the enol ether oxygen in the RCM product is exocyclic).2 	  
 
Scheme 4.4 RCM synthesis of carbasugars 
 
Stereoselective hydroboration oxidation of the enol ether mixture gave a 1:1 
mixture of the syn and anti alcohols, which was acetylated to give 4.32a/4.32a’ and 
4.32b/4.32b’ [Scheme 4.4]. It’s noteworthy that the hydroboration reaction worked 
cleanly only when the borane dimethyl sulfide complex reagent was used in excess. 
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Figure 4.3 1H-NMR of RCM product 4.31a/4.31a’ and 4.31b/4.31b’ 
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diastereomeric pairs 4.32a/4.32a’ and 4.32b/4.32b’, which were then characterized by 
NMR [Table 4.1].  
The relative stereochemistry was assigned by analysis of J values for vicinal protons on 
the cyclohexane ring. The large J values in 4.32a/4.32a’ (J3’,4’ = 9.28 & 9.70 Hz) 
supported a diastereomeric pair with equatorial substituents at positions C3 and C4 
[Figure 4.4]. A	  value	  of	  J3’,4’ = 5.40 Hz supported the cis-3,4 relative stereochemistry as 
in 4.32b/4.32b’ [Figure 4.5]. 
	  
Table 4.1 NMR comparison of anti/syn distereomeric β-carba-xylosides 
 
These results confirm that the RCM approach can be used as an alternative to the 
OCC approach. Moreover, the successful synthesis of 4.31a/4.31a’ and 4.31b/4.31b’ 
shows that the RCM method can be used for both cis – and trans - 3,4 – substituted 
carbasugars. The RCM strategy for the 3,4-cis – carbapyranoside was next applied to an 
enantiomerically pure olefin-acid precursor and cholestanol.  
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Figure 4.4 1H-NMR of RCM product 4.32a/4.32a’ 
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Figure 4.5 1H-NMR of RCM products 4.31b/4.31b’ 
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4.4.2 RCM strategy for  carba-arabino pyranosides  	  
An enantioselective synthesis of an olefin-acid precursor 4.36 for carba 
arabinosides was first developed [Scheme 4.5]. Zinc mediated reductive elimination on 
the iodoriboside16 4.33 gave the alkene-aldehyde 4.34. The crude aldehyde was converted 
to the αβ-unsaturated methyl ester 4.35 by Wittig olefination with 
methyl(triphenylphosphoranylidene)acetate (Ph3P=CHCO2Me). Selective hydrogenation 
of the conjugated alkene followed by hydrolysis of the ester provided the desired olefin-
acid 4.36.  	  
 
Scheme 4.5 RCM synthesis of cyclic carbasugars 
 
DCC coupling of 4.36 and cholestanol followed by Tebbe reaction on the derived 





























2.  Ac2O, DMAP70% (2 steps)












five steps from ribose
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enol ether 4.38. Stereoselective hydroboration oxidation on 4.38 followed by acetylation 
of the resulting alcohol gave 4.39 as a single diastereomer in 90% yield.  
The stereochemistry of 4.39 was assigned as before by J analysis [Table 4.2]. The J 
values in 4.39 (J1’,2’ = 9.5, J2’,3’ = 9.9, J3’,4’ = 5.1 Hz) supported equatorial 
substituents at C1, C2, and C3 [Figure 4.6].  The large J values for H-2’ is consistent 
with the stereochemical assignment for both 4.32b/4.32b’ and 4.39 and supports the 
given structures. In the same vein, the small coupling constants 5.3 and 5.1 Hz for H-3’ in 
4.32b/4.32b’ and 4.39 respectively, agree with the 3,4-cis assignments in both structures.  
	  
Table 4.2 NMR comparison of 3’,4’ cis β-carba-xylosides 4.32b/4.32b’ and 4.39 
	  
 	  	  	  	  
























6.1, t, J = 9.5 Hz




5.6, dd, J = 9.5, 9.9 Hz
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Figure 4.6 1H-NMR of RCM product 4.39 	  	  	  	  
	   92	  
4.4.3 OCC strategy for the carba-arabinose ring of OSW-1 	  
Given the success of the OCC approach for carbasugars with a 3,4 cis vicinal diol, 
we also tested the OCC strategy on the arabinose segment of OSW-1. A similar carba-
cholesterol 4.46 was used as a test case [Scheme 4.6]. The key intermediate 1-thio-1,2-O-
isopropylidene acetal-acid 4.43, was prepared from 4.4017, via the method that was 
previously developed in this laboratory.1b Noteworthy is the Suarez fragmentation on 
4.40 using diacetoxyiodosobenzene (DIB) provided acetoxyacetal 4.41. Controlled acetal 
exchange on 4.41 gave thioacetal 4.42. DIBAL-H reduction of 4.42 followed by a two 
steps oxidation sequence on the derived alcohol provided 4.43 with no evidence for 
oxidation of the thiophenyl residue. DCC mediated coupling of 4.43 and cholesterol 
provided ester 4.44. Tebbe olefination of the derived ester followed by treatment of the 
subsequent enol ether with MeOTf provided the cyclic enol ether 4.45 in excellent yield. 
 
 































(four steps from 4-Piv-O-butanal)
PhSH, BF3.OEt2 
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Stereoselective hydroboration-oxidation on 4.45 followed by acetylation of the derived 
alcohol gave the β-carba-arabinoside 4.46, as a single stereoisomer. It should be noted 
that both the enol ether and the alkene in the steroid segment underwent hydroboration-
oxidation.  Stereochemical assignment was done as before by calculating J values for the 
carbinol protons of the cyclohexane [Table 4.3]. Base on their J values (J1’,2’ = 9.50, 
J2’,3’ = 9.89, J3’,4’ = 5.10 Hz) and (J1’,2’ = 8.00, J2’,3’ = 8.00, J3’,4’ = 5.00 Hz) 
respectively, the carbasugar rings of β-carba-xylose-cholestanol derivative 4.39, and its 
cholesterol equivalent 4.46 have a similar stereochemical profiles and support equatorial 
substituents at C1’, C2’ and C3’ [Figure 4.7].   	  	  




























6.1, t, J = 9.5 Hz




5.6, dd, J = 9.5, 9.9 Hz
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Figure 4.7 1H-NMR of RCM product 4.46 
 
 
	   95	  
 
4.4.4 RCM strategy for carba-xylo pyranosides 
 
Our next goal was to develop an enantioselective synthesis of an olefin-acid 
precursor 4.50 to test the RCM strategy on the carba xyloside analogue of OSW-1 
[Scheme 4.7]. The iodoarabinoside 4.47, obtained in five steps from arabinose,18 was 
transformed to 4.51 via a similar reaction sequence to that used in the carba – arabinoside 
synthesis. RCM on 4.51 with Grubbs II catalyst provided enol ether 4.52 in 80% yield. 
Hydroboration-oxidation on 4.52 followed by acetylation of the derived alcohol led to β-
carba-xyloside 4.53 in 63% yield as a single diastereomer.  
 
 
Scheme 4.7 RCM Synthesis of β-carba-xyloside 
 
Observation of NOE signals between the H1’ and H3’, and H2’ and H4’ 
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Stereochemical assignment of 4.53 was done by analysis of J values for vicinal 
protons on the cyclohexane ring [Table 4.4]. Values of J1’,2’ = J2’,3’ = J3’,4’ = 9.5 – 9.6 Hz 
supported a diastereomer having all the substituents in the equatorial positions [Figure 
4.9]. 
 
Figure 4.8 Conformational analysis of 4.53 
 








































5.5, t, J = 9.5 Hz






3.2, td,  J = 10.0,  J = 9.9,  J = 4.9 
4.9, t, J = 9.6 Hz
3.3, t, J = 9.5 Hz
3.4,  td,  J = 10.7,  J = 9.6,  J = 4.7























Figure 4.9 1H-NMR of RCM product 4.53 
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The foregoing results illustrate two strategically similar strategies for the modular 
synthesis of carbasugar analogues of OSW-1: (i) An oxocarbenium ion cyclization 
(OCC) on a cyclic enol ether-thioacetal (e.g 4.44 -> 4.45) and (ii) a ring closing 
metathesis (RCM) on an enol ether-alkene (e.g. 4.37 -> 4.38; 4.51 -> 4.52). The RCM 
strategy can be applied to the syntheses of β-carba-arabinosides and β-carba-xylosides 
[Scheme 4.8]. However, the OCC synthesis is limited to β-carba-arabinosides. 
 
 	  
Scheme 4.8 OCC & RCM syntheses of carba-glycosides 	  
4.4.5 Studies on carba-disaccharides of OSW-1 
 
We envisaged two RCM-based strategies for the complete carba-disaccharide 
framework in OSW-1: (1) a linear synthesis [Scheme 4.9] and (2) a convergent synthesis 





















OCC synthesis of β-carba-arabinosides








































	   99	  
alcohol is converted via an esterification-olefination sequence to enol-ether 4.55. RCM 
on 4.55 affords 4.56, which after a stereoselective hydroboration oxidation, followed by 
benzylation of the resulting alcohol gives 4.57. Acid hydrolysis of 4.57 gives the free 
alcohol derivative, which is coupled to acid 4.28a and the resulting ester subjected to a 
similar transformation previously described for 4.54 è 4.56 to give enol ether 4.60. 
Stereoselective hydroboration oxidation on 4.60 gives compound 4.61. Alcohol 
protecting group operations on 4.61 leads to OSW-1.  
In the convergent approach the steroidal alcohol and a carba - disaccharide acid precursor 
4.62, after an esterification-olefination sequence followed by the usual RCM-
oxidation/acetylation sequence, is converted to the OSW-1-bis-carba glycoside 4.65 
[Scheme 4.10].  	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Scheme 4.10 Convergent synthetic plan for OSW-1-bis-carba analogue 
 
Evaluation of the linear strategy started with the synthesis of the alkenoic acid 
segment 4.54. Thus methyl-D-ribofuranoside 4.66 was converted to a mixture of p-
methoxybenzylidines 4.67. DIBAL-H mediated opening of the acetal in 4.67 gave diol 
4.68 as a single regioisomer. Selective iodination of 4.68 and protection of the resulting 








































	   101	  
 
Scheme 4.11 THP model of bis-carba-glycoside 
 
Zinc promoted reductive elimination on 4.70 gave aldehyde 4.71, which was 
transformed to the desired alkenoic acid 4.54, following the same sequence of reactions 
used for the related carba-arabinoside precursor 4.36. The transformation of 4.71 to 4.54 
was achieved in 89% overall yield. 
With 4.54 in hand, the next step was to perform the esterification-methylenation 
sequence. Thus, DCC coupling of acid 4.54 and cholestanol, followed by Takai 
methylenation on the derived ester generated olefin-enol ether 4.74 in 84% from 4.54. 
Standard RCM condition on 4.74 gave 4.75 in 88% yield. Hydroboration-oxidation on 
4.75 gave alcohol 4.76, which was acetylated to give the THP-substituted β-carba-
arabinoside 4.77. It is important to note that the synthesis of the in essence constitutes a 
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a substitute for the second sugar ring. For easier characterization of the product the THP 
acetal of 4.77 was hydrolyzed and the free alcohol protected to give the diacetate 
derivative 4.78. Alcohol 4.76 was also protected as the benzyl ether, which was further 
derivative to give the alcohol substrate 4.79 [Figures 4.10, 4.11].  
 
 




























4.76 R1 = THP; R2 = H
4.77 R1 = THP; R2 = Ac
4.78 R1 = R2 = Ac
4.79 R1 = H; R2 = Bn
BH3.THF, Na2O2
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Figure 4.10 1H-NMR of RCM product 4.77 
 






















Figure 4.11 1H-NMR of RCM product 4.79 
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The convergent approach to our carba-disaccharide analogue of OSW-1 is also in 
progress [Scheme 4.13].  The ribose-derived alcohol 4.80 and acid 4.50 were subjected to 
the usual two steps esterification-methylenation sequence to give 4.82 in 60% over two 
steps. Next, the key RCM operation was successfully performed on 4.82, to give enol 
ether 4.83 in 72% yield. The stereoselective hydroboration of 4.83 to fully furnish the 
carba-xylose alcohol 4.84 is currently under investigation. 
  
 
Scheme 4.13 Enantioselective Synthesis of carba-disaccharide precursor 4.83  
 
4.5 Future Work 
In the linear approach, the carba – xyloside segment will be next introduced 
in 4.79 following the protocol described in Scheme 4.14. The complete 
convergent approach to OSW-1 carbadisaccharide is outlined in Scheme 4.15. 
Both sequences follow reactions that are similar to those described in the 
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Scheme 4.14 Enanteoselective Synthesis of OSW-1-bis-carba-disaccharide analogue 
 
Scheme 4.15 Convergent strategy to OSW-1 carbadisaccharide 
 
4.6 Conclusion 	  
The RCM reaction has been used successfully to synthesize carba glycosides from 
highly oxygenated alkene-enol ethers. Carba-arabinose and the carba-xylose analogues of 
the sugar subunits in OSW-1 were synthesized in a model. An OCC strategy was also 
developed, but this method is limited to the carba-arabinose analogue. Application of 
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4.7 Experimental 	  





A mixture of pent-4-en-1-ol (5.7 g, 6.6 mmol), trityl chloride (22.1g 7.9 mmol), 
and pyridine (40 mL) in DCM (200 mL) were stirred at rt under an inert atmosphere until 
TLC indicated the disappearance of the starting material. The reaction mixture was then 
poured into aqueous 5N NaOH (100 mL) and the organic layer separated. The aqueous 
layer was extracted with DCM and the combined organic phase was washed with brine, 
dried (Na2SO4), and concentrated in vacuo to give a residual oil. FCC of the oil gave 4.22 
(17.4 g, 80%): Rf = 0.60 (20% EtOAc/petroleum ether); 1H NMR (500 MHz, CDCl3) δ 
1.56 (m, 2H), 2.01 (q, 2H, J = 7.2 Hz), 2.93 (t, 2H, J = 6.5 Hz), 4.75-4.85 (m, 2H), 5.63 
(m, 1H), 7.06-7.11 (ovrlp m, 5H), 7.13-7.17 (ovrlp m, 4H, Ar-buried under C6D6 solvent 
peak), 7.30 (ovrlp d, 6H, J = 7.3 Hz); 13C NMR (125 MHz, CDCl3) δ 29.6, 30.7, 63.2, 







m-CPBA (6.3 g, 36.5 mmol) was suspended in a mixture of 4M NaH2PO4 buffer 
and CH2Cl2 (100 mL). The suspension was added to a solution of 4.22 (10.0 g, 30.5 
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layer was separated, and washed with saturated aqueous NaHCO3, saturated aqueous 
Na2S2O3, and brine, dried (Na2SO4) and concentrated in vacuo. The residue was purified 
by FCC to afford 4.23 (9.4 g, 90%): Rf = 0.70 (20% EtOAc/petroleum ether); 1H NMR 
(500 MHz, CDCl3) δ 1.74 (m, 4H), 3.05 (q, 2H, J = 6.1 Hz), 3.70 (m, 1H), 4.46 (d, 1H, J 
= 11.1 Hz), 4.61 (d, 1H, J = 12.0 Hz), 7.19-7.22 (ovrlp m, 4H), 7.24-7.31 (ovrlp m, 10H, 
Ar-buried under CDCl3 solvent peak), 7.39-7.41 (ovrlp m, 6H); 13C NMR (125 MHz, 
CDCl3) δ 14.4, 21.3, 25.5, 27.1, 60.6, 63.0, 72.7, 83.4, 86.6, 127.1, 128.0, 128.2, 128.3, 








Benzene thiol (1.6 mL, 14.8 mmol) in anhydrous CH2Cl2 (50 mL) at 0 OC, under 
an atmosphere of argon, was treated with n-BuLi (1.5 mL, 15.9 mmol) for 1 h. The 
resulting thiophenolate was slowly cannulated into a mixture of epoxide 4.23 (5.0 g, 14.5 
mmol). The reaction mixture was allowed to warm to rt and further stirred until TLC 
indicated the disappearance of the starting material. The mixture was then poured into 
saturated NH4Cl and the organic layer was separated. The aqueous layer was extracted 
with EtOAc and the combined organic phase washed with brine, dried (Na2SO4), and 
concentrated in vacuo. FCC of the residual oil gave 4.24 (5.5 g, 84%): Rf = 0.50 (20% 
EtOAc/petroleum ether); 1H NMR (500 MHz, C6D6) δ 1.34 (s, 1H), 1.41-1.47 (m, 2H), 
1.50-1.62 (m, 2H), 2.23 (dd, 1H, J = 2.7, 4.9 Hz), 2.50 (t, 1H, J = 4.3 Hz), 2.68 (m, 1H), 
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6H, J = 8.1 Hz, Ar); 13C NMR (125 MHz, C6D6) δ 27.0 (C4), 30.1 (C3), 47.8 (C1), 52.8 







A mixture of 4.24 (5.0 g, 11.0 mmol) and NaH (0.9 g, 60% in mineral oil, 22.1 
mmol), in dry DMF (45 mL) at 0 OC under an argon atmosphere was vigorously stirred 
for 0.5 h. The reaction mixture was then allowed to warm to rt and stirred for an 
additional 0.5 h. Bu4NI (0.4 g, 1.1 mmol) was then added and the reaction mixture was 
again cooled to 0 OC, at which time BnBr (1.6 mL, 13.5 mmol) was slowly added. The 
reaction was warmed to rt, and after 2 h TLC indicated the disappearance of the starting 
material. The reaction mixture was then poured into water and the aqueous phase 
extracted with diethyl ether. The combined organic phase was washed with brine, dried 
(Na2SO4), filtered, and concentrated under reduced pressure. FCC of the residue afforded 
4.25 (5.9 g, 98%): Rf = 0.61 (10% EtOAc/petroleum ether); 1H NMR (500 MHz, CDCl3) 
δ 1.51-1.59 (m, 2H), 1.61-1.65 (m, 1H), 1.70-1.74 (m, 1H), 2.86-2.94 (ovrlp m, 3H), 3.04 
(dd, 1H, J = 5.5, 13.3 Hz), 3.43 (m, 1H), 4.30 (d, 1H, J = 11.6 Hz), 4.43 (d, 1H, J = 11.6 
Hz), 7.10-7.20 (ovrlp m, 19H), 7.30 (d, 6H, J = 7.2 Hz); 13C NMR (125 MHz, CDCl3) δ 
25.9, 30.6, 38.2, 63.5, 71.8, 77.9, 86.6, 126.2, 127.1, 127.8, 127.9, 128.1, 128.5, 128.9, 













	   110	  





Compound 4.25 (2.0 g, 3.7 mmol) in DCM (60 mL) was cooled to -78 OC and mCPBA 
(0.64 g, 3.7 mmol) was then added. The reaction mixture was kept at that temperature for 
2 hr, after which TLC indicated the disappearance of the starting material. After that the 
mixture was warmed to 0 OC and saturated aqueous NaHCO3 was added, the organic 
layer was separated, washed with brine, dried (Na2SO4) and concentrated in vacuo. The 
crude sulfoxide was used in the next step without further purification (2.0 g, 96%). NMR 
analysis was done on the crude to confirm the product: Rf = 0.5 (20% EtOAc/petroleum 
ether); 1H NMR (500 MHz, CDCl3) δ 1.48-1.64 (ovrlp m, 4H), 2.90 (t, 2H, J = 6.0 Hz), 
3.07 (dd, 1H, J = 4.3, 14.6 Hz), 3.32 (dd, 1H, J = 6.4, 14.6 Hz), 3.88 (t, 1H, J = 5.5 Hz), 
4.25 (s, 2H), 7.99 (d, J = 5.8 Hz), 7.09-7.16 (ovrlp m, 15H), 7.27 (d, 6H, J = 8.3 Hz), 
7.33 (t, 2H, J = 7.5 Hz), 7.44 (t, 1H, J = 6.7 Hz), 7.73 (d, 2H, J = 8.3 Hz); 13C NMR (125 
MHz, CDCl3) δ 25.4, 31.3, 61.0, 63.3, 71.6, 73.8, 86.7, 127.1, 127.9, 127.99, 128.1, 
128.5, 128.6, 128.9, 129.4, 133.7, 137.8, 140.4, 144.5; ESIHRMS (M+Na)+ calculated for 
C39H38O4SNa 583.2283, found 583.2275.  
The crude sulfoxide derivative (2.0 g, 3.6 mmol) from the previous step was 
dissolved in acetic anhydride (3.0 mL) and sodium acetate (1.5 g, 18.0 mmol). The 
reaction mixture was refluxed for 12 h after which time TLC indicated the disappearance 
of the starting material. The reaction mixture was then diluted with EtOAc then MeOH (6 
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aqueous NaHCO3 was added, the organic layer was separated, washed with brine, dried 
(Na2SO4) and concentrated in vacuo. FCC of the residue gave 1:1 diastereomeric mixture  
of the mix thioacetal 4.26 (1.9 g, 90%): Rf = 0.65 (20% EtOAc/petroleum ether); 1H 
NMR (500 MHz, CDCl3) δ 1.51-1.77 (ovrlp m, 4H), 1.88 (s, 2H), 2.10 (s, 2H), 2.89-2.92 
(m, 2H), 3.50 (m, 1H), 4.37 (d, 1H, J = 11.5 Hz), 4.59 (d, 1H, J = 11.0 Hz), 6.19 (d, 1H, J 
= 2.7 Hz), 7.08-7.16 (ovrlp m, 20H), 7.28-7.36 (ovrlp m, 5H); 13C NMR (125 MHz, 
CDCl3) δ 21.27, 26.28, 27.86, 63.26, 72.61, 79.78, 82.92, 86.57, 127.07, 128.55, 128.88, 
129.25, 132.44, 132.89, 133.56, 138.05, 144.54, 166.62, 169,91; ESIHRMS (M+Na)+ 
calculated for C39H38O4Na 625.2389, found 625.2392. 
 






To a solution of vinyl magnesium bromide (0.6 mL, 4.0 mmol) in anhydrous 
diethyl ether (10 mL), at -78 OC, was added t-BuLi (2.2 mL of a 1.7 M solution in 
pentane, 3.8 mmol) under an inert atmosphere. The reaction was maintained at this 
temperature for 1 h, then warm up to -40 OC and stir for an additional 0.5 h. The resulting 
solution of vinyllithium was cannulated into a mixture of thioacetal 4.26 (500 mg, 0.8 
mmol in dry ether (3 mL) at -40 OC. The reaction mixture was stirred at -40 OC for 30 
min then warmed to rt and allowed to stir at that temperature for another 0.5 h. The 
reaction was then poured into aqueous NH4Cl and the aqueous phase extracted with ether. 
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concentrated in vacuo.  FCC of the residue gave a mixture of allylic alcohols (298 mg, 
75%) as a yellow oil: Rf = 0.50 (20% EtOAc/petroleum ether); 1H NMR (500 MHz, 
CDCl3) δ 1.57-1.63 (m, 2H), 1.68-1.73 (m, 2H), 2.44 (d, 1H, J = 4.4 Hz), 3.02-3.06 (m, 
2H), 3.33 (m, 1H), 4.05 (q, 1H, J = 6.0 Hz), 4.49 (d, 1H, J = 11.3 Hz), 4.58 (d, 2H, J = 
11.3 Hz), 5.18-5.36 (m, 2H), 5.84 (m, 1H), 7.19-7.22 (ovrlp m, 4H), 7.25-7.32 (ovrlp m, 
14H), 7.40-7.42 (ovrlp m, 6H); 13C NMR (125 MHz, CDCl3) δ 25.7, 27.7, 63.6, 72.7, 
73.6, 74.6, 82.1, 86.6, 117.7, 127.1, 127.9, 128.0, 128.04, 128.06, 128.7, 128.9, 128.9, 
137.7, 137.8, 138.4, 138.5, 144.4, 144.5.      
A mixture of the product from the previous step  (200 mg, 0.4 mmol) and NaH 
(33 mg, 0.8 mmol), in dry DMF (2 mL) at 0 OC under an argon atmosphere was 
vigorously stirred for 0.5 h. The reaction mixture was then allowed to warm to rt and 
stirred for an additional 0.5 h. Bu4NI (15 mg, 40 µmol) was then added and the reaction 
mixture was recooled to 0 OC at which time PMBCl (0.1 mL, 0.6 mmol) was slowly 
intriduced. The ice bath was removed and after 2 h the mixture was poured into water. 
The aqueous phase was then extracted with diethyl ether, the combined organic phase 
washed with brine, dried (Na2SO4), filtered, and concentrated under reduced pressure. 
FCC afforded the PMB-ether (±) 4.27a anti and (±) 4.27b syn (237 mg, 95%) as a 2:1 
mixture: Rf = 0.60 (20% EtOAc/petroleum ether); 1H NMR (500 MHz, CDCl3) δ 1.41-
1.48 (m, 1H), 1.53-1.60 (m, 1H), 1.62-1.75 (m, 2H), 2.96 (t, 2H, J = 6.6 Hz), 3.39 (m, 
1H), 3.83 (t, 1H, J = 6.8 Hz), 4.34 (d, 1H, J = 12.4 Hz), 4.45 (d, 1H, J = 11.3 Hz), 4.58 
(d, 1H, J = 12.4 Hz), 4.65 (d, 1H, J = 11.3 Hz), 5.22 (m, 2H), 5.76 (m, 1H), 7.15-7.18 
(ovrlp m, 4H), 7.20-7.26 (ovrlp m, 14H), 7.36-7.38 (ovrlp m, 7H); 13C NMR (125 MHz, 
	   113	  
CDCl3) δ 26.3, 27.7, 63.7, 70.7, 73.4, 81.3, 82.8, 86.5, 118.9, 127.0, 127.6, 127.7, 127.89, 
127.9, 128.2, 128.45, 128.5, 128.9, 135.7, 138.8, 139.0, 144.6.  
 




The trityl ether mixture (±) 4.27a/4.27b (200 mg, 0.3 mmol) from the previous 
step was dissolved in a mix solvent: MeOH (2 mL) and DCM (1mL). PTSA.H2O (13 mg, 
0.1 mmol) was added to the reaction flask and the mixture stirred for 1 h after which 
time, TLC indicated the disappearance of the starting material. The reaction ixture was 
poured into NaHCO3 solution and the aqueous phase extracted with EtOAc. The 
combined organic phase was washed with brine, dried (Na2SO4), filtered, and 
concentrated under reduced pressure to give a crude alcohol 116 mg, 100 %). Without 
further purification, the alcohol (100 mg, 0.3 mmol) was subjected to a standard PCC 
oxidation protocol to give the resulting aldehyde (88 mg, 88%); Rf = 0.6 (20% ethyl 
acetate: petroleum ether). 1H NMR (500 MHz, CDCl3) δ 1.68 (m, 1H), 1.84 (m, 1H), 2.37 
(ovrlp m, 2H), 3.41 (m, 1H, H-C4), 3.75 (s, 3H), 3.84 (t, 1H, J = 6.4 Hz, H-C3), 4.26 (d, 
1H, J = 11.4 Hz), 4.42 (d, 1H, J = 11.4 Hz), 4.51 (d, 1H, J = 11.4 Hz), 4.66 (d, 1H, J = 
11.4 Hz), 5.28 (ovrlp m, 2H, H-C1), 5.76 (m, 1H, H-C2), 6.81 (d, 2H, J = 7.5 Hz), 7.18-
7.27 (ovrlp m, 7H, Ar buried under CDCl3 solvent peak), 9.59 (s, 1H); 13C NMR (125 
MHz, CDCl3) δ 23.8, 40.5, 55.5, 70.4, 73.4, 80.2, 82.1, 113.9, 119.3, 127.9, 128.4, 128.5, 
129.6, 130.6, 135.2, 138.5, 159.3, 202.6.  
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mmol), afforded the carboxylic acid (±) 4.28a/4.28b in a 2:1 ratio (67 mg, 98%): Rf = 0.5 
(30% ethyl acetate: petroleum ether); 1H NMR (500 MHz, CDCl3) δ 1.70-1.86 (m, 2H, 
H-C3), 2.34-2.51 (m, 2H, H-C2), 3.50-3.58 (m, 1H, H-C4), 3.76 (s, 3H), 3.83-3.88 (m, 
1H, H-C5), 4.28 (d, 2H, J = 11.6 Hz), 4.47 (d, 2H, J = 10.9 Hz), 4.52 (d, 2H, J = 11.9 
Hz), 4.70 (d, 2H, J = 11.4 Hz), 5.25-5.31 (m, 2H, H-C7), 5.79 (m, 1H, H-C6), 6.82 (d, 
2H, J = 8.3 Hz, Ar), 7.20-7.28 (ovrlp m, 7H, Ar buried under CDCl3 solvent peak); 13C 
NMR (125 MHz, CDCl3) δ 14.3, 22.6, 26.1, 34.3, 55.5, 70.2, 70.4, 72.9, 73.6, 80.1, 80.3, 
81.8, 82.3, 114.0, 119.4, 119.6, 127.8, 128.0, 128.2, 128.6, 129.5, 129.6, 130.6, 135.2, 
135.7, 138.5, 138.6, 159.3, 178.4, 178.5. 
 
Alkene-ester diastereomers 4.29a/4.29a’ and 4.29b/4.29b’ 	  
 	  
DCC coupling of the acid mixture 4.28a/4.28a’ and 4.28b/4.28b’ from the 
previous step (60 mg, 0.2 mmol) with cholestanol (0.1 g, 0.3 mmol) under standard 
esterification protocol afforded the respective ester mixture 4.29a/4.29a’ and 
4.29b/4.29b’ in a 2:1 ratio (94 mg, 80%) as a colorless oil: Rf = 0.8 (15% ethyl acetate: 
petroleum ether); 1H NMR (500 MHz, CDCl3) δ 0.52-0.55 (m, 1H), 0.56 (s, 3H), 0.72 (s, 
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1.06 (ovrlp m, 6H), 1.11-1.17 (ovrlp m, 4H), 1.19-1.26 (ovrlp m, 6H), 1.35-1.48 (ovrlp 
m, 5H), 1.55-1.69 (ovrlp m, 4H), 1.70-1.84 (ovrlp m, 2H), 1.88 (m, 1H), 2.18-2.32 (m, 
2H), 3.39-3.46 (m, 1H), 3.71 (s, 3H), 3.79 (t, 1H, J = 6.2 Hz), 4.24 (d, 1H, J = 12.3 Hz), 
4.41-4.51 (m, 2H), 4.54-4.59 (m, 1H), 4.65 (d, 1H, J = 11.6 Hz), 5.20-5.28 (m, 2H, H-
C7), 5.73 (m, 1H, H-C6), 6.77 (d, 2H, J = 8.4 Hz), 7.17 (t, 3H, J = 7.3 Hz), 7.23-7.24 
(ovrlp m, 4H, Ar-buried under CDCl3 solvent peak); 13C NMR (125 MHz, CDCl3) δ 12.2, 
12.4, 18.8, 21.4, 22.7, 23.0, 24.0, 24.4, 26.4, 26.43, 27.6, 27.7, 28.2, 28.4, 28.8, 30.9, 
31.0, 32.2, 34.2, 35.6, 35.63, 36.0, 36.3, 36.9, 39.7, 40.1, 42.8, 44.8, 54.4, 55.4, 56.4, 
56.6, 70.1,70.3, 72.8, 73.5, 73.8, 80.3, 80.5, 81.9, 82.3, 113.9, 119.1, 119.3, 127.66, 
127.7, 128.1, 128.11, 128.14, 128.5, 128.42, 128.45, 129.4, 129.5, 130.7, 130.73, 135.3, 
135.8, 138.78, 138.8, 159.22, 159.25, 173.3, 173.4. 
 




A solution of titanium tetrachloride (0.8 mL, 2 M in CH2Cl2, 1.6 mmol) was 
added to cool (0 OC) THF (2mL). The resulting mixture was stirred for 30 min at which 
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suspension was allowed to warm to ambient temperature and stirred for 30 min. At this 
point, zinc dust (0.2 g, 3.1 mmol) and lead (ll) chloride (3 mg, 10 µmol) were added in 
one portion, and stirring at ambient temperature was continued for 10 min. A solution of 
ester mixture 4.29a/4.29a’ and 4.29b/4.29b’ (75 mg, 0.1 mmol) and dibromomethane 
(0.1 ml, 1.4 mmol) in THF (1 mL) was then added via cannula to the reaction flask in one 
portion. The mixture was stirred at 60 OC for 1 h, cooled to 0 OC, then quenched by 
addition of saturated potassium carbonate (0.5 mL). The resulting mixture was stirred for 
30 min (while warming to ambient temperature), diluted with ether (5 mL), and stirred 
vigorously for 15 min. The resulting mixture was filtered through basic alumina using 3% 
triethylamine-ether as the eluent. The greenish-blue precipitate that resulted was 
triturated and thoroughly extracted by vigorous stirring over diethyl ether (10 – 15 mL) 
for 30 min. The combined ethereal extracts were concentrated in vacuo, azeotroped with 
benzene (3 x 10 mL), and redissolved in dry toluene (3 mL). NMR analysis was done to 
confirm the presence of the enol ether mixture 4.30a/4.30a’ and 4.30b/4.30b’ before the 
key Grubbs mediated cyclization: Rf = 0.8 (15% ethyl acetate: petroleum ether); 1H NMR 
(500 MHz, C6D6) δ 0.29 (s, 1H), 0.47 (s, 2H), 0.53 (m, 1H), 0.66 (s, 3H), 0.71 (d, 3H, J = 
5.3 Hz), 0.78-0.89 (ovrlp m, 4H), 0.95 (s, 3H), 0.98 (s, 3H), 1.03 (d, 3H, J = 6.6 Hz), 
1.10-1.17 (ovrlp m, 4H), 1.18-1.36 (ovrlp m, 13H), 1.41-1.47 (ovrlp m, 6H), 1.53-1.64 
(ovrlp m, 6H), 1.80 (m, 1H), 1.86-1.95 (m, 2H), 2.00-2.05 (ovrlp m, 3H), 2.16 (m, 1H), 
2.41 (m, 1H), 2.54 (m, 1H), 3.31 (s, 3H), 3.70 (m, 1H), 3.98 (m, 2H), 4.11 (s, 2H, H-C8), 
4.32 (d, 1H, J = 11.5 Hz), 4.57-4.62 (ovrlp m, 2H), 4.82 (d, 1H, J = 10.8 Hz), 5.17-5.29 
(m, 2H, H-C1), 5.89 (m, 1H, H-C2), 6.82 (d, 2H, J = 8.6 Hz), 7.12 (d, 1H, J = 7.4 Hz), 
7.19-7.31 (ovrlp m, 4H), 7.40 (t, 2H, J = 8.0 Hz); 13C NMR (125 MHz, C6D6) δ 1.8, 11.5, 
	   117	  
12.7, 12.8, 14.6, 14.7, 19.4, 21.9, 23.1, 23.4, 23.5, 23.7, 24.5, 24.7, 24.9, 25.1, 28.2, 28.4, 
28.8, 29.0, 29.4, 29.6, 29.7, 30.1, 30.2, 30.5, 30.6, 31.2, 32.7, 32.8, 34.4, 34.8, 34.9, 36.1, 
36.3, 36.6, 37.0, 37.5, 39.5, 39.6, 40.3, 40.8, 43.3, 45.3, 55.0, 55.1, 57.1, 57.2, 66.9, 68.4, 
70.7, 71.0, 73.3, 73.7, 75.8, 81.2, 81.7, 81.9, 82.9, 83.2, 114.4, 118.5, 118.9, 127.8, 
128.3-128.5 (buried under C6D6 solvent peak), 128.7, 128.8, 128.9, 129.0, 129.1, 129.2, 
129.4, 129.8, 131.1, 131.7, 133.7, 136.5, 137.0, 40.3, 160.0, 162.2, 167.9, 173.1.    	  
Cyclic enol ether diastereomers 4.31a/4.31a’ and 4.31b/4.31b’ 
 
 	  
After the crude enol ether mixture 4.30a/4.30a’ and 4.30b/4.30b’ (50 mg, 0.1 
mmol) was degassed thoroughly under nitrogen atmosphere for 30 min, the first aliquot 
(1/4) of Grubbs (ll) catalyst (30 mg, 35µmol, 35 mol %) was added and the reaction 
mixture heated to 60 OC. The remaining catalyst was added and heated in three equivalent 
portions over the next 3 h, and upon completion, the solvent was evaporated and the 
residue was partially separated and used for the oxidation step. NMR analysis confirmed 
the cyclic enol ether mixture 4.31a/4.31a’ and 4.31b/4.31b’: Rf = 0.8 (15% ethyl acetate: 
petroleum ether); 1H NMR (500 MHz, C6D6) δ 0.53 (t, 1H, J = 7.7 Hz), 0.66 (s, 3H), 0.71 
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1.10-1.17 (ovrlp m, 6H), 1.20-1.29 (ovrlp m, 7H), 1.40-1.46 (ovrlp m, 6H), 1.53-1.62 
(ovrlp m, 6H), 1.76-1.90 (ovrlp m, 4H), 2.00-2.07 (ovrlp m, 3H), 2.17-2.21 (m, 1H), 2.43 
(m, 1H), 3.30 (s, 3H), 3.78 (t, 1H, J = 3.4 Hz), 4.01 (m, 1H), 4.37 (t, 1H, J = 4.0 Hz), 
4.46-4.53 (ovrlp m, 2H), 4.60-4.67 (ovrlp m, 2H), 4.94 (dd, 1H, J = 4.1 Hz, J = 8.3 Hz), 
8.62 (d, 2H, J = 8.3 Hz), 7.11 (d, 1H, J = 7.2 Hz), 7.19 (t, 2H, J = 7.5 Hz), 7.34 (dd, 2H, J 
= 7.7 Hz, J = 10.4 Hz); 13C NMR (500 MHz, C6D6) δ 12.7, 14.6, 19.4, 21.9, 23.1, 23.4, 
23.7, 24.7, 24.9, 28.4, 28.6, 28.7, 28.8, 29.0, 29.3, 29.4, 32.8, 34.9, 35.1, 36.1, 36.2, 36.6, 
37.0, 37.4, 40.3, 40.9, 43.3, 45.3, 54.9, 55.0, 55.1, 57.1, 57.2, 71.0, 71.9, 73.0, 75.6, 78.1, 
94.7, 114.4, 127.9, 128.0, 128.3-128.7 (buried under C6D6 solvent peak), 128.8, 128.9, 
129.8, 132.9, 140.3, 156.7, 157.1, 159.9, 160.0; ESIHRMS (M+H)+ calculated for 
C48H71O4 711.5352, found 711.5334. 	  
Carbasugars 4.32a/4.32a’ and 4.32b/4.32b’ 	  
 	  
The cyclic enol ether mixture 4.31a/4.31a’ and 4.31b/4.31b’ (40 mg, 0.1 mmol) 
was dissolved in THF (3 mL) and cooled to 0 OC. BH3.Me2S (0.5 mL, 1M solution, 0.5 
mmol) was then added at that temperature, under an atmosphere of argon and the mixture 
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recooled to 0 OC and treated with a mixture of 3N NaOH (0.5 mL) and 30% aqueous 
H2O2 (0.5 mL) for 30 min. The solution was then diluted with ether and washed with 
saturated aqueous NaHCO3 and brine, dried (Na2SO4), filtered and evaporated under 
reduced pressure. FCC of the residue provided the respective alcohol (33 mg, 84%): Rf = 
0.6 (20% ethyl acetate: petroleum ether); 1H NMR (500 MHz, C6D6) δ 0.48 (t, 1H, J = 
8.5 Hz), 0.53 (s, 3H), 0.68 (s, 3H), 0.74 (s, 3H), 0.75 (s, 3H), 0.78 (d, 3H, J = 6.4 Hz), 
0.84-0.89 (ovrlp m, 3H), 0.92-1.03 (ovrlp m, 8H), 1.10-1.17 (ovrlp m, 12H), 1.18-1.22 
(ovrlp m, 7H), 1.30 (d, 1H, J = 5.6 Hz), 1.34-1.44 (ovrlp m, 5H), 1.52-1.55 (m, 2H), 
1.58-1.61 (m, 2H), 1.65-1.70 (m, 2H), 1.80-1.88 (m, 2H), 1.92-1.95 (m, 2H), 2.53 (bs, 
1H, OH), 3.12-3.17 (m, 1H), 3.20-3.34 (ovrlp m, 4H), 3.68 (s, 3H), 4.55 (s, 2H), 4.64 (d, 
1H, J = 10.8 Hz), 4.75 (d, 1H, J = 10.8 Hz), 6.74 (d, 1H, J = 8.4 Hz), 7.18-7.23 (ovrlp m, 
7H, Ar); 13C NMR (125 MHz, C6D6) δ 12.3, 12.5, 14.3, 18.2, 18.9, 21.5, 22.6, 22.8, 23.0, 
24.0, 24.4, 26.8, 26.9, 27.1, 28.2, 28.5, 28.9, 29.0, 29.1, 29.8, 30.0, 32.3, 35.4, 35.7, 35.9, 
36.0, 36.4, 36.5, 37.3, 37.4, 39.7, 40.3, 42.8, 45.2, 54.6, 55.5, 56.5, 56.7, 72.6, 75.2, 80.8, 
85.2, 114.0, 127.8, 128.6, 129.8, 131.4, 138.9, 159.4.    
Acetylation of the alcohol from the previous step (30 mg, 42 µmol) gave the 
acetylated carbasugar mixture 4.32a/4.32a’ and 4.32b/4.32b’ (33 mg, 90%) as a 
colorless oil which was purified by FCC: Rf = 0.6 (20% EtOAc: petroleum ether). 
4.32a/4.32a’; 1H NMR (500 MHz, C6D6) δ 0.53 (s, 3H), 0.72 (t, 1H, J = 9.0 Hz), 0.80 (s, 
3H), 0.85 (d, 3H, J = 6.0 Hz), 0.99 (s, 3H, J = 7.1 Hz), 1.05 (s, 3H), 1.06 (s, 3H), 1.09-
1.11 (m, 2H), 1.15 (d, 3H, J = 6.6 Hz), 1.22-1.26 (ovrlp m, 5H), 1.32-1.42 (ovrlp m, 
12H), 1.48 (t, 2H, J = 6.1 Hz), 1.57-1.62 (ovrlp m, 5H), 1.66-1.70 (m, 3H), 1.76-1.84 
(ovrlp m, 5H), 1.88-1.91 (m, 1H), 1.95-2.01 (m, 2H), 2.03 (s, 3H), 2.14-2.16 (m, 1H), 
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3.31-3.37 (m, 2H), 3.40-3.43 (ovrlp m, 4H), 3.58 (t, 1H, J = 9.4 Hz), 4.57 (d, 1H, J = 
11.7 Hz), 4.62 (d, 1H, J = 11.7 Hz), 4.89 (dd, 1H, J = 3.4 Hz, J = 11.2 Hz), 5.09 (d, 1H, J 
= 10.8 Hz), 5.49 (t, 1H, J = 9.6 Hz), 6.93 (d, 2H, J = 8.7 Hz), 7.33 (t, 3H, J = 7.5 Hz), 
7.48 (d, 4H, J = 6.8 Hz); 13C NMR (125 MHz, C6D6) δ 12.7, 12.8, 14.6, 19.4, 21.4, 21.5, 
22.0, 23.1, 23.4, 24.7, 24.9, 27.1, 28.8, 29.0, 29.6, 29.7, 30.5, 30.6, 32.9, 36.1, 36.3, 36.6, 
37.0, 37.9, 40.3, 40.9, 43.3, 45.6, 45.7, 55.1, 55.2, 57.1, 57.2, 72.8, 75.2, 77.2, 77.4, 77.6, 
79.0, 79.3, 81.5, 83.9, 84.0, 114.4, 127.9, 128.0, 128.9, 129.8, 132.1, 140.0, 169.6; 
ESIHRMS (M+Na)+ calculated for C50H74O6Na 793.5485, found 793.5375. 
4.32b/4.32b’; 1H NMR (500 MHz, C6D6) δ 0.40 (s, 3H), 0.60 (t, 1H, J = 8.2 Hz), 
0.68 (s, 3H), 0.74 (d, 3H, J = 5.5 Hz), 0.82-0.91 (ovrlp m, 4H), 0.93 (s, 3H), 0.95 (s, 3H0, 
1.03 (d, 4H, J = 6.7 Hz), 1.10-1.17 (ovrlp m, 4H), 1.20-1.30 (ovrlp m, 12H), 1.36-1.39 
(ovrlp m, 6H), 1.46 (ovrlp m, 5H), 1.54-1.60 (ovrlp m, 4H), 1.65-1.72 (ovrlp m, 5H), 
1.86 (m, 2H), 1.97 (s, 3H), 2.03 (m, 2H), 3.24 (d, 1H, J = 9.9 Hz), 3.31-3.36 (ovrlp m, 
5H), 3.68 (s, 1H), 4.36 (d, 1H, J = 11.8 1H, J = 9.6 Hz), 6.83 (d, 2H, J = 8.7 Hz), 7.09 (d, 
2H, J = 7.3 Hz), 7.28-7.35 (ovrlp m, 5H); 13C NMR (125 MHz, C6D6) δ 12.2, 12.3, 14.2, 
18.8, 21.0, 21.4, 22.6, 22.8, 22.9, 24.2, 24.4, 25.1, 26.0, 26.2, 28.2, 28.5, 29.0, 29.1, 29.2, 
30.0, 30.2, 32.4, 35.6, 35.7, 35.8, 36.0, 36.5, 37.3, 37.4, 39.7, 40.3, 42.7, 45.2, 54.6, 54.7, 
56.6, 71.3, 71.4, 72.8, 72.9, 75.0, 75.3, 77.4, 77.5, 78.1, 78.5, 81.2, 81.3, 113.9, 127.3, 
127.7-128.1 (buried under C6D6 solvent peak), 128.2, 128.3, 128.8, 131.1, 139.4, 159.5, 
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Cyclic alkenoic-acid 4.36 	  
 	  
4.35: Rf = 0.8 (20% EtOAc: petroleum ether); 1H NMR (500 MHz, CDCl3) δ 1.34 (s, 
3H), 1.48 (s, 3H), 3.67 (s, 3H), 4.63 (t, 1H, J = 7.4 Hz), 4.70 (t, 1H, J = 5.7 Hz), 5.12 (d, 
1H, J = 10.3 Hz), 5.29 (d, 1H, J = 17.1 Hz), 5.62 (m, 1H), 6.00 (d, 1H, J = 1.4 Hz), 6.72 
(d, 1H, J = 5.6 Hz); 13C NMR (125 MHz, CDCl3) δ 23.0, 25.3, 49.3, 75.1, 77.4, 116.9, 
119.8, 125.9, 131.0, 141.5, 164.0.  
Conjugated ester 4.35 (3.0 g, 14.2 mmol) was dissolved in MeOH (95 mL) and 
CuCl (0.1 g, 1.4 mmol) was added and the reaction mixture cooled to -78 OC. NaBH4 (2.7 
g, 70.8 mmol) was then added in one portion to the reaction. The brown slurry was stirred 
vigorously at -78 OC until the color changed from brown to black over a period of 2 h. A 
1 mL sample was removed by syringed, concentrated and used for an NMR analysis 
which, indicated the complete reduction of the starting material. The reaction was then 
slowly brought to rt, filtered and concentrated in vacuo to give a crude oil. FCC of the 
residual oil gave the reduced ester (2.97 g, 98%): Rf = 0.8 (20% EtOAc: petroleum ether); 
1H NMR (500 MHz, CDCl3) δ: 1.38 (s, 3H), 1.50 (s, 3H), 1.75-1.80 (m, 2H), 2.42 (m, 
1H), 2.52 (m, 1H), 3.70 (s, 3H), 4.18 (dt, 1H, J = 5.5 Hz, J = 2.7 Hz), 4.57 (t, 1H, J = 6.5 
Hz), 5.29 (d, 1H, J = 10.4 Hz), 5.37 (d, 1H, J = 17.1 Hz), 5.84 (m, 1H); 13C NMR (125 
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The alkene-methyl ester (1.21 g, 5.65 mmol) from the previous step was dissolved 
in a 2:1 THF:H2O (6 mL) mixture and 3N NaOH (6 mL) was added. An extra 6 mL of 
THF was added to clear up the suspension which was then stirred vigorously overnight. 
1N HCl (15 mL) was then added to the reaction mixture until, by pH indication, the 
mixture was weakly acidic. The aqueous layer was extracted with EtOAc and the 
combined organic phase was washed with brine, dried (Na2SO4), and concentrated in 
vacuo to give a residual oil. FCC of the oil gave 4.36 (1.12 g, 99%): Rf = 0.4 (20% 
EtOAc: petroleum ether); 1H NMR (600 MHz, CDCl3) δ 1.38 (s, 3H), 1.49 (s, 3H), 1.76 
(m, 2H), 2.46 (m, 1H), 2.55 (m, 1H), 4.19 (m, 1H), 4.57 (t, 1H, J = 6.9 Hz), 5.29 (d, 1H, J 
= 10.4 Hz), 5.37 (d, 1H, J = 17.2 Hz), 5.85 (m, 1H), 11.51 (bs, 1H); 13C NMR (125 MHz, 
CDCl3) δ 25.6, 25.8, 28.1, 30.6, 79.5, 108.6, 118.9, 133.6, 179.5; ESIHRMS (M+H)- 
calculated for C10H15O4 199.0970, found 199.0977. 	  
Cyclic alkene-enol ether 4.37 	  
 	  
DCC coupling of 4.36 (500 mg, 2.50 mmol) and cholestanol (972 mg, 2.50 
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the respective alkene-chlolestanol ester (1.40 g, 98%): Rf = 0.7 (10% EtOAc: petroleum 
ether); 1H NMR (500 MHz, CDCl3) δ 0.47 (t, 1H, J = 11.8 Hz), 0.65 (s, 3H), 0.68 (s, 3H), 
0.76-0.83 (m, 2H), 0.93 (s, 3H), 0.94 (s, 3H), 1.02 (d, 3H, J = 6.4 Hz), 1.12 (m, 5H), 
1.17-1.26 (m, 6H), 1.28 (s, 3H), 1.30-1.32 (m, 5H), 1.35-1.40 (m, 10H), 1.42-1.44 (m, 
3H), 1.47 (s, 3H), 1.57-1.60 (m, 5H), 1.68 (d, 1H, J = 10.1 Hz), 1.73-1.77 (m, 1H), 1.84-
1.89 (m, 2H), 1.98 (d, 1H, J = 12.8 Hz), 4.01 (m, 1H), 4.33 (t, 1H, J = 6.7 Hz), 4.93 (m, 
1H), 5.00 (d, 1H, J = 10.4 Hz), 5.18 (d, 1H, J = 17.0 Hz), 5.70 (m, 1H); 13C NMR (125 
MHz, CDCl3) δ 11.9, 12.0, 14.1, 18.7, 21.2, 22.5, 22.7, 22.8, 24.0, 24.2, 25.4, 26.4, 27.7, 
28.0, 28.3, 28.5, 29.5, 29.8, 29.9, 31.2, 32.0, 34.2, 35.2, 35.3, 35.9, 36.3, 36.6, 39.6, 40.0, 
42.5, 44.3, 54.0, 56.3, 73.3, 77.2, 79.3, 108.0, 117.2, 134.6, 172.1; ESIHRMS (M+H)+ 
calculated for C37H63O4 571.4726, found 571.4717. 
To a mixture of alkene-ester from the previous step (200 g, 0.35 mmol), and 
pyridine (0.10 mL) in a 3:1 mixture of anhydrous toluene:THF (6 mL), was added, under 
an argon atmosphere at –78 OC, Tebbe reagent (5.71 mL, 0.5M in THF). The reaction 
mixture was warmed to rt and stirred at this temperature for 1h. The reaction mixture was 
then slowly poured into a solution of 1N aqueous NaOH at 0 OC, and the resulting 
suspension extracted with ether. The combined organic phase was washed with brine, 
dried (Na2SO4), filtered and concentrated in vacuo. The crude material was filtered over 
basic alumina to give alkene-enol ether 4.37 (140 mg, 70% based on recovered starting 
material) as light yellow oil: Rf = 0.7 (on alumina, 10% EtOAc: petroleum ether: 2% 
TEA); 1H NMR (500 MHz, C6D6) δ 0.65 (td, 1H, J = 3.8 Hz, J = 3.4, J = 4.0 Hz), 0.78 (s, 
3H), 0.82 (s, 3H), 0.92 (m, 1H), 0.99 (m, 4H), 1.05 (m, 5H), 1.06 (m, 5H), 1.15 (d, 3H, J 
= 6.6 Hz), 1.26 (m, 6H), 1.46 (m, 27H), 1.56 (m, 6H), 1.64 (s, 3H), 1.70 (m, 4H), 1.74 
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(m, 2H), 1.90 (m, 2H), 2.01 (m, 2H), 2.13 (m, 2H), 2.43 (m, 1H), 2.64 m, 1H), 4.08 (m, 
1H), 4.17 (s, 1H), 4.23 (m,1H), 4.25 (s, 1H), 4.51 (t, 1H, J = 6.4 Hz), 5.15 (d, 1H, J = 
10.4 Hz), 5.32 (dt, 1H, J = 1.2, 1.3 Hz), 5.92 (m, 1H); 13C NMR (125 MHz, C6D6) δ 12.1, 
12.2, 14.2, 18.8, 21.3, 22.6, 22.8, 22.9, 24.1, 24.3, 25.7, 27.7, 28.2, 28.3, 28.5, 28.8, 29.1, 
29.6, 29.9, 30.0, 32.1, 32.2, 32.9, 34.2, 35.5, 35.7, 36.0, 36.5, 36.9, 39.7, 40.3, 42.7, 44.7, 
46.4, 54.4, 56.5, 56.6, 75.3, 77.7, 79.7, 81.3, 108.0, 117.0, 135.3, 161.2; ESIHRMS 
(M+H)+ calculated for C38H65O3 569.4934, found 569.4951. 	  
Cyclic enol ether 4.38 
 
 	  
Alkene-enol ether 4.37 (100 mg, 0.18 mmol) was subjected to Grubbs ΙΙ mediated 
olefin metathesis following a similar procedure that was used in the synthesis of 
4.31a/4.31a’ and 4.31b/4.31b’, to give the cyclic enol ether 4.38 (71 mg, 75%) as a light 
brown oil: Rf = 0.6 (on alumina, 10% EtOAc: petroleum ether: 2% TEA); 1H NMR (500 
MHz, C6D6) δ 0.66 (t, 1H, J = 11.5 Hz), 0.78 (s, 3H), 0.82 (s, 3H), 0.85-0.89 (m, 1H), 
0.94-1.0 (m, 10H), 1.05 (s, 3H), 1.07 (s, 3H), 1.15, (d, 3H, J = 6.6 Hz), 1.25 (m, 8H), 1.37 
(m, 9H), 1.51 (m, 1H), 1.55 (s, 3H), 1.58 (m, 3H), 1.65-1.70 (m, 3H), 1.71 (s, 3H), 1.72-
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4.81 (t, 1H, J = 5.1 Hz), 4.95 (d, 1H, J = 3.9 Hz); 13C NMR (125 MHz, C6D6) δ 12.1 (two 
signals), 18.8, 21.3, 22.6, 22.8, 24.1, 24.3, 24.7, 26.1, 26.7, 27.9, 28.2, 28.5, 28.6, 28.7, 
32.2, 34.2, 35.5, 35.6, 36.0, 36.5, 36.8, 39.7, 40.3, 42.7, 44.6, 54.4, 56.5, 56.6, 72.8, 73.6, 




Hydroboration oxidation on 4.38 (60 mg, 0.11 mmol) following a similar 
procedure that was performed on 4.31a/4.31a’ and 4.31b/4.31b’, resulted in the alcohol 
derivative of 4.38 as a colorless oil (50 mg, 80%): Rf = 0.6 (20% EtOAc: petroleum 
ether); 1H NMR (500 MHz, C6D6) δ 0.70 (td, 1H, J = 4.1, 2.3, 3.9 Hz), 0.81 (s, 3H), 0.85 
(s, 3H), 0.92-1.02 (m, 2H), 1.05 (d, 3H, J = 1.2 Hz), 1.07 (d, 3H, J = 1.2 Hz), 1.20-1.25 
(m, 2H), 1.33-1.43 (m, 12H), 1.46 (s, 3H), 1.58 (m, 4H), 1.63 (s, 3H), 1.67-1.77 (m, 4H), 
1.80 (m, 1H), 1.89 (m, 1H), 1.97-2.04 (m, 1H), 2.092.07-2.12 (m, 1H), 2.16 (t, 1H, J = 
3.0 Hz), 2.81 (s, 1H), 3.12 (td, 1H, J = 3.9, 9.7, 10.9 Hz), 3.38 (m, 1H), 3.93 (d, 1H, J = 
7.5 Hz), 4.08 (m, 1H), 4.12 (d, 1 H, J = 7.3 Hz); 13C NMR (125 MHz, C6D6) δ 12.2, 12.3, 
18.8, 21.4, 22.6, 22.8, 24.0, 24.2, 24.4, 24.7, 26.5, 28.2, 28.4, 28.5, 29.0, 30.0, 32.3, 35.3, 
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signals), 77.8, 80.8, 108.6. 
Acetylation of the alcohol from the previous step (40 mg, 0.07 mmol) following 
the procedure that was used in the synthesis of 4.32a/4.32a’ and 4.32b/4.32b’ gave 
carbasugar 4.39 as a colorless oil (42 mg, 99%): Rf = 0.7 (15% EtOAc: petroleum ether); 
1H NMR (500 MHz, CDCl3) δ 0.61 (td, 1H, J = 2.0, 4.2, 3.9 Hz), 0.67 (s, 3H), 0.88 (d, 
3H, J = 2.3 Hz), 0.90 (d, 3H, J = 2.3 Hz), 0.92 (d, 3H, J = 6.5 Hz), 0.98-1.06 (m, 4H), 
1.08-1.18 (m, 6H), 1.24-1.28 (m, 5H), 1.32-1.35 (m, 4H), 1.37 (s, 3H), 1.47-1.56 (m, 
4H), 1.58 (bs, 10H), 1.65-1.85 (m, 8H), 1.98 (m, 1H), 2.12 (s, 3H), 2.18-2.21 (m, 1H), 
3.26 (m, 2H), 4.0 (d, 1H, J = 7.8 Hz), 4.27 (m, 1H), 5.04 (d, 1H, J = 10.0 Hz); 13C NMR 
(125 MHz, CDCl3) δ 12.1, 12.3, 18.7, 21.2, 21.3, 22.6, 22.8, 23.6, 23.8, 24.2, 26.1, 26.5, 
27.9, 28.0, 28.3, 28.9, 29.4, 32.1, 35.3, 35.5, 35.7, 35.8, 36.2, 37.1, 39.5, 40.1, 42.6, 45.0, 




Methyl iodoarabinoside 4.47 (3.62 g, 7.97 mmol) was dissolved in EtOH (30 mL) 
in a 250 mL round bottom flask charged with a magnetic stir bar. Activated zinc dust 
(5.14 g, 79.7 mmol) and CH2Br2 (0.2 mL) were added and the mixture stirred for 2 hr, 
after which, TLC indicated the disappearance of the starting material. The reaction 
mixture was then filtered over a bed of celite, concentrated in vacuo, purified by FCC to 





 Zn, EtOH, CH2Br2
94%
4.47 4.48
five steps from arabinose
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NMR (500 MHz, CDCl3) δ 3.76 (d, 1H, J = 1.5 Hz), 4.10 (d, 1H, J = 4.1 Hz), 4.28 (d, 1H, 
J = 12.1 Hz), 4.56 (d, 1H, J = 6.7 Hz, J = 6.7 Hz), 4.68 (d, 1 H, J = 12.1 Hz), 5.29 (dd, 
2H, J = 10.6, 17.5 Hz), 5.87 (m, 1H), 7.19-7.29 (m, 10H), 9.6 (s, 1H); 13C NMR (125 
MHz, CDCl3) δ 70.7, 73.5, 79.9, 85.2, 119.9, 127.8, 127.9, 128.1, 128.2, 128.4, 128.5, 
133.8, 137.1, 137.5, 202.6; ESILRMS (M+Na)+ calculated for C19H20O3Na 319.1, found 
319.1. 	  
Conjugated methyl ester 4.49 
 
 	  
Aldehyde 4.48 (2.0 g, 6.76 mmol) and Wittig salt Ph3P=CHCO2Me (4.52 g, 13.52 
mmol) were dissolved in 40 mL of dry CH3CN in a 250 mL round bottom flask equipped 
with a magnetic stir bar and a nitrogen balloon. The reaction mixture was slowly brought 
to boiling then refluxed at that temperature for 2 hr. After cooling to room temperature, 
the mixture was filtered, concentrated under reduced pressure, purified by FCC to give 
the conjugated methyl ester 4.49 (2.38 g, 98%) as a colorless oil: Rf = 0.8 (20% EtOAc: 
petroleum ether); 1H NMR (500 MHz, CDCl3) δ 3.78 (s, 3H), 3.96 (dd, 1 H, J = 5.8, 6.5 
Hz), 4.14 (d, 1 H, J = 1.3 Hz), 4.45 (d, 1 H, J = 12.1 Hz), 4.54 (d, 1H, J = 12.0 Hz), 4.67 
(d, 2H, J = 12.1 Hz), 5.35 (dd, 2H, J = 8.8, 15.6 Hz), 5.80 (m, 1H), 6.11 (d, 1H, J = 1.4 
Hz), 6.96 (d, 1H, J = 5.7 Hz), 7.30-7.35 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 51.6, 
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145.1, 166.5; ESILRMS (M+Na)+ calculated for C22H24O4Na 375.2, found 375.2. 	  
Alkene-acid 4.50 	  
 
 
The conjugated ester 4.49 (1.20 g, 3.40 mmol) was reduced with NaBH4 (646 mg, 
17.1 mmol) in the presence of CuCl (40 mg, 0.34 mmol), following a similar procedure 
used in the 4.35 è 4.36 transformation, to give the reduced product as a colorless oil 
(1.18 g, 99%): Rf = 0.7 (10% EtOAc: petroleum ether). 1H NMR (500 MHz, CDCl3) δ 
1.77 (m, 1H), 1.96 (m, 1H), 2.40 (m, 1H), 3.55 (m, 1H), 3.63 (s, 3H), 3.94 (t, 1H, J = 6.7 
Hz), 4.43 (d, 1H, J = 11.9 Hz), 4.55 (d, 1H, J = 11.4 Hz), 4.67 (d, 1H, J = 12.0 Hz), 4.78 
(d, 1H, J = 11.4 Hz), 5.36 (m, 2H), 5.85 (m, 1H), 7.29-7.36 (m, 10H); 13C NMR (125 
MHz, CDCl3) δ 26.2, 30.2, 51.5, 70.6, 73.3, 80.0, 82.6, 119.1, 127.5, 127.6, 127.7, 128.0, 
128.3, 128.3, 128.4, 135.0, 138.5, 138.6, 174.1; ESILRMS (M+Na)+ calculated for 
C22H26O4Na 377.2, found 377.2. 
The ester from the previous step (1.10 g, 3.11 mmol) was hydrolyzed to the 
carboxylic acid 4.50 (1.05 g, quant) following the procedure that was used in the 
synthesis of 4.36. For acid 4.50: Rf = 0.6 (30% EtOAc: petroleum ether). 1H NMR (500 
MHz, CDCl3) δ 1.67 (m, 1H), 1.86 (m, 1H), 2.33 (m, 2H), 3.48 (m, 1H), 3.85 (t, 1H, J = 
6.7 Hz), 4.33 (d, 1H, J = 11.9 Hz), 4.47 (d, 1H, J = 11.4 Hz), 4.57 (d, 1H, J = 11.9 Hz), 
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10H); 13C NMR (125 MHz, CDCl3) δ 23.6, 27.8, 68.3, 71.1, 77.6, 80.2, 117.0, 125.3, 
125.4, 125.5, 125.8, 126.1, 132.5, 136.0, 136.1, 175.9; ESILRMS (M-H)- calculated for 
C21H23O4 339.17, found 339.1. 
 




Acid 4.50 (1.0 g, 2.94 mmol) was coupled with cholestanol (1.14 g, 2.94 mmol) 
following the esterification procedure that was used in the synthesis of 4.37. This resulted 
in the alkene-cholestanol ester as a colorless oil (1.80 g, 90%): Rf = 0.8 (20% EtOAc: 
petroleum ether); 1H NMR (500 MHz, CDCl3) δ 0.36 (td, 1H, J = 3.9, 3.1, 4.1 Hz), 0.53 
(s, 3H), 0.56 (s, 3H), 0.64-0.73 (m, 2H), 0.81 (s, 3H), 0.83 (s, 3H), 0.90 (d, 3H, J = 6.5 
Hz), 1.00, (m, 6H), 1.11 (m, 7H), 1.26 (m 2H), 1.32 (m, 3H), 1.39-1.49 (m, 5H), 1.55 (m 
1H), 1.73-1.88 (m, 4H), 2.04 (m, 1H), 2.32-2.45 (m, 2H), 3.50 (m, 1H), 3.78 (t, 1H, J = 
6.9 Hz), 4.17 (d, 1H, J = 12.1 Hz), 4.41 (dd, 2H, J = 11.6, 12.1 Hz), 4.62 (d, 1H, J = 11.7 
Hz), 4.79 (m, 1H), 5.03 (dd, 2H, J = 10.5, 17.3 Hz), 5.65 (m, 1H), 6.97-7.00 (m, 2H), 
7.07 (d, 4H, J = 7.3 Hz), 7.22 (t, 4H, J = 8.0 Hz); 13C NMR (125 MHz, CDCl3) δ 12.3 
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34.6, 35.6, 35.7, 36.2, 36.7, 37.0, 39.9, 40.4, 42.9, 44.7, 54.4, 56.7 (two signals), 70.8, 
73.4, 73.5, 80.4, 82.9, 118.5, 127.6 (two signals), 127.9, 128.1, 128.3, 128.5, 128.6, 
135.5, 139.3, 139.6, 172.8; ESIHRMS (M+Na)+ calculated for C48H70O4Na 733.53, found 
733.518. 
The ester from the previous step (1.0 g, 1.41 mmol) was subjected to a similar 
Takai methylenation protocol that was employed in the synthesis of 4.30a/4.30a’ and 
4.30b/4.30b’. This gave rise to the alkene-enol ether 4.51 as a yellow oil (658 mg, 66%): 
Rf = 0.7 (10% EtOAc: petroleum ether: 1% TEA); 1H NMR (500 MHz, C6D6) δ 0.65 
(ddd, 1H, J = 2.8, 3.9, 4.1 Hz), 0.78 (s, 3H), 0.82 (s, 3H), 0.89-0.97 (m, 2H), 1.05 (s, 3H), 
1.06 (s, 3H), 1.15 (d, 3H, J = 6.5 Hz), 1.24-1.48, (m, 18H), 1.53-1.58 (m, 4H), 1.65-1.76 
(m 6H), 1.91 (m, 1H), 1.97 (s, 3H), 1.98-2.05 (m 2H), 2.14 (m, 2H), 2.28 (m, 1H), 2.53 
(m, 1H), 2.65 (m, 1H), 3.79 (m, 1H), 4.08 (t, 2H, J = 6.0 Hz), 4.17 (s, 1H), 4.22 (s, 1H), 
4.44 (d, 1H, J = 12.1 Hz), 4.70 (dd, 2H, J = 2.4, 3.0 Hz), 4.91 (d, 1H, J = 11.6 Hz), 5.31 
(dd, 2H, J = 10.5, 17.4 Hz), 5.97 (m, 1H), 7.23 (d, 2H, J = 7.1 Hz), 7.31 (t, 4H, J = 8.0 
Hz), 7.48 (d, 4H, J = 7.5 Hz); 13C NMR (125 MHz, C6D6) δ 12.3, 12.4, 19.0, 21.6, 22.8, 
23.0, 24.4, 24.6, 27.9, 28.4, 28.7, 29.0, 29.3, 30.1, 30.2, 32.3, 32.4 (two signals), 34.5, 
35.7, 35.9, 36.2, 36.7, 37.1, 39.9, 40.5, 42.9, 45.0, 54.6, 56.1, 56.7, 56.8, 70.8, 73.3, 75.4, 
80.8, 81.5, 82.9, 118.2, 127.5, 127.6 (two signals), 127.7, 127.9, 128.1, 128.3, 128.4, 
128.5, 128.6, 135.9, 139.4, 139.9, 161.8; ESIHRMS (M+Na)+ calculated C49H72O3Na 
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Enol ether 4.52 
 
 	  
Enol ether 4.51 (200 mg, 0.28 mmol) was transformed, via Grubbs ΙΙ mediated 
olefin metathesis following a similar procedure used in the synthesis of 4.38, to enol ether 
4.52 (144 mg, 80%) as a light brown oil: Rf = 0.8 (20% EtOAc: petroleum ether: 1% 
TEA); 1H NMR (500 MHz, C6D6) δ 0.45 (ddd, 1H, J = 2.8, 3.7, 4.0 Hz), 0.58 (s, 3H), 
0.66-0.77 (m, 3H), 0.85 (s, 3H), 0.86 (s, 3H), 0.95 (d, 3H, J = 6.5 Hz), 1.02-1.10 (m, 7H), 
1.12-1.28 (m, 13H), 1.37 (m, 6H), 1.46-1.55 (m, 7H), 1.66-1.83 (m, 4H), 1.93 (m, 3H), 
2.10 (m, 1H), 2.34 (m, 1H), 3.68 (m, 1H), 3.93 (m, 1H), 4.27 (t, 1H, J = 4.2 Hz), 4.40 
(dd, 2H, J = 12.1, 14.2 Hz), 4.56 (d, 2H, 4.6 Hz), 4.9 (d, 1H, J = 4.0 Hz), 7.03 (d, 2H, J = 
7.2 Hz), 7.12 (t, 4H, J = 7.4 Hz), 7.26 (d, 2H, J = 7.5 Hz), 7.32 (d, 2H, J = 7.5 Hz); 13C 
NMR (125 MHz, C6D6) δ 12.3, 12.4, 19.0, 21.6, 22.8, 23.0, 24.3, 24.4, 24.6, 26.1, 28.1, 
28.4, 28.7, 29.0, 29.2, 30.2, 32.4, 34.7, 35.7, 35.9, 36.2, 36.7, 37.1, 39.9, 40.5, 42.9, 44.9, 
54.6, 56.7, 56.8, 71.1, 71.2, 75.1, 77.1, 77.5, 94.0, 126.9, 127.5, 127.6, 127.8, 127.9, 
128.1, 128.3 128.5, 128.9, 139.7, 140.1, 156.5; ESIHRMS (M+Na)+ calculated 





















Hydroboration oxidation on 4.52 (120 mg, 0.18 mmol) following a similar 
procedure that was performed on 4.31a/4.31a’ and 4.31b/4.31b’, gave the alcohol 
derivative of 4.52 (80 mg, 63%), following the oxidation procedure used to make 4.39.  
The crude alcohol was acetylated as before (cf. Scheme 4.3) to give β-carba-xyloside 
4.53 as a colorless oil (77 mg, quant): Rf = 0.8 (20% EtOAc: petroleum ether); 1H NMR 
(500 MHz, CDCl3) δ 0.51 (m, 1 H), 0.57 (s, 3H), 0.68 (s, 3H), 0.73 (t, 1H, J = 9.2 Hz), 
0.78 (d, 3H, J = 2.2 Hz), 0.80 (d, 3H, J = 2.2 Hz), 0.82 (d, 3H, J = 6.8 Hz), 0.91 (m, 5H), 
0.98-1.07 (m, 9H), 1.15-1.20 (m, 10H), 1.22-1.30 (m, 10H), 1.36-1.51 (m, 8H), 1.55-1.66 
(m, 5H), 1.73 (m, 2H), 1.87 (m, 2H), 1.90 (s, 3H), 1.97 (m, 2H), 3.17 (m, 1H), 3.23 (ddd, 
1H, J = 4.9, 9.9, 10.0 Hz), 3.43 (ddd, 1H, J = 4.7, 9.6, 10.7 Hz), 4.57 (d, 3H, J = 8.8 Hz), 
4.80 (d, 1H, J = 11.5 Hz), 4.85 (t, 1H, J = 9.6 Hz), 7.19-7.25 (m, 10H); 13C NMR (125 
MHz, CDCl3) δ 12.1, 12.3, 18.7, 21.2, 21.3, 22.6, 22.8, 23.8, 24.2, 26.4, 27.5, 28.0, 28.3, 
28.9, 29.4, 32.1, 35.4, 35.5, 35.7, 35.8, 36.2, 37.1, 39.5, 40.1, 42.6, 45.0, 54.4, 56.3, 56.5, 
72.6, 75.1, 76.7, 77.0, 79.0, 81.0, 83.5, 127.5, 127.6, 127.7, 127.8 (two signals), 128.0, 
128.3, 128.4 (two signals), 138.6, 138.8, 170.0; ESIHRMS (M+Na)+ calculated 
















 To Triol 4.66 (10.0 g, 0.061 mol), and p-anisaldehyde dimethyl acetal (12.46 mL, 
0.073 mol) in (300 mL) of a 1:1 DCM:DMF mixture, in a 500 mL round bottom flask 
equipped with a magnetic stir bar and a nitrogen balloon, was added PTSA (1.05 g, 6.10 
mmol) at 0 OC.  The reaction mixture was stirred at that temperature until TLC indicated 
the disappearance of the starting material. The reaction was then quenched with aqueous 
NaHCO3, extracted with EtOAc, dried (Na2SO4), concentrated in vacuo to give a crude 
oil. FCC of the residual oil gave 4.67 (16.9 g, 98%): Rf = 0.6 (20% EtOAc: petroleum 
ether). 1H NMR (500 MHz, CDCl3) δ 3.00 (dd, 1H, J = 3.1, 10.2 Hz), 3.35, (s, 3H), 3.51-
3.64 (ovrlp m, 2H), 3.69 (s, 3H), 4.41 (t, 1H, J = 2.6 Hz), 4.59 (d, 1H, J = 5.6 Hz), 4.86 
(d, 1H, J = 5.6 Hz), 4.97 (s, 1H), 5.80 (s, 1H), 6.78 (d, 2H, J = 8.8 Hz), 7.26 (d, 2H, J = 
8.7 Hz); 13C NMR (125 MHz, CDCl3) δ 55.5, 55.8, 64.3, 81.2, 85.3, 88.4, 104.3, 109.4, 
114.1, 128.1, 128.3, 160.9; minor product: Rf = 0.65 (20% EtOAc: petroleum ether). 1H 
NMR (500 MHz, CDCl3) δ 3.17 (dd, 1H, J = 2.6, 10.9 Hz), 3.35, (s, 3H), 3.51-3.64 (ovrlp 
m, 2H), 3.69 (s, 3H), 4.48 (t, 1H, J = 2.8 Hz), 4.55 (d, 1H, J = 6.2 Hz), 4.77 (d, 1H, J = 
6.2 Hz), 5.00 (s, 1H), 5.61 (s, 1H), 6.78 (d, 2H, J = 8.8 Hz), 7.30 (d, 2H, J = 8.7 Hz); 13C 
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 Benzylidene acetal 4.67 (12.0 g, 0.043 mol) was dissolved with DCM (212 mL) 
in a 500 mL round bottom flask charged with a magnetic stirrer and nitrogen. The 
mixture was cooled to 0 OC before DIBALH (43 mL of 1 M solution in DCM, 1mol 
equiv.) was slowly added. The reaction mixture was vigorously stirred at that temperature 
for 1 hr then slowly warmed to rt and stirring was continued for an additional hr, at which 
time TLC indicated the disappearance of the starting material. The reaction mixture was 
then slowly poured into water, extracted with EtOAc, dried (Na2SO4), concentrated in 
vacuo to give a thick oily residue. FCC of the residue gave a colorless oil, 4.68 (11.5 g, 
95%): Rf = 0.4 (20% EtOAc: petroleum ether); 1H NMR (500 MHz, CDCl3) δ 2.02 (dd, 
1H, J = 4.0, 8.8 Hz), 2.52 (d, 1H, J = 8.0 Hz), 3.27 (s, 3H), 3.50 (m, 1H), 3.66 (t, 1H, J = 
3.2 Hz), 3.69 (s, 3H), 3.78 (d, 1H, J = 5.4 Hz), 3.95 (q, 1H, J = 3.7 Hz), 4.12-4.15 (m, 
1H), 4.44 (d, 1H, J = 11.3 Hz), 4.53 (d, 1H, J = 11.3 Hz), 4.76 (s, 1H), 6.78 (d, 2H, J = 
8.6 Hz), 7.16 (d, 2H, J = 8.5 Hz); 13C NMR (125 MHz, CDCl3) δ 55.5, 56.0, 63.3, 71.1, 
73.1, 82.8, 86.2, 128.5, 129.2, 130.0, 159.9; ESIHRMS (M+Na)+ calculated C14H20O6Na 
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To a solution of 4.68 (5.0 g, 17.6 mmol) in dry toluene (176 mL) was added 
triphenylphosphine (9.24, 0.04 mol) and imidazole (2.40 g, 0.04 mol) and the mixture 
cooled to 0 OC while stirring under an inert atmosphere. Iodine (5.37 g, 0.02 mol) was 
then added and the mixture allowed to cool to rt while stirring vigorously. The reaction 
was monitored closely by TLC, which indicated the disappearance of the starting material 
after 2 hr. The reaction mixture was then diluted with ether and washed with saturated 
sodium thiosulfate and brine. The organic layer was dried (Na2SO4) and concentrated 
under reduced pressure. FCC of the residue provided 4.69 (5.55 g, 80%): Rf = 0.7 (20% 
EtOAc: petroleum ether): 1H NMR (500 MHz, CDCl3) δ 2.62 (d, 1H, J = 9.4 Hz), 3.24 
(dd, 1H, J = 6.6, 10.4 Hz), 3.32-3.39 (ovrlp m, 4H), 3.79 (s, 3H), 3.88 (d, 1H, J = 5.2 
Hz), 3.95 (q, 1H, J = 6.1 Hz), 4.09 (m, 1H), 4.52 (d, 1H, J = 11.3 Hz), 4.64 (d, 1H, J = 
11.2 Hz), 4.86 (s, 1H), 6.88 (d, 2H, J = 8.6 Hz), 7.24 (d, 2H, J = 8.4 Hz, partially buried 
under the CDCl3 solvent peak); 13C NMR (125 MHz, CDCl3) δ 7.97, 55.5, 55.6, 73.0, 
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Iodoriboside 4.69 (3.10 g, 7.87 mmol) was dissolved in a 1:1 DCM:dihydropyran 
(10 mL) mixture in a 100 mL round bottom flask, equipped with a magnetic stir bar. 
PTSA (0.27 g, 1.57 mmol) was added to the mixture and the reaction stirred for 2 h after 
which, the reaction was quenched with aqueous NaHCO3. The organic layer was 
separated and the aqueous phase extracted with diethyl ether. The combined organic 
phase was washed with brine, dried (Na2SO4) and concentrated under reduced pressure. 
FCC of the residue provided 4.70 (3.75 g, quant.): Rf = 0.6 (10% EtOAc: petroleum 
ether); 1H NMR (500 MHz, CDCl3) δ 1.72 (m, 2H), 1.83 (m, 3H), 3.33 (s, 2H), 3.36 (s, 
1H), 3.49 (m, 2H), 3.54 (m, 1H), 3.78 (s, 3H), 3.85 (m, 2H), 3.90 (t, 1H, J = 3.9 Hz), 4.01 
(m, 1H), 4.06 (m, 1H), 4.10-4.17 (m, 1H), 4.48 (m, 1H), 4.59 (d, 1H, J = 3.6 Hz), 4.69 
(m, 1H), 4.79-4.88 (m, 2H), 4.93 (m, 1H), 6.84 (d, 2H, J = 8.9 Hz), 7.23 (d, 1H, J = 6.1 
Hz), 7.28 (d, 1H, J = 8.5 Hz); 13C NMR (125 MHz, CDCl3) δ 8.7, 9.1, 19.1 (two signals), 
19.7, 19.8 (two signals), 19.9, 25.3 (two signals), 25.5, 30.3, 30.7 (two signals), 31.0, 
55.2, 55.3 (two signals), 62.4, 93.0, 63.1, 63.4, 72.1, 72.2, 78.1, 79.6, 79.7, 80.5, 81.1, 
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Compound 4.70 (3.50 g, 7.32 mmol) was subjected to zinc mediated reductive 
elimination to give 4.71 (2.25 g, 96%) following a similar procedure outlined for the 
synthesis of 4.48. The crude aldehyde was used in the subsequent step without further 
purification. For aldehyde 4.71: Rf = 0.7 (20% EtOAc: petroleum ether); 1H NMR (500 
MHz, CDCl3) δ 1.76 (m, 5H), 1.89 (m, 3H), 3.54 (m, 4H), 3.83 (m, 4H), 3.90 (m, 2H), 
4.06 (m, 1H), 4.45-4.54 (m, 1H), 4.60-4.75 (m, 3H), 4.85 (m, 1H), 4.98 (dd, 1H, J = 4.9, 
5.1 Hz), 5.33 (m, 2H), 5.76-6.01 (m, 1H), 6.90 (m, 2H), 7.30 (m, 2H), 9.65 (dd, 1H, J = 
1.8, 2.2 Hz); 19.8 (two signals), 25.3, 25.4, 25.5, 30.7, 31.0, 55.3, 63.0, 63.4, 84.6, 94.7, 




 The crude aldehyde 4.71 (2.0 g, 6.25 mmol) from the previous step and 
Ph3P=CHCO2Et (6.79 g, 18.75 mmol) were converted to the conjugated ethyl ester 
following a similar procedure used for the synthesis of 4.49. FCC of the product gave 
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NMR (500 MHz, C6D6) δ 1.18-1.38 (ovrlp m, 4H), 1.51-1.58 (m, 2H), 1.60-1.65 (m, 1H), 
1.69-1.79 (m, 1H), 3.30 (d, 3H, J = 1.6 Hz), 3.39 (s, 3H), 3.89-3.78 (m, 1H), 3.90-4.03 
(m, 1H), 4.34 (d, 1H, J = 11.6 Hz), 4.36-4.48 (ovrlp m, 2H), 5.03 (t, 1H, J = 3.1 Hz), 
5.08-5.39 (m, 2H), 5.69-5.90 (m, 1H), 6.31 (dd, 1H, J = 1.2, 15.8 Hz), 6.77 (dd, 2H, J = 
6.4, 8.6 Hz), 7.18 (m, 2H, partially buried under C6D6 solvent peak), 7.27 (dd, 1H, J = 
5.9, 15.8 Hz); 13C NMR (125MHz, C6D6) δ 19.6, 26.2, 26.3, 31.1, 51.4, 51.5, 55.1, 55.2, 
61.8, 62.1, 71.6, 71.8, 78.4, 78.6, 80.7, 81.2, 95.1, 98.5, 114.4, 114.5, 117.1, 119.7, 123.6, 
124.1, 128.7, 129.8, 129.9, 130.8, 131.0, 135.5, 136.6, 145.8, 146.6, 160.1, 160.2, 166.5, 
166.6. 
 





The conjugated ethyl ester 4.72 (2.20 g, 5.64 mmol) was selectively reduced with 
NaBH4 (1.07 g, 28,3 mmol) in the presence of CuCl (66 mg) to give 4.73, following a 
similar procedure used in the transformation 4.49 è 4.50. Compound 4.73 was produced 
as a colorless oil (2.41 g, 90%): Rf = 0.8 (15% ethyl acetate: petroleum ether); 1H NMR 
(500 MHz, CDCl3) δ 1.37-1.45 (ovrlp m, 5H), 1.68-1.75 (m, 3H), 2.19-2.24 (m, 1H), 
2.30-2.39 (m, 1H), 3.33-3.43 (m, 2H), 3.49 (s, 3H), 3.68 (s, 3H), 3.71-3.83 (m, 2H), 4.09-
4.35 (ovrlp m, 2H), 4.42-4.77 (ovrlp m, 3H), 5.17 (m, 2H), 5.75 (m, 1H), 6.74 (m, 2H), 
7.12-7.16 (m, 2H, partially buried under the CDCl3 solvent); 13C NMR (125 MHz, 
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79.8, 80.3, 95.0, 98.4, 113.9, 114.0, 116.9, 119.5, 129.4, 129.6, 129.8, 129.9, 135.1, 
136.4, 159.3, 159.4, 174.3, 174.4. 
 




Following a similar procedure that was used in the synthesis of 4.50, ethyl ester 
4.73 (2.0 g, 5.13 mmol) was hydrolyzed to give acid 4.54 (1.87 g, quant): Rf = 0.6 (20% 
ethyl acetate: petroleum ether). 1H NMR (500 MHz, CDCl3) δ 1.46-1.72 (ovrlp m, 6H), 
1.76-1.87 (m, 2H), 2.31-2.51 (m, 2H), 3.42-3.55 (m, 2H), 3.65-3.75 (m, 1H), 3.76 (s, 
3H), 3.79-3.94 (m, 1H), 4.19-4.56 (ovrlp m, 2H), 4.63-4.87 (ovrlp m, 2H), 5.18-5.33 (m, 
2H), 5.72-5.91 (m, 1H), 6.83 (d, 2H, J = 8.7 Hz), 7.21-7.25 (m, 2H, partially buried under 
CDCl3 solvent peak), 11.40 (bs, 1H); 13C NMR (125 MHz, CDCl3) δ 19.4, 25.2, 25.6, 
25.7, 26.0, 30.5, 30.6, 30.8, 30.9, 55.4, 62.1, 62.4, 72.1, 72.4, 78.1, 78.4, 79.6, 80.0, 95.1, 
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Under standard esterification conditions, acid 4.54 (1.05 g. 2.88 mmol) and 
cholestanol (1.12 g, 2.88 mmol) were coupled to give the ester (1.91 g, 90%) as a 
colorless oil: Rf = 0.8 (15% EtOAc: petroleum ether); 1H NMR (500 MHz, C6D6) δ 0.53 
(ovrlp m, 4H), 0.69 (s, 3H), 0.75 (d, 6H, J = 6.6 Hz), 0.78 (d, 1H, J = 6.4 Hz), 0.86-0.91 
(ovrlp m, 4H), 0.95-1.03 (ovrlp m, 6H), 1.09-1.22 (ovrlp m, 10H), 1.35-1.45 (ovrlp m, 
8H), 1.52-1.63 (ovrlp m, 5H), 1.67-1.73 (ovrlp m, 4H), 1.84 (d, 1H, J = 12.6 Hz), 2.17-
2.33 (m, 2H), 3.36-3.45 (m, 2H), 3.68 (s, 3H), 3.73-3.82 (m, 1H), 4.22 (dd, 1H, J = 3.1, 
7.4 Hz), 4.29 (d, 1H, J = 11.1 Hz), 4.49-4.77 (ovrlp m, 3H), 5.09-5.24 (m, 2H), 5.64-5.80 
(m, 1H), 6.75 (d, 2H, J = 7.8 Hz), 7.14 (d, 2H, J = 8.3 Hz, partially buried under CDCl3 
solvent peak); ); 13C NMR (125 MHz, C6D6) δ 12.2, 12.4, 18.8, 19.3, 19.5, 21.4, 22.7, 
23.0, 24.0, 24.4, 25.7, 25.8, 26.5, 27.7, 28.2, 28.4, 28.8, 30.7, 30.9, 31.0, 31.1, 32.2, 34.2, 
35.6, 36.0, 36.3, 36.9, 39.7, 40.2, 42.8, 44.8, 54.4, 55.4, 56.4, 56.6, 61.8, 62.4, 72.1, 72.5, 
73.7, 78.1, 78.5, 80.0, 80.4, 94.9, 98.3, 113.8, 113.9, 116.8, 119.4, 129.7, 129.8, 130.8, 
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A solution of titanium tetrachloride (3.8 mL, 2 M in CH2Cl2, 7.67 mmol) was 
added to THF (4 mL) at 0 OC. The resulting mixture was stirred for 30 min at which point 
TMEDA (2.23 mL, 14.8 mmol) was added in one portion. The resulting yellow-brown 
suspension was allowed to warm to rt and stirred for 30 min. At this point, zinc dust (1.09 
g, 16.65 mmol) and lead (ll) chloride (13 mg, 0.045 mmol) were added in one portion, 
and stirring was continued for 10 min. A solution of the ester from the previous step  (300 
mg, 0.45 mmol) and dibromomethane (0.29 mL, 4.19 mmol) in THF (3 mL) was then 
added via cannula to the reaction flask in one portion. The mixture was stirred at 60 OC 
for 1 h, cooled to 0 OC, then quenched by addition of saturated potassium carbonate (1.0 
mL). The resulting mixture was stirred for 30 min (while warming to ambient 
temperature), diluted with ether (20 mL), and stirred vigorously for 15 min. The resulting 
mixture was filtered through basic alumina using 3% triethylamine-ether as the eluent. 
The greenish-blue precipitate that resulted was triturated and thoroughly extracted by 
vigorous stirring over diethyl ether (15 – 20 mL) for 30 min. The combined ethereal 
extracts were concentrated in vacuo to give a dark brown residue which was filtered over 
basic alumina, using 1% of triethyl amine in the eluent used to wash the alumina bed, and 
used in the subsequent step without further pufification. The solvent was evaporated to 
give the diastreomeric mixture 4.74 (179 mg, 60%): Rf = 0.8 (15% EtOAc: petroleum 
ether: 1% TEA). 1H NMR (500 MHz, C6D6) δ 0.64 (m, 1H), 0.78 (s, 3H), 0.81 (m, 1H), 
0.83 (s, 3H), 0.89 (m, 2H), 0.96 (m, 1H), 1.05 (m, 5H), 1.06 (m, 5H), 1.15 (d, 4H, J = 6.5 
Hz), 1.25 (m, 5H), 1.40 (m, 12H), 1.47 (m, 5H), 1.57 (m, 8H), 1.71 (m, 8H), 1.95 (m, 
4H), 2.13 (m, 3H), 3.43 (m, 4H), 3.58 (m, 1H), 4.07-4.20 (m, 3H), 4.26 (m, 1H), 4.59 (m, 
1H), 4.72-4.81 (m, 1H), 5.00 (m, 1H), 5.28-5.42 (m, 2H), 6.02-6.23 (m, 1H), 6.94 (m, 
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2H), 7.42-7.51 (m, 2H); 13C NMR (125 MHz, C6D6) δ 12.1, 12.2, 18.8, 19.2, 21.3, 22.6, 
22.8, 24.1, 24.3, 25.8, 25.9, 27.8, 28.2, 28.5, 28.8, 29.5, 29.9, 30.0, 30.8, 32.2, 32.4, 34.2, 
35.5, 35.7, 36.0, 36.5, 36.9, 39.7, 40.3, 42.7, 44.7, 54.4, 54.5, 56.5, 56.6, 61.2, 72.4, 75.1, 
78.6, 80.6, 81.3, 94.6, 113.8 (two signals), 118.5, 127.7, 127.9, 129.2, 129.4, 129.5, 
135.8, 161.6,  
 




After the enol ether 4.74 (80 mg, 0.11 mmol) was degassed thoroughly under 
nitrogen atmosphere for 30 min, the first aliquot (1/4) of Grubbs (ll) catalyst (134 mg, 
0.158 mmol, 35 mol %) was added and the reaction mixture heated to 60 OC. The 
remaining catalyst was added and heated in three equivalent portions over the next 3 h, 
and upon completion, the solution was cooled to 0 OC, concentrated in vacuo, filtered 
over basic alumina and the alumina bed washed with 1% triethyl amine and EtOAc, The 
solvent was evaporated, to give 4.75 (60 mg, 70%) as a light brown oil which was used in 
the subsequent step without further purification. For 4.75: Rf = 0.7 (10% EtOAc: 
petroleum ether, 1% TEA); 1H NMR (500 MHz, C6D6) δ 0.53 (m, 1H), 0.66 (s, 3H), 0.70 
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1.45 (m, 5H), 1.58 (m, 5H), 1.76 (m, 2H), 1.87 (m, 2H), 2.01 (m, 2H), 2.19 (m, 1H), 2.36 
(m, 1H), 3.31 (s, 3H), 3.56 (m, 1H), 3.99 (m, 1H), 4.13 (m, 1H), 1.41-5.25 (m, 4H), 6.83 
(m, 2H), 7.28-7.51 (m, 2H); 13C NMR (125 MHz, C6D6) δ 12.7 (two signals), 19.4, 21.9, 
23.1, 23.4, 24.7, 24.9, 26.4, 26.6, 28.3, 28.8, 29.0, 29.3, 29.4, 30.6, 31.9, 32.8 (two 
signals), 35.2 (two signals), 36.1, 36.2, 36.6, 37.0, 37.4, 40.3, 40.9, 43.3, 45.1 (two 
signals), 45.2 (two signals), 54.9 (two signals), 55.1 (two signals), 57.1 (two signals),  
57.2 (two signals), 62.2 (two signals), 62.6 (two signals), 70.5 (two signals), 71.6 (two 
signals), 72.4 (two signals), 74.8 (two signals), 75.6 (four signals), 76.7, 77.9, 93 (two 
signals), 95.3 (two signals), 96.1 (two signals), 97.4 (two signals), 100.1 (two signals), 
114.4 (four signals), 128.3, 128.5, 128.7, 128.9, 129.4, 129.6, 129.7, 129.9, 156.8 (two 
signals), 157.3, 158.0, 159.9 (two signals). 
 
Diastereomeric alcohols 4.76 
 
 	  
Enol ether 4.75 (70 0.10 mg, mmol) was azeotroped with benzene (3 x 10 mL), 
and redissolved in dry THF (5 mL). The solution was cooled to 0 OC, and excess 
BH3.THF (1.0 mL, 1 M in THF, 1.0 mmol) was added, and the resulting mixture was 
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(5 mL, 1 M, 5 mmol) and hydrogen peroxide (5 mL, 30% in water, 0.20 mol) were added 
sequentially dropwise, and the solution was allowed to warm to room temperature over 2 
h at which point TLC showed a clean product spot. The solution was extracted with ether 
(3 x 5 mL), and the combined ethereal extracts were washed with brine (1 x 10 mL), 
dried (Na2SO4), filtered and concentrated in vacuo. FCC of the residue over silica 
provided the mixture of diastereomeric alcohols 4.76 in a 2:1 ratio, as a colorless oil (49 
mg, 65%): Rf = 0.6 (20% EtOAc: petroleum ether); 1H NMR (500 MHz, C6D6) δ 0.57 
(m, 3H), 0.67 (s, 3H), 0.69 (s, 3H), 0.74 (s, 3H), 0.78 (s, 2H), 0.87 (m, 10H), 0.93 (s, 7H), 
0.94 /9s, 7H), 1.02 (m, 7H), 1.13 (m, 5H), 1.26 (m 17H), 1.45 (m, 7H), 1.60 (m, 7H), 
1.79 (m, 4H), 1.88 (m, 2H), 2.01 (m, 2H), 2.77 (bs, 1H), 3.22 (m, 1H), 3.33 (s, 6H), 3.35-
3.56 (m, 5H), 3.67-4.07 (m, 3H), 4.35 (m, 3H), 4.49 (s, 1H), 4.66 (d, 1H, J = 11.6 Hz), 
4.82 (d, 1H, J = 11.6 Hz), 5.32 (bs,1H), 6.83 (d, 4H, J = 8.4 Hz), 7.28 (d, 2H, J = 8.3 Hz), 
7.38 (d, 2H, J = 8.3 Hz); 13C NMR (125 MHz, C6D6) δ 12.7, 12.8, 12.9 (two signals), 
14.6, 19.4, 20.3, 20.4, 22.0 (three signals), 23.0, 23.1, 23.4, 24.7, 24.9 (two signals), 25.4, 
25.7, 26.0, 26.1, 26.3, 26.4, 28.8, 29.0, 29.5, 29.6 (two signals), 30.4, 30.6 (two signals), 
31.6, 31.7, 32.4, 32.8, 32.9, 34.8, 36.0 (two signals), 36.1 (two signals), 36.3, 36.4, 36.6, 
37.0, 37.7, 37.9, 38.0, 39.1, 40.3, 40.8, 40.9, 43.3, 45.5 (two signals), 45.7, 55.0, 55.1, 
55.2 (two signals), 57.1 (three signals), 57.2, 62.8, 63.0, 65.3, 71.4, 71.9, 72.5, 73.7, 74.6, 
75.4, 77.4, 77.6, 78.4, 79.7, 80.2, 81.7, 82.0, 97.5, 101.2, 114.4, 127.3, 127.8 (two 
signals), 128.0 (two signals), 128.3, 128.5, 128.9, 129.6, 129.8, 132.1, 132.5, 160.0 (two 
signals).   
 
 




Alcohol 4.76 (45 mg, 0.06 mm0l) was acetylated to give the mixture of acetates 
4.77 in a 3:1 ratio (47 mg, 99%): Rf = 0.8 (20% EtOAc: petroleum ether); 1H NMR (500 
MHz, C6D6) δ 0.72 (t, J = 11.5 Hz), 0.79 s, 3H), 0.87 )s, 3H), 0.96 (m, 2H), 1.05 (s, 3H), 
1.06 (s, 3H), 1.15 (d, J = 6.4 Hz), 1.26 (m, 2H), 1.39 (m, 7H), 1.57 (m, 7H), 1.69 (m, 4H), 
1.79 (m, 7H), 1.97 (m, 3H), 2.13 (m, 1H), 2.15 (s, 3H), 3.41 (m, 1H), 3.43 (s, 3H), 3.47 
(m, 2H), 3.60 (m, 1H), 3.84 (m, 1H), 3.88 (d, 1H, J = 10.2 Hz), 4.13 (m, 1H), 4.53 (q, 2H, 
J = 11.9 Hz), 4.92 (m, 1 H), 6.06 (t, 1H, J = 9.7 Hz), 6.88 (d, 2H, J = 8.4 Hz), 7.34 (d, 2H, 
J = 8.3 Hz); 13C NMR (125 MHz, C6D6) δ 12.2, 12.3, 18.6, 18.8, 21.1, 21.4, 22.6, 22.8, 
24.1, 24.4, 25.8 (two signals), 28.2, 28.5, 29.1, 29.9, 30.5, 32.4, 35.6, 35.8 (two signals), 
36.0, 36.5, 37.3, 39.7, 40.3, 42.7, 45.2, 54.6, 54.7, 56.6 (two signals), 60.6, 71.1, 71.3, 
71.7, 74.5, 75.7, 75.8, 76.2, 77.5, 78.0, 78.1, 80.5, 93.7, 100.6, 113.8, 127.7, 127.9, 128.1, 



























To better characterize acetate 4.77, the THP acetal of 4.75 (45 mg, 0.06 mmol) 
was hydrolyzed to give the free alcohol derivative, which was acetylated to give the 
diacetate 4.78 (44 mg, 98%): Rf = 0.6 (10% EtOAc: petroleum ether); 1H NMR (500 
MHz, CDCl3) δ 0.60 (m, 1H), 0.66 (s, 3H), 0.78 (s, 3H), 0.89 (m, 20H), 1.01 (m 6H), 
1.13 (m, 9H), 1.32 (M, 13H), 1.53 (m, 7H), 1.66 (m, 5H), 1.81 (m, 6H), 1.96 (m, 2H), 
2.06 (m, 4H), 2.38 (m, 2H), 3.28 (m, 1H), 3.37 (m, 1H), 3.83 (s, 3H), 3.85 (m, 1H), 4.50 
(q, 2H, J = 12.0 Hz), 4.77 (dd, 1H, J = 1.3, 10.2 Hz), 5.40 (t, 1H, J = 9.8 Hz), 6.88 (d, 2H, 
J = 7.3 Hz), 7.26 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 12.1, 12.3, 14.2, 18.7, 21.1 
(two signals), 21.2, 22.6, 22.7, 22.9, 23.8, 24.2, 28.0, 28.3, 29.4 (two signals), 29.5, 29.6, 
29.7 (two signals), 32.0, 32.1, 35.5, 35.8, 36.2, 37.1, 39.5, 40.0, 42.6, 45.0, 54.4, 55.3, 






























  A small portion of alcohol 4.76 (15 mg, 0.02 mmol) was dissolved with  DMF 
(1.0 mL) in a 5 mL round bottom flask equipped with a magnetic stir bar and a nitrogen 
balloon. The mixture was cooled to 0 OC then NaH (1.62 mg, 60% in mineral oil, 0.04 
mmol) was carefully added and the reaction mixture was allowed to warm to rt and 
stirred for an additional 0.5 h. Bu4NI (0.9 g, 2.4 mmol) was then added. The reaction 
mixture was re-cooled to 0 OC and BnBr (3.4 mL, 28.2 mmol) was slowly added. The ice 
bath was removed and the reaction was kept at rt until the reaction was completed. After 
2 h the reaction was quenched by pouring the mixture into water. The mixture was 
extracted with diethyl ether and the combined organic phase was washed with brine, 
dried (Na2SO4), filtered, and concentrated in vacuo. FCC of the crude residue yielded 
4.79 (13 mg, 85%): Rf = 0.61 (20% EtOAc/petroleum ether); 1H NMR (500 MHz, 
CDCl3) δ 0.61 (m, 1H), 0.67 (s, 3H), 0.81 (s, 3H), 0.89 (dd, 4H, J = 2.2, J = 6.6 Hz), 0.92 
(d, 3H, J = 6.4 Hz), 1.01 (m, 3H), 1.12 (m, 4H), 1.22-1.36 (m, 10H), 1.48-1.55 (m, 2H), 
1.59 (s, 3H), 1.66-1.99 (m, 7H), 2.91 (bs, 1H), 3.42 (m, 1H), 3.48 (m, 1H), 3.65 (m, 2H), 
3.78 (m, 1H), 3.83 (s, 2H), 4.50 (d. 1H. J = 11.5 Hz), 4.58 (d, 1H, J = 11.5 Hz), 4.74 (d, 
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13C NMR (125 MHz, CDCl3) δ 12.1, 12.3, 18.7, 21.3, 22.6, 22.8, 23.8, 24.2, 25.6, 28.0, 
28.2, 28.8, 29.3, 32.1, 35.2, 35.5, 35.8, 36.2, 37.1, 39.5, 40.1, 42.6, 44.9, 54.4, 55.3, 56.3, 





The ribose-derived diol 4.68 (3.0 g, 0.011 mol) was dissolved in a DMF/DCM mixture 
(10/200 mL) and then treated with imidazole (1.44 g, 0.021 mol). TBDPSCl (2.75 mL, 
0.011 mol) was then added and the reaction stirred at rt for 1 hr when TLC indicated the 
dissapperance of the starting material. The reaction mixture was filtered, concentrated 
under reduced pressure, and the residual oil purified by FCC to give 4.80 (4.85 g, 88%): 
Rf = 0.51 (20% EtOAc/petroleum ether); 1H NMR (500 MHz, CDCl3) δ 1.08 (s, 9H), 
2.54 (bs, 1H), 3.36 (s, 3H), 3.75 (t, 1H, J = 4.8 Hz), 3.83 (d, 1H, J = 4.1 Hz), 3.84 (s, 3H), 
3.90 (dd, 1H, J = 1.3, 5.1 Hz), 4.04 (q, 1H, J = 5.3 Hz), 4.30 (bs, 1H), 4.57 (d, 1H, J = 
11.4 Hz), 4.71 (d, 1H, J = 11.2 Hz), 4.94 (d, 1H, J = 1.2 Hz), 6.92 (d, 2H, J = 8.6 Hz), 
7.31 (d, 2H, J = 8.6 Hz), 7.42 (m, 6H), 7.72 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 
19.3, 26.8, 55.3 (two signals), 64.6, 71.0, 72.6, 82.0, 84.7, 106.0, 114.0, 127.7 (two 
signals), 128.3, 129.3, 129.6, 129.7 (two signals), 133.4, 135.7, 159.6; TOF MS ES+ 
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Ester 4.81 	  
 
Acid 4.50 (120 mg, 0.375 mmol) and alcohol 4.80 (196 mg, 0.375mmol) were 
coupled under standard DCC esterification protocol to give 4.81 (300 mg, 96%) as a 
colorless oil: Rf = 0.8 (20 % EtOAc: petroleum ether); 1H NMR (500 MHz, CDCl3) δ 
1.56 (s, 9H), 1.75 (m, 1H), 1.95 (m, 1H), 2.37 (m, 1H), 2.49 (m, 1H), 3.36 (s, 3H), 3.54 
(m, 1H), 3.72 (m, 2H), 3.78 (s, 3H), 3.91 (t, 1H, J = 6.7 Hz), 4.10 (m, 1H), 4.21 (q, 1H, J 
= 4.6 Hz), 4.42 (d, 1H, J = 12.1 Hz), 4.49 (s, 2H), 4.51 (d, 1H, J = 11.8 Hz), 4.65 (d, 1H, 
J = 12.1 Hz), 4.73 (d, 1H, J = 11.3 Hz), 4.90 (d, 1H, J = 2.0 Hz), 5.27 (t, 1H, J = 5.0 Hz), 
5.32 (d, 1H, J = 12.5 Hz), 5.34 (d, 1H, J = 5.1 Hz), 5.81 (m, 1H), 6.84 (d, 2H, J = 8.5 Hz), 
7.23 (d, 2H, J = 8.5 Hz), 7.30-7.44 (m, 15H), 7.70 (m, 5H); 13C NMR (125 MHz, CDCl3) 
δ 19.2, 26.1, 26.8, 30.3, 55.2, 55.6, 64.5, 70.5, 72.7, 73.0, 73.3, 80.0, 0.7, 81.9, 82.5, 
107.0, 113.8, 119.1, 127.5, 127.6, 127.7 (three signals), 128.0, 128.3 (two signals), 129.4, 
129.7 (two signals), 129.8, 133.3 (two signals), 135.0, 135.6, 135.7, 138.5 (two signals), 
159.3, 172.9; TOF MS ES+ (M+Na)+ calculated C52H62O9NaSi 867.3904 found 867.3926. 
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A solution of titanium tetrachloride (2.0 mL, 2 M in CH2Cl2, 4.04 mmol) was 
added THF (2 mL) at 0 OC. The resulting mixture was stirred for 30 min at which point 
TMEDA (1.11 mL, 7.4 mmol) was added in one portion. The resulting yellow-brown 
suspension was allowed to warm rt and stirred for 30 min. At this point, zinc dust (0.5 g, 
8.32 mmol) and lead (ll) chloride (6.5 mg, 0.022 mmol) were added in one portion, and 
stirring was continued for 10 min. A solution of the ester 4.81 (200 mg, 0.24 mmol) and 
dibromomethane (0.15 mL, 2.95 mmol) in THF (2 mL) was then added via cannula to the 
reaction flask in one portion. The mixture was stirred at 60 OC for 1 h, cooled to 0 OC, 
then quenched by addition of saturated potassium carbonate (1.0 mL). The resulting 
mixture was stirred for 30 min (while warming to ambient temperature), diluted with 
ether (20 mL), and stirred vigorously for 15 min. The resulting mixture was filtered 
through basic alumina using 3% triethylamine-ether as the eluent. The greenish-blue 
precipitate that resulted was triturated and thoroughly extracted by vigorous stirring over 
diethyl ether (10 – 15 mL) for 30 min. The combined ethereal extracts were concentrated 
in vacuo to give a dark brown residue which was filtered over basic alumina, using 1% of 
triethyl amine in the eluent used to wash the alumina bed, and used in the subsequent step 
without further pufification. The solvent was evaporated to give the diastreomeric 
mixture 4.82 (130 mg, 66%): Rf = 0.7 (15% EtOAc: petroleum ether, 1% TEA); 1H NMR 
(500 MHz, C6D6) δ 1.09 (s, 9H), 1.78 (m, 1H), 1.93 (m, 1H), 2.26 (m, 1H), 2.40 (m, 1H), 
3.14 (s, 3H), 3.20 (m, 3H), 3.50 (m, 1H), 3.73 (dd, 1H, J = 4.0, J = 4.1 Hz), 3.80 (t, 1H, J 
= 6.8 Hz), 3.88 (dd, 1H, J = 3.8, 3.9 Hz), 3.93 (d, 1H, J = 2.0 Hz), 4.05 (d, 1H, J = 2.0 
Hz), 4.17 (d, 1H, J = 4.4 Hz), 4.19 (d, 2H, J = 12.3 Hz), 4.35 (d, 1H, J = 11.4 Hz), 4.43 (t, 
2H, J = 12.6 Hz), 4.50 (d, 1H, J = 11.8 Hz), 4.54 (m, 1H), 4.64 (d, 1H, J = 11.7 Hz), 4.86 
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(m, 1H), 5.0-5.10 (m, 3H), 5.67 (m, 1H), 6.70 (d, 2H, J = 8.8 Hz), 7.0 (m, 3H), 7.10-7.25 
(m, 15H), 7.71 (m, 4H); 13C NMR (125 MHz, C6D6) δ 1.4, 19.5, 27.1, 29.3, 30.2, 31.7, 
54.8, 55.2, 64.4, 70.8, 72.6, 73.3, 75.3, 79.9, 80.9, 82.1, 82.9, 83.1, 107.5, 114.1, 118.3, 
127.5, 127.6, 127.7, 127.9, 128.1 (two signals), 128.3, 128.5, 128.6, 129.6, 130.0 (two 
signals), 130.8, 133.8, 133.9, 135.9, 136.1 (two signals), 139.3, 139.8, 159.8, 162.9; TOF 
MS ES+ (M+Na)+ calculated C52H62O8NaSi 865.4112 found 865.4128. 	  
RCM product 4.83 
 	  
Enol ether 4.82 (110 mg, 0.13 mmol) was degassed thoroughly under nitrogen 
atmosphere for 30 min, the first aliquot of Grubbs (ll) catalyst (33 mg, 0.04 mmol, 35 mol 
%) was added and the reaction mixture heated to 60 OC. A second portion of the catalyst 
was added over the next 3 h, and upon completion, the solution was cooled to 0 OC, 
concentrated in vacuo, filtered over basic alumina and the alumina bed washed with 1% 
triethyl amine and EtOAc, The solvent was evaporated, to give 4.83 (80 mg, 76%) as a 
light brown oil which was used in the subsequent step without further purification. Enol 
ether 4.83: Rf = 0.75 (10% EtOAc: petroleum ether, 1% TEA); 1H NMR (500 MHz, 
C6D6) δ 1.32 (s, 9H), 1.87 (m, 1H), 2.11 (m, 1H), 2.22 (m, 1H), 2.54 (m, 1H), 3.35 (s, 
3H), 3.42 (s, 3H), 3.84 (bs, 1H), 3.98 (t, 1H, J = 3.3 Hz), 4.13 (dd, 1H, J = 2.9, 3.5 Hz), 
4.28 (bs, 1H), 4.44-4.54 (m, 3H), 4.59-4.62 (m, 2H), 4.71 (d, 1H, J = 11.2 Hz), 4.82 (m, 
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(m, 4H); 13C NMR (125 MHz, C6D6) δ 18.2, 21.9, 23.6, 25.6, 25.7, 28.8, 53.4, 53.5, 62.9, 
69.3, 69.7, 71.1, 73.6, 74.4, 74.6, 77.5, 80.5, 93.3, 106.1, 112.7, 126.1, 126.2, 126.3, 
126.4, 126.5, 126.7, 127.1 (two signals), 128.4, 128.5, 129.3, 132.4, 132.5, 134.6, 134.7, 
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F2 − Processing parameters
SFO2        500.1320005 MHz
P
L13              20.00 dB
P
L12              17.00 dB
P




D2             80.00 usec
N
U
























SFO1        125.7703643 MHz
P
L1                3.50 dB
P1                 5.00 usec
N
U
















































d11          0.03000000 sec














































































ES         0.458222 Hz
SWH           30030.029 Hz
DS                    4
NS                  128


















































 5 mm CPDCH 13C
I
NSTRUM           spect



































































































































































































SF          500.1300235 MHz
SI                32768
F2 − Processing parameters
SFO1        500.1330885 MHz
P
L1               −0.50 dB
P1                 9.25 usec
N
U


































EST   0 sec

















































































ES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
















































 5 mm CPDCH 13C
I
NSTRUM           spect




































































































































































































































SF          125.7577630 MHz
SI                32768
F2 − Processing parameters
SFO2        500.1320005 MHz
P
L13              20.00 dB
P
L12              17.00 dB
P




D2             80.00 usec
N
U
























SFO1        125.7703643 MHz
P
L1                3.50 dB
P1                 5.00 usec
N
U
















































d11          0.03000000 sec














































































ES         0.458222 Hz
SWH           30030.029 Hz
DS                    4
NS                  128


















































 5 mm CPDCH 13C
I
NSTRUM           spect






























































































































































































SF          500.1300230 MHz
SI                32768
F2 − Processing parameters
SFO1        500.1330885 MHz
P
L1               −3.00 dB
P1                 9.30 usec
N
U


































EST   0 sec














































































ES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                   32
















































 5 mm DUL 13C−1
I
NSTRUM           spect




































































































































































































































SF          125.7577610 MHz
SI                32768
F2 − Processing parameters
SFO2        500.1320005 MHz
P
L13              16.50 dB
P
L12              15.69 dB
P




D2             80.00 usec
N
U
























SFO1        125.7703643 MHz
P
L1      0 dB
P1                 5.00 usec
N
U
















































d11          0.03000000 sec













































































ES         0.458222 Hz
SWH           30030.029 Hz
DS                    4
NS                  512


















































 5 mm DUL 13C−1
I
NSTRUM           spect










































































































































































































SF          500.1300638 MHz
SI                32768
F2 − Processing parameters
SFO1        500.1330885 MHz
P
L1               −3.00 dB
P1                 9.30 usec
N
U


































EST   0 sec
















































































ES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
















































 5 mm DUL 13C−1
I
NSTRUM           spect















































































































































































































































































































































































































































































































































































F1 [ppm] 5  4  3  2 









































































































































































































































































































































































































































































D0                   1

















































































ES         0.244532 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
















































 5 mm CPDCH 13C
I
NSTRUM           spect



































































































































































































































SFO1        125.7703643 MHz
P
L1                3.50 dB
P1                 5.00 usec
N
U

































d11          0.03000000 sec














































































ES         0.458222 Hz
SWH           30030.029 Hz
DS                    4
NS                  128


















































 5 mm CPDCH 13C
I
NSTRUM           spect





















































































































































































































































































































































































































































































































































































































































































































































































































































































F1 [ppm] 5.0  4.8  4.6  4.4  4.2 









































































































































































































































































































































































































































































































































































































































































































































































































































































F1 [ppm] 5.2  5.0  4.8  4.6  4.4  4.2  4.0 







F1 [ppm] 95  90  85  80  75  70 


































































































































































































































































































SF          500.1300000 MHz
M
C2                  QF

















































































SF          500.1300000 MHz



























ES        52.083332 Hz






















D0                   1
P16             1000.00 usec
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[ r e l ] 0   5 0   1 0 0   1 5 0  
7 . 2 4 8 9
7 . 2 3 2 0
7 . 2 1 5 6
7 . 2 1 0 2
6 . 8 4 2 6
6 . 8 3 8 2
6 . 8 2 5 2
6 . 8 2 1 3
5 . 7 5 7 8
5 . 3 3 3 4
5 . 2 9 5 6
5 . 2 7 0 8
5 . 2 3 2 6
5 . 2 0 4 3
5 . 1 8 3 2
4 . 8 6 5 0
4 . 8 5 8 4
4 . 7 1 4 8
4 . 6 9 2 6
4 . 6 6 4 2
4 . 6 5 6 8
4 . 6 4 2 5
4 . 6 3 4 3
4 . 5 3 6 4
4 . 4 6 1 1
4 . 4 3 8 9
4 . 4 0 4 1
4 . 3 8 2 0
4 . 3 1 5 7
4 . 2 1 3 4
4 . 2 0 6 8
4 . 1 9 8 4
4 . 1 9 1 7
3 . 8 9 9 7
3 . 8 7 7 3
3 . 8 5 4 6
3 . 7 6 5 7
3 . 7 5 8 3
3 . 7 4 5 7
3 . 5 3 6 9
3 . 5 2 9 7
3 . 4 8 1 3
3 . 4 7 3 8
3 . 4 6 7 5
3 . 4 6 4 0
3 . 4 5 7 8
3 . 4 5 0 6
3 . 4 4 2 4
2 . 4 9 9 8
2 . 4 8 2 1
2 . 4 6 7 5
2 . 4 5 5 1
2 . 3 8 1 7
2 . 3 6 3 9
2 . 3 4 8 8
2 . 3 3 4 4
1 . 8 4 6 0
1 . 8 3 0 8
1 . 8 1 8 0
1 . 8 1 1 9
1 . 8 0 3 2
1 . 7 9 4 8
1 . 7 8 6 2
1 . 7 7 1 7
1 . 7 1 5 6
1 . 7 0 6 9
1 . 7 0 2 9
1 . 6 9 5 3
1 . 6 8 8 9
1 . 6 8 1 8
1 . 6 7 4 4
1 . 6 6 8 7
1 . 6 6 2 1
1 . 6 4 1 0
1 . 6 2 9 8
1 . 6 0 1 9
1 . 5 9 4 7
1 . 5 8 6 4
1 . 5 7 6 0
1 . 5 6 7 7
1 . 5 5 7 3
1 . 5 4 6 5
1 . 5 3 9 0
1 . 5 2 8 4
1 . 5 0 5 2
1 . 4 9 4 8
1 . 4 8 5 1
0 . 8 0 1 5
2 . 4 5 0 3
2 . 3 4 5 5
1 . 0 0 0 0
2 . 0 3 4 0
1 . 9 3 6 4
2 . 2 8 1 2
1 . 4 4 6 8
4 . 1 8 4 4
2 . 0 6 8 6
2 . 3 8 1 2
2 . 4 6 9 5
2 . 9 4 6 9



















[ r e l ] 0   2 0   4 0   6 0  
1 7 9 . 8 7 5 5
1 7 9 . 7 1 7 5
1 5 9 . 4 0 8 3
1 5 9 . 3 3 9 4
1 5 9 . 2 3 7 2
1 5 9 . 2 0 1 6
1 3 6 . 4 6 4 0
1 3 6 . 2 9 9 6
1 3 5 . 5 6 8 1
1 3 4 . 9 2 9 4
1 3 0 . 8 5 3 2
1 3 0 . 8 2 3 9
1 3 0 . 7 5 0 4
1 3 0 . 5 9 8 0
1 3 0 . 4 9 5 8
1 2 9 . 9 1 1 7
1 2 9 . 8 3 8 3
1 2 9 . 7 3 8 6
1 2 9 . 6 6 7 1
1 2 9 . 6 1 2 0
1 2 9 . 5 8 4 0
1 2 9 . 4 1 5 6
1 1 9 . 5 6 6 6
1 1 8 . 6 0 6 2
1 1 6 . 9 7 4 4
1 1 3 . 9 6 1 5
1 1 3 . 8 8 7 5
1 1 3 . 8 3 0 3
9 9 . 3 4 2 0
9 8 . 5 9 9 5
9 8 . 4 3 1 8
9 8 . 3 5 8 4
9 8 . 0 8 3 0
9 5 . 0 6 5 2
8 1 . 5 6 8 8
8 1 . 3 7 3 4
8 0 . 0 8 9 1
7 9 . 6 1 4 3
7 9 . 1 5 6 9
7 8 . 8 5 1 8
7 8 . 3 9 0 4
7 8 . 1 5 3 4
7 8 . 1 0 0 0
7 7 . 7 4 7 5
7 2 . 4 4 4 6
7 2 . 0 8 2 2
7 1 . 6 2 2 0
7 1 . 5 7 5 6
7 0 . 3 4 9 7
6 9 . 9 8 3 1
6 3 . 6 1 9 2
6 2 . 7 0 4 0
6 2 . 4 2 4 5
6 2 . 1 5 0 6
6 2 . 0 7 4 9
5 5 . 4 1 4 8
3 1 . 1 3 1 2
3 0 . 8 9 5 9
3 0 . 8 4 0 4
3 0 . 7 6 1 3
3 0 . 6 5 8 0
3 0 . 5 7 6 9
3 0 . 5 1 9 9
3 0 . 4 8 6 3
2 9 . 8 4 5 8
2 6 . 4 3 9 4
2 6 . 0 1 8 4
2 5 . 6 9 0 5
2 5 . 6 3 3 4
2 5 . 5 1 9 1
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F1 − Acquisition parameters
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